
<html lang="en"     class="pb-page"  data-request-id="4341a94a-8334-4e96-a120-a16c4b4a0cb3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm901319p;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-1"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists" /></meta><meta name="dc.Creator" content="Fabrizio  Micheli" /></meta><meta name="dc.Creator" content="Luca  Arista" /></meta><meta name="dc.Creator" content="Giorgio  Bonanomi" /></meta><meta name="dc.Creator" content="Frank E.  Blaney" /></meta><meta name="dc.Creator" content="Simone  Braggio" /></meta><meta name="dc.Creator" content="Anna Maria  Capelli" /></meta><meta name="dc.Creator" content="Anna  Checchia" /></meta><meta name="dc.Creator" content="Federica  Damiani" /></meta><meta name="dc.Creator" content="Romano  Di-Fabio" /></meta><meta name="dc.Creator" content="Stefano  Fontana" /></meta><meta name="dc.Creator" content="Gabriella  Gentile" /></meta><meta name="dc.Creator" content="Cristiana  Griffante" /></meta><meta name="dc.Creator" content="Dieter  Hamprecht" /></meta><meta name="dc.Creator" content="Carla  Marchioro" /></meta><meta name="dc.Creator" content="Manolo  Mugnaini" /></meta><meta name="dc.Creator" content="Jacqui  Piner" /></meta><meta name="dc.Creator" content="Emiliangelo  Ratti" /></meta><meta name="dc.Creator" content="Giovanna  Tedesco" /></meta><meta name="dc.Creator" content="Luca  Tarsi" /></meta><meta name="dc.Creator" content="Silvia  Terreni" /></meta><meta name="dc.Creator" content="Angela  Worby" /></meta><meta name="dc.Creator" content="Charles R.  Ashby, Jr." /></meta><meta name="dc.Creator" content="Christian  Heidbreder" /></meta><meta name="dc.Description" content="The discovery of new highly potent and selective dopamine (DA) D3 receptor antagonists has recently allowed the characterization of the DA D3 receptor in a range of preclinical animal models of dru..." /></meta><meta name="Description" content="The discovery of new highly potent and selective dopamine (DA) D3 receptor antagonists has recently allowed the characterization of the DA D3 receptor in a range of preclinical animal models of dru..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 5, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901319p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901319p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901319p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901319p" /></link>
        
    
    

<title>1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901319p" /></meta><meta property="og:title" content="1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0006.jpeg" /></meta><meta property="og:description" content="The discovery of new highly potent and selective dopamine (DA) D3 receptor antagonists has recently allowed the characterization of the DA D3 receptor in a range of preclinical animal models of drug addiction. A novel series of 1,2,4-triazol-3-yl-azabicyclo[3.1.0]hexanes, members of which showed a high affinity and selectivity for the DA D3 receptor and excellent pharmacokinetic profiles, is reported here. Members of a group of derivatives from this series showed good oral bioavailability and brain penetration and very high in vitro affinity and selectivity for the DA D3 receptor, as well as high in vitro potency for antagonism at this receptor. Several members of this series also significantly attenuate the expression of conditioned place preference (CPP) to nicotine and cocaine." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901319p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901319p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901319p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901319p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901319p&amp;href=/doi/10.1021/jm901319p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 374-391</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9013086" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901421c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D<sub>3</sub> Receptor Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Micheli">Fabrizio Micheli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Arista">Luca Arista</a></span><span class="author-xref-symbol author-aff-symbol"><sup>+</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Bonanomi">Giorgio Bonanomi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank+E.++Blaney">Frank E. Blaney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Braggio">Simone Braggio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna+Maria++Capelli">Anna Maria Capelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Checchia">Anna Checchia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Damiani">Federica Damiani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∧</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romano++Di-Fabio">Romano Di-Fabio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Fontana">Stefano Fontana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriella++Gentile">Gabriella Gentile</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristiana++Griffante">Cristiana Griffante</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Hamprecht">Dieter Hamprecht</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carla++Marchioro">Carla Marchioro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manolo++Mugnaini">Manolo Mugnaini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqui++Piner">Jacqui Piner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emiliangelo++Ratti">Emiliangelo Ratti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Tedesco">Giovanna Tedesco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Tarsi">Luca Tarsi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Terreni">Silvia Terreni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Worby">Angela Worby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+R.++Ashby%2C++Jr.">Charles R. Ashby, Jr.</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Heidbreder">Christian Heidbreder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Neurosciences Centre of Excellence</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Molecular Discovery Research</span></div><div class="aff-info" id="affa"><span class="aff-symbol">§</span> <span class="aff-text"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div><div class="aff-info" id="aff10"><span class="aff-symbol">∥</span> <span class="aff-text">Neurosciences Centre of Excellence</span></div><div class="aff-info" id="aff11"><span class="aff-symbol">⊥</span> <span class="aff-text">Molecular Discovery Research</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Safety Assessment</span></div><div class="aff-info" id="affb"><span class="aff-symbol">▽</span> <span class="aff-text">GlaxoSmithKline Medicines Research Centre, NFSP, Harlow, U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">○</span> <span class="aff-text">Department of Pharmaceutical Sciences, Saint John’s University, Jamaica, New York 11439</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">◆</span> <span class="aff-text">Reckitt Benckiser Pharmaceuticals, Richmond, Virginia 23235</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">¶</span> <span class="aff-text">Boehringer Ingelheim, Milan, Italy</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">+</span> <span class="aff-text">Novartis Institute Research, Basel, Switzerland</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">∧</span> <span class="aff-text">European Patent Office, Munich, Germany</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39-045-8218515. Fax: +39-045-8218196. E-mail: <a href="/cdn-cgi/l/email-protection#0e486f6c7c67746761204b2043676d666b62674e697d65206d6163"><span class="__cf_email__" data-cfemail="f3b59291819a899a9cddb6ddbe9a909b969f9ab3948098dd909c9e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901319p&amp;href=/doi/10.1021%2Fjm901319p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 374–391</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 5, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 September 2009</li><li><span class="item_label"><b>Published</b> online</span>5 November 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901319p" title="DOI URL">https://doi.org/10.1021/jm901319p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D374%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFabrizio%2BMicheli%252C%2BLuca%2BArista%252C%2BGiorgio%2BBonanomi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D1%26contentID%3Djm901319p%26title%3D1%252C2%252C4-Triazolyl%2BAzabicyclo%255B3.1.0%255Dhexanes%253A%2BA%2BNew%2BSeries%2Bof%2BPotent%2Band%2BSelective%2BDopamine%2BD3%2BReceptor%2BAntagonists%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D391%26publicationDate%3DJanuary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901319p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2398</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901319p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Micheli&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Arista&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Bonanomi&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;E. Blaney&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Braggio&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Maria Capelli&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Checchia&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Damiani&quot;},{&quot;first_name&quot;:&quot;Romano&quot;,&quot;last_name&quot;:&quot;Di-Fabio&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Fontana&quot;},{&quot;first_name&quot;:&quot;Gabriella&quot;,&quot;last_name&quot;:&quot;Gentile&quot;},{&quot;first_name&quot;:&quot;Cristiana&quot;,&quot;last_name&quot;:&quot;Griffante&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Hamprecht&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;Marchioro&quot;},{&quot;first_name&quot;:&quot;Manolo&quot;,&quot;last_name&quot;:&quot;Mugnaini&quot;},{&quot;first_name&quot;:&quot;Jacqui&quot;,&quot;last_name&quot;:&quot;Piner&quot;},{&quot;first_name&quot;:&quot;Emiliangelo&quot;,&quot;last_name&quot;:&quot;Ratti&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Tedesco&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Tarsi&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Terreni&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Worby&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;R. Ashby&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Heidbreder&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;374-391&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901319p&quot;},&quot;abstract&quot;:&quot;The discovery of new highly potent and selective dopamine (DA) D3 receptor antagonists has recently allowed the characterization of the DA D3 receptor in a range of preclinical animal models of drug addiction. A novel series of 1,2,4-triazol-3-yl-azabicyclo[3.1.0]hexanes, members of which showed a high affinity and selectivity for the DA D3 receptor and excellent pharmacokinetic profiles, is reported here. Members of a group of derivatives from this series showed good oral bioavailability and brain penetration and very high in vitro affinity and selectivity for the DA D3 receptor, as well as high in vitro potency for antagonism at this receptor. Several members of this series also significantly attenuate the expression of conditioned place preference (CPP) to nicotine and cocaine.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901319p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901319p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901319p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901319p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901319p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901319p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901319p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901319p&amp;href=/doi/10.1021/jm901319p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901319p" /></input><a href="/doi/pdf/10.1021/jm901319p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901319p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901319p%26sid%3Dliteratum%253Aachs%26pmid%3D19891474%26genre%3Darticle%26aulast%3DMicheli%26date%3D2010%26atitle%3D1%252C2%252C4-Triazolyl%2BAzabicyclo%255B3.1.0%255Dhexanes%253A%2BA%2BNew%2BSeries%2Bof%2BPotent%2Band%2BSelective%2BDopamine%2BD3%2BReceptor%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D1%26spage%3D374%26epage%3D391%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291304" title="Organic reactions">Organic reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of new highly potent and selective dopamine (DA) D<sub>3</sub> receptor antagonists has recently allowed the characterization of the DA D<sub>3</sub> receptor in a range of preclinical animal models of drug addiction. A novel series of 1,2,4-triazol-3-yl-azabicyclo[3.1.0]hexanes, members of which showed a high affinity and selectivity for the DA D<sub>3</sub> receptor and excellent pharmacokinetic profiles, is reported here. Members of a group of derivatives from this series showed good oral bioavailability and brain penetration and very high in vitro affinity and selectivity for the DA D<sub>3</sub> receptor, as well as high in vitro potency for antagonism at this receptor. Several members of this series also significantly attenuate the expression of conditioned place preference (CPP) to nicotine and cocaine.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The location of the dopamine (DA<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: BAZ, benzoazepine; CPP, conditioned place preference; ACh, acetylcholine ; hERG, human ether-a go-go K<sup>+</sup> channel; NCE, novel chemical entity; PK, pharmacokinetic; P450, cytochrome P450; hCl<sub>i</sub>, human intrinsic clearance; MW, molecular weight; clogD, calculated logD; PSA, polar surface area; <i>F</i>%, bioavailability; B/B, brain/blood; Cl<sub>b</sub>, blood clearance; <i>V</i><sub>d</sub>, distribution volume; SDM, site-directed mutagenesis; FLIPR, fluorescent imaging plate reader; GPCR, G-protein coupled receptor; TM, trans membrane; SPA, scintillation proximity assay; ECG, electrocardiogram; DA, dopamine; NT, not tested.</p></div>) D<sub>3</sub> receptor in the rodent and human brain, changes in the expression of these receptors upon exposure to drugs of abuse, and a growing body of preclinical evidence in models of substance dependence, suggest that selective DA D<sub>3</sub> receptor antagonists may be a point of therapeutic intervention for substance dependence or abuse [for reviews see refs <a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">1−6</a>]. The observation that selective DA D<sub>3</sub> receptor antagonists regulate the motivation to self-administer drugs and disrupt drug-associated cue-induced craving has contributed in guiding state-of-the-art medicinal chemistry research efforts to develop a highly selective DA D<sub>3</sub> receptor antagonist.</div><div class="NLM_p last">We have recently reported<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> that a series of 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines, which have high in vitro and in vivo selectivity, can significantly attenuate or block the effects of drugs of abuse in a number of animal models of addiction. The aim of the present work is related to the pioneering and original substitution, for this specific thiotriazole series, of the benzoazepine (BAZ) scaffold by a aryl azabicyclo[3.1.0]hexane template that is endowed with promising developability characteristics; a detailed structure activity relationship (SAR) and a series of in vitro and in vivo experiments are provided to characterize this series of highly potent and selective DA D<sub>3</sub> receptor antagonists.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During the past decade, one aspect of GSK research in CNS drug discovery was directed toward the discovery of novel chemical entities (NCEs) that selectively modulate the DA D<sub>3</sub> receptor. The successful result of this work led to the discovery of <i>trans</i>-<i>N</i>-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2yl)ethyl]cyclo-hexyl]-4-quinolinecarboxamide (SB-277011, <b>1</b>)<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(-5, 6)</a> and to the more recent BAZ scaffolds 7-(1,3-dimethyl-1<i>H</i>-pyrazol-5-yl)-3-(3-{[4-methyl-5-(2-methyl-5-quinolinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepine (<b>2</b>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> 2-methyl-7-(3-{[4-methyl-5-(2-methyl-5-quinolinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-6,7,8,9-tetrahydro-5<i>H</i>-[1,3]oxazolo[4,5-<i>h</i>][3]benzazepine (<b>3</b>),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and 8-(3-{[4-methyl-5-(2-methyl-5-quinolinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-2-(trifluoromethyl)-7,8,9,10-tetrahydro-6<i>H</i>-[1,3]oxazolo[4,5-<i>g</i>][3]benzazepine (<b>4</b>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the previously reported GSK selective DA D<sub>3</sub> receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The major step forward from <b>1</b> to the last three BAZ derivatives (<b>2</b>−<b>4</b>) was the introduction into the scaffold of appropriate developability characteristics (i.e., acceptable P450 profile, low intrinsic clearance (Cl<sub>i</sub>), and good bioavailability (<i>F</i>%)) in preclinical species. Furthermore, in contrast to other DA D<sub>3</sub> receptor antagonists,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> derivative <b>2</b> showed a reduced hERG liability in vitro and no prolongation of the QTc interval in vivo.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Given these positive preclinical results, our next goal was to investigate the possibility to achieve a similar preclinical profile using a different template. Accordingly, we planned to explore if, in this specific series of aryl thiotriazoles, the BAZ scaffold could be replaced with an alternative basic moiety.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are several options to approach the potential replacement of a certain portion of a molecule within a given scaffold: it is possible either to use a database of commercial or in house ring systems, to perform literature searches, to rely on de novo design, or to go through a massive combinatorial task replacing the given portion with all the fragments available in a specific store. For this specific thiotriazole system, a mix of all these techniques was used to replace the BAZ moiety, and a number of different structures were identified. Among them, the potential BAZ replacement that is reported in this manuscript is represented by an aryl azabicyclo[3.1.0]hexane moiety. The choice of this original scaffold was based on a number of reasons including the attractive physicochemical characteristics, predicted in silico (namely the polar surface area and the calculated logD) and, despite the associated structural complexity, the possibility to appropriately decorate the pendant aryl ring of the azabicyclo[3.1.0]hexane due to some in house synthetic experience.</div><div class="NLM_p">By exploiting a screening cascade previously reported,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> all the newly prepared compounds were assayed for their agonistic and antagonistic properties using a functional GTPγS assay expressing the human DA D<sub>3</sub> receptor. To proceed with this cascade, the NCEs had to fulfill the following key characteristics: (1) at least 100-fold selectivity vs DA D<sub>2</sub> and histamine H1 receptors (functional assays), and (2) 100-fold selectivity vs the hERG ion channel (dofetilide binding assay). Furthermore, to ensure that the selected templates were endowed with appropriate pharmacokinetic (PK) and developability characteristics from the beginning of the exploration, the NCEs went through generic developability screens such as CYPEX bactosome P450 inhibition and rat and human in vitro clearance in liver microsomes early in the screening cascade.</div><div class="NLM_p">In contrast to the previously described BAZ system,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the aryl azabicyclo[3.1.0]hexane contains two stereogenic centers. Accordingly, both the racemate and each single enantiomer were submitted to test. Compounds were prepared according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Additional information can also be found in refs <a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">10,11</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedures for the Preparation of Compounds <b>5</b>−<b>105</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) T3P in AcOEt; (ii) 4-methyl-3-thiosemicarbazide; (iii) NaOH; (iv) K<sub>2</sub>CO<sub>3</sub>/acetone; (v) K<sub>2</sub>CO<sub>3</sub>/DMF or CH<sub>3</sub>CN.</p></p></figure><div class="NLM_p">The results of the exploration are reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_p">The first compound of the series to be prepared and to be considered the reference point of our exploration was the racemic nonsubstituted phenyl azabicyclo[3.1.0]hexane <b>5</b> and its pure enantiomers <b>6</b> and <b>7</b>, respectively. This is usually an important step in generating SAR to fully appreciate the role of the substituents that will decorate a system, although the unsubstituted systems might sometime behave differently from the decorated ones. In this specific case, derivative <b>7</b> not only showed a similar potency at the DA D<sub>3</sub> receptor compared to derivative <b>1</b> but also had a 40-fold selectivity over the DA D<sub>2</sub> receptor. These results suggested that the working hypothesis might be correct and constituted a good starting point for further exploration. Interestingly enough, but not unexpectedly, a difference in affinity at the DA D<sub>3</sub> receptor was also noticed in the two enantiomers. The docking<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> of derivative <b>2</b> in the DA D<sub>3</sub> receptor model seemed to suggest the need for a lipophilic area in the region where the BAZ sits and the presence of some specific interactions with the hydrophilic pyrazole substituent (close to S182 and S192). For that reason, the meta/para position of the pendant aromatic ring on the azabicyclo[3.1.0]hexane was appropriately explored, and the results are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The 3,4-dichloro substitution (<b>8</b>−<b>10</b>) increased the lipophilicity to 5.2 without leading to an increased potency at the desired target, while the bulkier 4-<i>t</i>-butyl derivative (<b>11</b>−<b>13</b>, clogD = 5.4) increased the potency at D<sub>3</sub> and selectivity over the DA D<sub>2</sub> receptor (400-fold). This observation might result from the steric clash with some residues in the DA D<sub>3</sub> receptor of the substituents in position 3 and 4 of the aryl ring with respect to the single 4-substitution, even if the binding pocket in the receptor model appeared to be rather tolerant. A reduction of steric hindrance and clogD was achieved with the bromo derivatives (<b>14</b>−<b>16</b>, clogD = 4.5) and with the chloro derivatives (<b>21</b>−<b>23</b>, clogD = 4.3) without affecting significantly the affinity at the desired target. The introduction of the highly polar and hydrophilic cyano derivative <b>17</b> led to a reduction in affinity at the desired target with limited effect on hERG affinity. The electron-donating properties of the methoxy derivatives (<b>18</b>−<b>20</b>) did not seem to have a major influence on the affinity in this series. The highest potency and selectivity at the desired target (>1000 fold over DA D<sub>2</sub> receptor and >100 over H1 and hERG targets) were achieved with the p-CF<sub>3</sub> derivative <b>24</b>. This derivative was also endowed with a promising in vitro PK profile (inhibition on all P450 isoforms >1 μM and relatively low hCl<sub>i</sub>, namely 1.1 mL/min/g liver). In this specific series, the higher affinity achieved at the DA D<sub>3</sub> receptor was linked to one specific isomer, which was characterized as the enantiomer endowed with the (1<i>S</i>,5<i>R)</i> absolute stereochemistry. This attribution was achieved both through vibrational circular dichroism (VCD) and X-ray techniques; further and more specific details on this topic will be the subject of a separate analytical communication. Once completed, this first and very preliminary investigation of the left-hand side part of the molecule was followed by an introductory exploration of the right-hand side of the thiotriazole portion of the template. Considering the overall activity shown by the substituents reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> on the aryl system, the trifluoromethyl group was kept as the reference point, and the single (1<i>S</i>,5<i>R</i>)-[3.1.0]hexane enantiomer was chosen for the exploration; nonetheless, to confirm the validity of the working hypothesis associated to the stereochemistry of the compound, one of the derivatives was prepared as a racemate; the single enantiomers were subsequently separated and were both independently evaluated for their biological activity. The results of this exploration are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The regioisomeric quinoline <b>25</b> showed an increase in potency and a slightly reduced hERG activity; the introduction of more basic/hydrophilic substituents (<b>27</b>−<b>34</b>) led to a general slight reduction of activity both at the hERG and at the DA D<sub>3</sub> receptor, leading to a more balanced profile. Derivatives <b>27</b> and <b>28</b> showed low hERG affinity with a well-adjusted profile which included good in vitro PK properties (inhibition on all P450 isoforms was >10 μM for both derivatives and their hCl<sub>i</sub> was respectively 1.7 and 1.0 mL/min/g liver); therefore, both derivatives were further progressed to assess their in vivo PK properties in preclinical species.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> After oral administration, they both showed moderate Cl<sub>b</sub> in rats (18 and 13 mL/min/kg, respectively), identical half-life (<i>T</i><sub>1/2</sub> = 2.1 h), similar distribution volumes (<i>V</i><sub>d</sub> = 2.5 and 2.2 L/kg, respectively), and almost identical bioavailability (<i>F</i>% = 50 and 46%, respectively); the brain penetration values were also comparable (B/B = 1.6 and 2, respectively), making them ideal candidates for further progression.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Activity at the Human DA D<sub>3</sub> Receptor and Selectivity for Quinolinyl Derivatives<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">R</th><th align="center" char=".">hD<sub>3</sub>-GTPγS fp<i>K</i><sub>i</sub></th><th align="center" char=".">hD<sub>2</sub>-GTPγS fp<i>K</i><sub>i</sub></th><th align="center">hH<sub>1</sub>-FLIPR pKb</th><th align="center" char=".">hERG pIC<sub>50</sub></th><th align="center" char=".">PSA<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th align="center" char=".">cLogD<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">not applicable</td><td align="char" char=".">8.4</td><td align="char" char=".">6.4</td><td align="left">6.2</td><td align="char" char=".">5.7</td><td align="char" char=".">69</td><td align="char" char=".">3.8</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">not applicable</td><td align="char" char=".">8.8</td><td align="char" char=".">6.5</td><td align="left">6.1</td><td align="char" char=".">5.7</td><td align="char" char=".">65</td><td align="char" char=".">5.3</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">not applicable</td><td align="char" char=".">7.2</td><td align="char" char="."><5.6</td><td align="left"><5.6</td><td align="char" char="."><5.0</td><td align="char" char=".">98</td><td align="char" char=".">5.0</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">not applicable</td><td align="char" char=".">8.4</td><td align="char" char="."><6.1</td><td align="left">6.3</td><td align="char" char=".">5.7</td><td align="char" char=".">73</td><td align="char" char=".">6.3</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">H (rac)</td><td align="char" char=".">7.6</td><td align="char" char=".">6.8</td><td align="left">7.3</td><td align="char" char=".">5.7</td><td align="char" char=".">47</td><td align="char" char=".">3.4</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">H (se)</td><td align="char" char="."><6.3</td><td align="char" char="."><5.5</td><td align="left">7.2</td><td align="char" char=".">5.3</td><td align="char" char=".">47</td><td align="char" char=".">3.4</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">H (se)</td><td align="char" char=".">8.3</td><td align="char" char=".">6.7</td><td align="left">NT</td><td align="char" char=".">6.1</td><td align="char" char=".">47</td><td align="char" char=".">3.4</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">3,4-diCl (rac)</td><td align="char" char=".">7.9</td><td align="char" char=".">5.3</td><td align="left">7.3</td><td align="char" char=".">6.2</td><td align="char" char=".">47</td><td align="char" char=".">5.2</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">3,4-diCl (se)</td><td align="char" char=".">7.4</td><td align="char" char=".">6.4</td><td align="left">7.2</td><td align="char" char=".">5.8</td><td align="char" char=".">47</td><td align="char" char=".">5.2</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">3,4-diCl (se)</td><td align="char" char=".">6.8</td><td align="char" char=".">5.9</td><td align="left">7.5</td><td align="char" char=".">6.0</td><td align="char" char=".">47</td><td align="char" char=".">5.2</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">4-<i>t</i>-Bu (rac)</td><td align="char" char=".">8.8</td><td align="char" char=".">6.5</td><td align="left">5.8</td><td align="char" char=".">6.6</td><td align="char" char=".">47</td><td align="char" char=".">5.4</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">4-<i>t</i>-Bu (se)</td><td align="char" char=".">7.7</td><td align="char" char=".">5.7</td><td align="left">NT</td><td align="char" char=".">6.6</td><td align="char" char=".">47</td><td align="char" char=".">5.4</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left">4-<i>t</i>-Bu (se)</td><td align="char" char=".">8.7</td><td align="char" char=".">6.1</td><td align="left">NT</td><td align="char" char=".">6.6</td><td align="char" char=".">47</td><td align="char" char=".">5.4</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">4-Br (rac)</td><td align="char" char=".">8.4</td><td align="char" char=".">5.4</td><td align="left">7.7</td><td align="char" char=".">6.9</td><td align="char" char=".">47</td><td align="char" char=".">4.5</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">4-Br (se)</td><td align="char" char="."><6.3</td><td align="char" char="."><6.1</td><td align="left">7.0</td><td align="char" char=".">6.3</td><td align="char" char=".">47</td><td align="char" char=".">4.5</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left">4-Br (se)</td><td align="char" char=".">8.9</td><td align="char" char="."><6.1</td><td align="left">6.6</td><td align="char" char=".">6.6</td><td align="char" char=".">47</td><td align="char" char=".">4.5</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="left">4-CN (rac)</td><td align="char" char=".">7.5</td><td align="char" char=".">5.2</td><td align="left">7.3</td><td align="char" char=".">6.2</td><td align="char" char=".">71</td><td align="char" char=".">3.1</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left">4-OMe (rac)</td><td align="char" char=".">8.2</td><td align="char" char=".">5.9</td><td align="left">7.4</td><td align="char" char=".">6.2</td><td align="char" char=".">56</td><td align="char" char=".">3.5</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">4-OMe (se)</td><td align="char" char=".">8.9</td><td align="char" char="."><6.4</td><td align="left">7.5</td><td align="char" char=".">6.2</td><td align="char" char=".">56</td><td align="char" char=".">3.5</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">4-OMe (se)</td><td align="char" char=".">7.5</td><td align="char" char=".">5.9</td><td align="left">6.6</td><td align="char" char=".">5.6</td><td align="char" char=".">56</td><td align="char" char=".">3.5</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">4-Cl (rac)</td><td align="char" char=".">8.2</td><td align="char" char="."><6.2</td><td align="left">6.0</td><td align="char" char=".">6.7</td><td align="char" char=".">47</td><td align="char" char=".">4.3</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">4-Cl (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">6.7</td><td align="left">6.3</td><td align="char" char=".">5.8</td><td align="char" char=".">47</td><td align="char" char=".">4.3</td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">4-Cl (se)</td><td align="char" char=".">7.4</td><td align="char" char=".">6.1</td><td align="left">7.8</td><td align="char" char=".">5.7</td><td align="char" char=".">47</td><td align="char" char=".">4.3</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">4-CF<sub>3</sub> (rac)</td><td align="char" char=".">9.1</td><td align="char" char="."><5.9</td><td align="left">6.8</td><td align="char" char=".">6.8</td><td align="char" char=".">47</td><td align="char" char=".">4.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">fp<i>K</i><sub>i</sub> = functional p<i>K</i><sub>i</sub> obtained from the GTPγS functional assay. FLIPR = fluorescent imaging plate reader. SEM for D<sub>3</sub> GTPγS, H1 FLIPR, and HERG data sets is ±0.1 and for the D<sub>2</sub> GTPγS data is ±0.2. (rac) = racemate. (se) = single enantiomer.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Å̂<sup>2</sup>.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">ACD logD 7.4. version 11.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Activity at the Human DA D<sub>3</sub> Receptor and Selectivity for 4-Trifluoromethyl Derivatives<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">R</th><th align="center" char=".">hD<sub>3</sub>-GTPγS fp<i>K</i><sub>i</sub></th><th align="center" char=".">hD<sub>2</sub>-GTPγS fp<i>K</i><sub>i</sub></th><th align="center" char=".">hH<sub>1</sub>-FLIPR pKb</th><th align="center" char=".">hERG pIC<sub>50</sub></th><th align="center" char=".">PSA<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th align="center" char=".">cLogD<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>25</b></td><td align="left">2-methyl-6-quinolinyl (se)</td><td align="char" char=".">9.6</td><td align="char" char=".">6.2</td><td align="char" char=".">7.3</td><td align="char" char=".">6.3</td><td align="char" char=".">47</td><td align="char" char=".">4.5</td></tr><tr valign="top"><td align="left"><b>26</b></td><td align="left">phenyl (se)</td><td align="char" char=".">9.2</td><td align="char" char=".">6.8</td><td align="char" char=".">7.4</td><td align="char" char=".">6.2</td><td align="char" char=".">34</td><td align="char" char=".">4.1</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">2-methyl-3-pyridinyl (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">6.5</td><td align="char" char=".">6.9</td><td align="char" char=".">5.3</td><td align="char" char=".">47</td><td align="char" char=".">3.1</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">4-pyridazinyl (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">6.7</td><td align="char" char=".">7.0</td><td align="char" char=".">5.4</td><td align="char" char=".">60</td><td align="char" char=".">1.4</td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="left">5-pyrimidinyl (se)</td><td align="char" char=".">8.8</td><td align="char" char="."><6.0</td><td align="char" char=".">7.3</td><td align="char" char=".">5.5</td><td align="char" char=".">60</td><td align="char" char=".">2.1</td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left">3-methyl-2-furanyl (se)</td><td align="char" char=".">9.3</td><td align="char" char=".">6.4</td><td align="char" char=".">7.1</td><td align="char" char=".">6.7</td><td align="char" char=".">47</td><td align="char" char=".">3.9</td></tr><tr valign="top"><td align="left"><b>31</b></td><td align="left">6-methyl-3-pyridinyl (se)</td><td align="char" char=".">9.1</td><td align="char" char=".">6.2</td><td align="char" char=".">7.1</td><td align="char" char=".">6.1</td><td align="char" char=".">47</td><td align="char" char=".">2.7</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left">2,4-dimethyl-1,3-thiazol-5-yl (se)</td><td align="char" char=".">9.6</td><td align="char" char=".">6.6</td><td align="char" char=".">7.4</td><td align="char" char=".">5.7</td><td align="char" char=".">47</td><td align="char" char=".">2.1</td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left">5-methyl-2-pyrazinyl (se)</td><td align="char" char=".">9.2</td><td align="char" char=".">6.3</td><td align="char" char=".">7.2</td><td align="char" char=".">6.1</td><td align="char" char=".">60</td><td align="char" char=".">2.6</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left">4-methyl-1,3-oxazol-5-yl (rac)</td><td align="char" char=".">9.3</td><td align="char" char=".">6.9</td><td align="char" char=".">7.4</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.1</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left">4-methyl-1,3-oxazol-5-yl (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">7.0</td><td align="char" char=".">7.5</td><td align="char" char=".">6.1</td><td align="char" char=".">60</td><td align="char" char=".">2.1</td></tr><tr valign="top"><td align="left"><b>36</b></td><td align="left">4-methyl-1,3-oxazol-5-yl (se)</td><td align="char" char=".">7.3</td><td align="char" char="."><6.1</td><td align="char" char=".">7.5</td><td align="char" char=".">6.2</td><td align="char" char=".">60</td><td align="char" char=".">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">fp<i>K</i><sub>i</sub> = functional p<i>K</i><sub>i</sub> obtained from the GTPγS functional assay. FLIPR = fluorescent imaging plate reader. SEM for D<sub>3</sub> GTPγS, H1 FLIPR, and HERG data sets is ±0.1 and for the D<sub>2</sub> GTPγS data is ±0.2.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">Å̂<sup>2</sup>.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last">ACD logD 7.4. version 11.</p></div></div></div><div class="NLM_p">Derivatives <b>32</b> and <b>34</b> also showed excellent in vitro properties considering both their affinity/selectivity values and their PK profile; accordingly, they also underwent in vivo PK evaluation in rats. The thiazolyl derivative <b>32</b> showed an overall good PK profile after oral administration with a moderate Cl<sub>b</sub> (26 mL/min/kg), a half-life value (<i>T</i><sub>1/2</sub> = 2.0 h) comparable to that of previously analyzed derivatives, a moderate distribution volume (<i>V</i><sub>d</sub> = 3.9 L/kg), a moderate bioavailability (<i>F</i>% = 23%), and a good brain penetration (B/B = 2.2). The oxazolyl derivative <b>34</b> showed a low Cl<sub>b</sub> (14 mL/min/kg), a comparable half-life (<i>T</i><sub>1/2</sub> = 3.2 h), a similar distribution volume (<i>V</i><sub>d</sub> = 3.5 L/kg), and superior bioavailability and brain penetration (<i>F</i>% = 85% and B/B = 3.6, respectively).</div><div class="NLM_p">The (1<i>S</i>,5<i>R</i>) derivative <b>35</b>, in agreement with the working plan, was the product endowed with the highest affinity at the DA D<sub>3</sub> receptor and was therefore further characterized as single enantiomer: its in vitro and in vivo PK profiles fully matched the results already observed with the racemic derivative <b>34</b>. Considering their general profile and the good selectivity window achieved, these results led to a further characterization of all these products in the screening cascade as described below.</div><div class="NLM_p">At this point of the exploration, despite the identification of a number of potentially interesting compounds to be fully characterized along the screening cascade, a second SAR expansion of the left-hand side was carried out. In this further iteration, the newly identified heteroaromatic systems were maintained on the right-hand side of the molecule, whereas a computational strategy was applied as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> It was noticed that, in the previous BAZ template, the key elements responsible for the activity of the molecule at the DA D<sub>3</sub> receptor were also responsible for the activity within the hERG channel. At that time, the visualization within the DA D<sub>3</sub> receptor model and within the hERG channel model of the amino acid residues interacting with specific regions of the molecule allowed the rational design of the best substituents able to maximize the window between these two affinities. Briefly, both the DA D<sub>3</sub> receptor (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) and the hERG channel model<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) were used to dock the compounds and to assess the substituents that maintain the specific interactions in the DA D<sub>3</sub> model (namely the salt bridge between the basic nitrogen and Asp110 on transmembrane helix 3 (TM3), the interaction with Ser192 (TM5) and Ser182 (second extracellular loop), and the potential π-stacking interactions with Phe345 and His349 (TM6)). At the same time, those appropriately identified substituents should be able to disrupt the interactions of the molecule within the hERG channel (namely the specific interactions with Tyr652 and Phe656 in the S6 helices and the ones in the pore turn region of the channel model), particularly by reducing their aromatic π interactions.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Relevant interactions of derivative <b>35</b> in docking to the DA D<sub>3</sub> receptor model. Portions of the backbone ribbon has been removed for clarity. (B) Interactions of compound <b>35</b> in the hERG channel models. The backbone ribbon of the pore domain is included but that of the S5 and S6 helices has been removed for clarity. For details about the modeling techniques, please refer to ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">7</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is worth noting that the DA D<sub>3</sub> receptor model can explain the DA D<sub>3</sub>/D<sub>2</sub> selectivity of these compounds because of the hydrogen bond between the triazole ring and Thr368. The corresponding residue in the DA D<sub>2</sub> receptor is a phenylalanine (Phe), which would be expected to cause a severe steric clash with these ligands.</div><div class="NLM_p">In the current exploration, in addition to the decorations of the aryl group identified from the modeling work mentioned above, a further selection of substituents with different physicochemical properties was also included to probe the SAR for this series.</div><div class="NLM_p">Among the different right-hand side heteroaromatic derivatives reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and used in this exploration, we would like to report here the results achieved with the oxazolyl moiety present in derivative <b>35</b>. These results are tabulated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The derivatives were synthesized and tested both as racemates and single enantiomers to verify if the “favorite” stereochemistry previously identified to achieve the higher affinity on the DA D<sub>3</sub> receptor (i.e., the (1<i>S</i>,5<i>R</i>) stereochemistry) was specific only for that thiotriazole subseries series or might have had a wider application in this specific series of aryl [3.1.0] thiotriazoles.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Activity at the Human DA D<sub>3</sub> Receptor and Selectivity for 5-Oxazolyl Derivatives<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0001.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">R</th><th align="center" char=".">hD<sub>3</sub>-GTPγS fp<i>K</i><sub>i</sub></th><th align="center" char=".">hD<sub>2</sub>-GTPγS fp<i>K</i><sub>i</sub></th><th align="center" char=".">hH<sub>1</sub>-FLIPR pKb</th><th align="center" char=".">hERG pIC<sub>50</sub></th><th align="center" char=".">PSA<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th align="center" char=".">cLogD<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>37</b></td><td align="left">phenyl (rac)</td><td align="char" char=".">7.9</td><td align="char" char=".">6.7</td><td align="char" char=".">6.8</td><td align="char" char=".">5.8</td><td align="char" char=".">60</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="left">4-<i>t</i>-Bu (rac)</td><td align="char" char=".">9.1</td><td align="char" char=".">7.1</td><td align="char" char="."><5.6</td><td align="char" char=".">6.2</td><td align="char" char=".">60</td><td align="char" char=".">3.0</td></tr><tr valign="top"><td align="left"><b>39</b></td><td align="left">4-<i>t</i>-Bu (se)</td><td align="char" char=".">8.5</td><td align="char" char="."><6.0</td><td align="char" char=".">6.6</td><td align="char" char=".">6.4</td><td align="char" char=".">60</td><td align="char" char=".">3.0</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="left">4-<i>t</i>-Bu (se)</td><td align="char" char=".">9.5</td><td align="char" char=".">7.1</td><td align="char" char=".">6.3</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">3.0</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left">4-Br (rac)</td><td align="char" char=".">8.7</td><td align="char" char=".">6.9</td><td align="char" char=".">7.9</td><td align="char" char=".">6.4</td><td align="char" char=".">60</td><td align="char" char=".">2.2</td></tr><tr valign="top"><td align="left"><b>42</b></td><td align="left">4-Br (se)</td><td align="char" char=".">9.4</td><td align="char" char=".">6.9</td><td align="char" char=".">8.1</td><td align="char" char=".">6.3</td><td align="char" char=".">60</td><td align="char" char=".">2.2</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="left">4-Br (se)</td><td align="char" char=".">6.4</td><td align="char" char="."><5.9</td><td align="char" char=".">6.0</td><td align="char" char=".">6.1</td><td align="char" char=".">60</td><td align="char" char=".">2.2</td></tr><tr valign="top"><td align="left"><b>44</b></td><td align="left">4-OMe (rac)</td><td align="char" char=".">8.3</td><td align="char" char=".">6.9</td><td align="char" char="."><5.5</td><td align="char" char=".">5.9</td><td align="char" char=".">69</td><td align="char" char=".">1.1</td></tr><tr valign="top"><td align="left"><b>45</b></td><td align="left">4-OMe (se)</td><td align="char" char=".">8.7</td><td align="char" char=".">6.6</td><td align="char" char=".">6.0</td><td align="char" char=".">5.7</td><td align="char" char=".">69</td><td align="char" char=".">1.1</td></tr><tr valign="top"><td align="left"><b>46</b></td><td align="left">4-OMe (se)</td><td align="char" char=".">7.0</td><td align="char" char="."><5.8</td><td align="char" char=".">6.0</td><td align="char" char=".">5.6</td><td align="char" char=".">69</td><td align="char" char=".">1.1</td></tr><tr valign="top"><td align="left"><b>47</b></td><td align="left">3-OMe (rac)</td><td align="char" char=".">8.1</td><td align="char" char=".">6.3</td><td align="char" char=".">6.3</td><td align="char" char=".">5.8</td><td align="char" char=".">69</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>48</b></td><td align="left">3-OMe (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">7.0</td><td align="char" char=".">6.6</td><td align="char" char=".">5.4</td><td align="char" char=".">69</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>49</b></td><td align="left">3-OMe (se)</td><td align="char" char=".">6.6</td><td align="char" char="."><6.4</td><td align="char" char="."><5.5</td><td align="char" char=".">5.2</td><td align="char" char=".">69</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>50</b></td><td align="left">4-Cl (rac)</td><td align="char" char=".">8.9</td><td align="char" char=".">6.5</td><td align="char" char=".">6.4</td><td align="char" char=".">6.1</td><td align="char" char=".">60</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>51</b></td><td align="left">4-Cl (se)</td><td align="char" char=".">9.4</td><td align="char" char=".">6.8</td><td align="char" char=".">7.2</td><td align="char" char=".">6.4</td><td align="char" char=".">60</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>52</b></td><td align="left">4-Cl (se)</td><td align="char" char=".">6.3</td><td align="char" char="."><6.2</td><td align="char" char=".">8.0</td><td align="char" char=".">6.1</td><td align="char" char=".">60</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>53</b></td><td align="left">3-Cl (rac)</td><td align="char" char=".">8.3</td><td align="char" char=".">7.0</td><td align="char" char=".">6.9</td><td align="char" char=".">5.8</td><td align="char" char=".">60</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>54</b></td><td align="left">3-Cl (se)</td><td align="char" char=".">9.1</td><td align="char" char=".">7.3</td><td align="char" char=".">7.2</td><td align="char" char=".">6.5</td><td align="char" char=".">60</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>55</b></td><td align="left">3-Cl (se)</td><td align="char" char=".">7.9</td><td align="char" char=".">6.3</td><td align="char" char=".">6.5</td><td align="char" char=".">5.9</td><td align="char" char=".">60</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>56</b></td><td align="left">4-F (rac)</td><td align="char" char=".">8.2</td><td align="char" char=".">6.3</td><td align="char" char=".">7.8</td><td align="char" char=".">5.7</td><td align="char" char=".">60</td><td align="char" char=".">1.3</td></tr><tr valign="top"><td align="left"><b>57</b></td><td align="left">4-F (se)</td><td align="char" char=".">8.1</td><td align="char" char=".">6.4</td><td align="char" char=".">6.6</td><td align="char" char=".">6.5</td><td align="char" char=".">60</td><td align="char" char=".">1.3</td></tr><tr valign="top"><td align="left"><b>58</b></td><td align="left">4-F (se)</td><td align="char" char=".">6.3</td><td align="char" char=".">6.5</td><td align="char" char=".">7.7</td><td align="char" char=".">5.7</td><td align="char" char=".">60</td><td align="char" char=".">1.3</td></tr><tr valign="top"><td align="left"><b>59</b></td><td align="left">3-F (rac)</td><td align="char" char=".">8.3</td><td align="char" char=".">6.7</td><td align="char" char=".">7.4</td><td align="char" char=".">5.7</td><td align="char" char=".">60</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>60</b></td><td align="left">3-F (se)</td><td align="char" char=".">8.3</td><td align="char" char=".">6.8</td><td align="char" char=".">6.7</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>61</b></td><td align="left">3-F (se)</td><td align="char" char=".">6.4</td><td align="char" char="."><6.2</td><td align="char" char=".">6.1</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>62</b></td><td align="left">3-CF<sub>3</sub> (rac)</td><td align="char" char=".">9.3</td><td align="char" char=".">7.5</td><td align="char" char=".">5.6</td><td align="char" char=".">5.5</td><td align="char" char=".">60</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"><b>63</b></td><td align="left">3-CF<sub>3</sub> (se)</td><td align="char" char=".">9.3</td><td align="char" char=".">7.5</td><td align="char" char=".">6.2</td><td align="char" char=".">5.1</td><td align="char" char=".">60</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"><b>64</b></td><td align="left">3-CF<sub>3</sub> (se)</td><td align="char" char=".">7.8</td><td align="char" char="."><6.4</td><td align="char" char=".">7.1</td><td align="char" char=".">5.6</td><td align="char" char=".">60</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"><b>65</b></td><td align="left">2-CF<sub>3</sub> (rac)</td><td align="char" char=".">7.5</td><td align="char" char="."><6.1</td><td align="char" char=".">6.1</td><td align="char" char=".">5.2</td><td align="char" char=".">60</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>66</b></td><td align="left">4-OCF<sub>3</sub> (rac)</td><td align="char" char=".">8.7</td><td align="char" char="."><6.4</td><td align="char" char=".">7.4</td><td align="char" char=".">6.7</td><td align="char" char=".">69</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>67</b></td><td align="left">4-OCF<sub>3</sub> (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">6.8</td><td align="char" char=".">6.1</td><td align="char" char=".">6.6</td><td align="char" char=".">69</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>68</b></td><td align="left">4-OCF<sub>3</sub> (se)</td><td align="char" char=".">7.3</td><td align="char" char=".">6.0</td><td align="char" char=".">6.5</td><td align="char" char=".">6.5</td><td align="char" char=".">69</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>69</b></td><td align="left">3,4-diCl (rac)</td><td align="char" char=".">8.5</td><td align="char" char=".">7.9</td><td align="char" char=".">7.1</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>70</b></td><td align="left">3,4-diCl (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">7.5</td><td align="char" char=".">6.3</td><td align="char" char=".">6.3</td><td align="char" char=".">60</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>71</b></td><td align="left">3,4-diCl (se)</td><td align="char" char=".">7.6</td><td align="char" char=".">5.8</td><td align="char" char=".">7.9</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>72</b></td><td align="left">2-F, 4-CF<sub>3</sub> (rac)</td><td align="char" char=".">8.8</td><td align="char" char=".">6.6</td><td align="char" char="."><5.5</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.9</td></tr><tr valign="top"><td align="left"><b>73</b></td><td align="left">2-F, 4-CF<sub>3</sub> (se)</td><td align="char" char=".">6.9</td><td align="char" char="."><6.2</td><td align="char" char=".">6.3</td><td align="char" char=".">6.3</td><td align="char" char=".">60</td><td align="char" char=".">2.9</td></tr><tr valign="top"><td align="left"><b>74</b></td><td align="left">2-F, 4-CF<sub>3</sub> (se)</td><td align="char" char=".">8.9</td><td align="char" char=".">6.2</td><td align="char" char=".">5.7</td><td align="char" char=".">6.1</td><td align="char" char=".">60</td><td align="char" char=".">2.9</td></tr><tr valign="top"><td align="left"><b>75</b></td><td align="left">2-Me, 4-CF<sub>3</sub> (rac)</td><td align="char" char=".">7.0</td><td align="char" char="."><6.0</td><td align="char" char=".">6.0</td><td align="char" char=".">6.4</td><td align="char" char=".">60</td><td align="char" char=".">2.6</td></tr><tr valign="top"><td align="left"><b>76</b></td><td align="left">3-CF<sub>3</sub>, 4-F (rac)</td><td align="char" char=".">8.9</td><td align="char" char=".">7.0</td><td align="char" char=".">6.3</td><td align="char" char=".">5.7</td><td align="char" char=".">60</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="left"><b>77</b></td><td align="left">3-CF<sub>3</sub>, 4-F (se)</td><td align="char" char=".">9.6</td><td align="char" char=".">7.5</td><td align="char" char=".">6.4</td><td align="char" char=".">5.6</td><td align="char" char=".">60</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="left"><b>78</b></td><td align="left">3-CF<sub>3</sub>, 4-F (se)</td><td align="char" char=".">7.1</td><td align="char" char=".">6.0</td><td align="char" char=".">6.6</td><td align="char" char=".">6.3</td><td align="char" char=".">60</td><td align="char" char=".">2.5</td></tr><tr valign="top"><td align="left"><b>79</b></td><td align="left">2-F, 5-CF<sub>3</sub> (rac)</td><td align="char" char=".">8.8</td><td align="char" char=".">6.1</td><td align="char" char=".">7.3</td><td align="char" char=".">5.9</td><td align="char" char=".">60</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>80</b></td><td align="left">2-F, 5-CF<sub>3</sub> (se)</td><td align="char" char=".">6.9</td><td align="char" char="."><6.1</td><td align="char" char="."><5.7</td><td align="char" char=".">5.4</td><td align="char" char=".">60</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>81</b></td><td align="left">2-F, 5-CF<sub>3</sub> (se)</td><td align="char" char=".">8.4</td><td align="char" char=".">6.8</td><td align="char" char="."><5.5</td><td align="char" char=".">5.0</td><td align="char" char=".">60</td><td align="char" char=".">2.4</td></tr><tr valign="top"><td align="left"><b>82</b></td><td align="left">2-F, 3-CF<sub>3</sub> (rac)</td><td align="char" char=".">9.1</td><td align="char" char=".">6.9</td><td align="char" char=".">6.5</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>83</b></td><td align="left">2-F, 3-CF<sub>3</sub> (se)</td><td align="char" char=".">7.2</td><td align="char" char=".">6.6</td><td align="char" char=".">6.5</td><td align="char" char=".">5.5</td><td align="char" char=".">60</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>84</b></td><td align="left">2-F, 3-CF<sub>3</sub> (se)</td><td align="char" char=".">8.9</td><td align="char" char=".">7.2</td><td align="char" char=".">6.2</td><td align="char" char=".">5.4</td><td align="char" char=".">60</td><td align="char" char=".">2.8</td></tr><tr valign="top"><td align="left"><b>85</b></td><td align="left">3-F, 4-CF<sub>3</sub> (rac)</td><td align="char" char=".">9.2</td><td align="char" char=".">6.2</td><td align="char" char=".">5.8</td><td align="char" char=".">6.4</td><td align="char" char=".">60</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>86</b></td><td align="left">3-F, 4-CF<sub>3</sub> (se)</td><td align="char" char=".">9.3</td><td align="char" char=".">7.1</td><td align="char" char=".">6.7</td><td align="char" char=".">6.2</td><td align="char" char=".">60</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>87</b></td><td align="left">3-F, 4-CF<sub>3</sub> (se)</td><td align="char" char=".">6.7</td><td align="char" char="."><6.2</td><td align="char" char=".">7.3</td><td align="char" char=".">6.2</td><td align="char" char=".">60</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>88</b></td><td align="left">3-F, 5-CF<sub>3</sub> (rac)</td><td align="char" char=".">9.2</td><td align="char" char=".">7.5</td><td align="char" char=".">7.2</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"><b>89</b></td><td align="left">3-F, 5-CF<sub>3</sub> (se)</td><td align="char" char=".">9.1</td><td align="char" char=".">7.9</td><td align="char" char=".">NT</td><td align="char" char=".">5.7</td><td align="char" char=".">60</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"><b>90</b></td><td align="left">3-F, 5-CF<sub>3</sub> (se)</td><td align="char" char=".">7.6</td><td align="char" char="."><6.4</td><td align="char" char=".">7.1</td><td align="char" char=".">5.7</td><td align="char" char=".">60</td><td align="char" char=".">1.8</td></tr><tr valign="top"><td align="left"><b>91</b></td><td align="left">2-F, 4-Me (rac)</td><td align="char" char=".">7.1</td><td align="char" char="."><6.2</td><td align="char" char=".">6.1</td><td align="char" char=".">5.2</td><td align="char" char=".">60</td><td align="char" char=".">2.0</td></tr><tr valign="top"><td align="left"><b>92</b></td><td align="left">2-F, 4-Me (se)</td><td align="char" char="."><6.2</td><td align="char" char="."><6.1</td><td align="char" char=".">5.6</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.0</td></tr><tr valign="top"><td align="left"><b>93</b></td><td align="left">2-F, 4-Me (se)</td><td align="char" char=".">8.0</td><td align="char" char=".">6.2</td><td align="char" char=".">6.5</td><td align="char" char=".">4.4</td><td align="char" char=".">60</td><td align="char" char=".">2.0</td></tr><tr valign="top"><td align="left"><b>94</b></td><td align="left">2-F, 4-Cl (rac)</td><td align="char" char=".">8.2</td><td align="char" char="."><6.2</td><td align="char" char=".">7.3</td><td align="char" char=".">6.3</td><td align="char" char=".">60</td><td align="char" char=".">2.7</td></tr><tr valign="top"><td align="left"><b>95</b></td><td align="left">2-F, 4-Cl (se)</td><td align="char" char=".">6.5</td><td align="char" char="."><6.1</td><td align="char" char=".">5.5</td><td align="char" char=".">6.0</td><td align="char" char=".">60</td><td align="char" char=".">2.7</td></tr><tr valign="top"><td align="left"><b>96</b></td><td align="left">2-F, 4-Cl (se)</td><td align="char" char=".">8.6</td><td align="char" char=".">6.5</td><td align="char" char=".">7.2</td><td align="char" char=".">6.4</td><td align="char" char=".">60</td><td align="char" char=".">2.7</td></tr><tr valign="top"><td align="left"><b>97</b></td><td align="left">3-CF<sub>3</sub>, 4-OMe (rac)</td><td align="char" char=".">8.9</td><td align="char" char=".">6.8</td><td align="char" char=".">7.0</td><td align="char" char=".">5.9</td><td align="char" char=".">69</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>98</b></td><td align="left">3-CF<sub>3</sub>, 4-OMe (se)</td><td align="char" char=".">6.7</td><td align="char" char="."><6.3</td><td align="char" char="."><5.6</td><td align="char" char=".">5.9</td><td align="char" char=".">69</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>99</b></td><td align="left">3-CF<sub>3</sub>, 4-OMe (se)</td><td align="char" char=".">8.9</td><td align="char" char=".">6.6</td><td align="char" char=".">7.4</td><td align="char" char=".">5.9</td><td align="char" char=".">69</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>100</b></td><td align="left">3-Cl, 4-OMe (rac)</td><td align="char" char=".">8.3</td><td align="char" char=".">6.3</td><td align="char" char=".">6.9</td><td align="char" char=".">5.4</td><td align="char" char=".">69</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>101</b></td><td align="left">3-Cl, 4-OMe (se)</td><td align="char" char=".">8.5</td><td align="char" char=".">6.4</td><td align="char" char=".">6.8</td><td align="char" char=".">5.7</td><td align="char" char=".">69</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>102</b></td><td align="left">3-Cl, 4-OMe (se)</td><td align="char" char=".">6.7</td><td align="char" char="."><6.1</td><td align="char" char=".">5.9</td><td align="char" char=".">6.1</td><td align="char" char=".">69</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>103</b></td><td align="left">3-OCF<sub>3</sub> (rac)</td><td align="char" char=".">8.8</td><td align="char" char=".">6.8</td><td align="char" char=".">6.6</td><td align="char" char=".">6.2</td><td align="char" char=".">69</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>104</b></td><td align="left">3-OCF<sub>3</sub> (se)</td><td align="char" char=".">7.3</td><td align="char" char="."><6.1</td><td align="char" char="."><5.5</td><td align="char" char=".">6.0</td><td align="char" char=".">69</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>105</b></td><td align="left">3-OCF<sub>3</sub> (se)</td><td align="char" char=".">9.0</td><td align="char" char=".">7.7</td><td align="char" char=".">6.5</td><td align="char" char=".">6.0</td><td align="char" char=".">69</td><td align="char" char=".">2.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">fp<i>K</i><sub>i</sub> = functional p<i>K</i><sub>i</sub> obtained from the GTPγS functional assay. FLIPR = fluorescent imaging plate reader. SEM for D<sub>3</sub> GTPγS, H1 FLIPR, and HERG data sets is ±0.1 and for the D<sub>2</sub> GTPγS data is ±0.2.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">Å̂<sup>2</sup>.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">ACD logD 7.4. version 11.</p></div></div></div><div class="NLM_p">Once again, it was decided to start the exploration using the unsubstituted phenyl derivative <b>37</b> as reference compound, and in agreement with the need of SAR generation, some of the previously used substituents were also analyzed. In this specific subseries, in agreement with what is reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, no major variation in the DA D<sub>3</sub> affinity was noticed among the 4-<i>t</i>-Bu (<b>40</b>), the 4-Br (<b>42</b>), and the 4-Cl (<b>51</b>) substituents; the major difference was linked to lipophilicity values and to the selectivity versus the H1 and DA D<sub>2</sub> receptors of compound <b>51</b>. A further reduction in the size of the substituent in position 4 (F, <b>57</b>) led to a reduced affinity at the primary target. The slight reduction of DA D<sub>3</sub> affinity observed with the 4-OMe derivative <b>45</b> might be associated with its electrodonating properties, as the same effect was not observed with the 4-OCF<sub>3</sub> derivative <b>67</b>. The single substitution in position 3 of the aryl ring also seems to parallel the results already achieved in the subseries reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, with the exception of the 3-CF<sub>3</sub> derivative <b>63</b>, where an increase in the affinity at the primary target led also to a slight increase in the affinity at the DA D<sub>2</sub> receptor. The next step in the analysis of the results of the exploration is related to the double substitution of the phenyl system. This was done using substituents that did not raise the clogD values to unacceptably high values. The 3,4-bis-chloro substitution in derivative <b>70</b>, in this specific subseries, did not suffer of the slight decrease in affinity at the primary target previously reported for the quinoline derivative <b>8</b>; unfortunately, this substitution did not achieve the desired selectivity over the DA D<sub>2</sub> receptor. The 2-F, 4-CF<sub>3</sub> derivative <b>74</b> showed an overall very balanced profile, while the 2-F, 4-Me derivative <b>93</b> exhibited a reduced affinity at the desired receptor; this might be related to its lower lipophilicity as potentially confirmed by the results of the 2F, 4-Cl derivative <b>96</b>. The 4-F, 3-CF<sub>3</sub> substitution (<b>77</b>) led to the highest DA D<sub>3</sub> affinity observed in this subseries, possibly due to the substituent in position 3 potentially interacting at best with the appropriate residues within the receptor pocket, as also observed for derivative <b>63</b>. Again, the introduction of potentially electrodonating properties in the methoxy derivative <b>99</b> led to a slight decrease in affinity in agreement with what was observed for derivative <b>44</b>. A simultaneous substitution of both “meta” positions, as in the 3,5- substituted derivative <b>89</b>, showed positive results as far as the affinity at the primary target was concerned, but the selectivity at the DA D<sub>2</sub> receptor was slightly reduced.</div><div class="NLM_p">Among the compounds that were selected in agreement with the receptor/channel models studies for their electron-withdrawing ability and, therefore, for their potential ability to negatively affect the π interactions within the hERG channel, derivatives <b>51</b>, <b>74</b>, <b>77</b>, <b>84</b>, and <b>86</b> showed an overall balanced affinity profile; from the in vitro PK point of view, they showed the appropriate P450 and Cl<sub>i</sub> parameters to be further progressed in vivo and accordingly they were chosen for further characterization. The best in vivo profiles obtained after oral administration in rats were associated with derivatives <b>51</b> and <b>74</b> that showed a moderate Cl<sub>b</sub> (40 and 18 mL/min/kg, respectively), a sufficiently long half-life (<i>T</i><sub>1/2</sub> = 1.3 and 3.7 h), a moderate distribution volume (<i>V</i><sub>d</sub> = 2.6 and 4.3 L/kg) associated with a good bioavailability (<i>F</i>% = 31% and 47%), and brain penetration (B/B = 2.7 and 3.1, respectively). Therefore, in addition to the compounds previously identified, these two derivatives were also selected for further characterization.</div><div class="NLM_p">To ensure that no potential gaps were left during the chemical exploration of this new template, an automated analysis of all the DA D<sub>3</sub> fp<i>K</i><sub>i</sub> and hERG pIC<sub>50</sub> data was performed using the SAR-Toolkit<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in addition to the “classical” computational techniques described so far.</div><div class="NLM_p">The “R-group/D-score” analysis is available as part of the SAR-Toolkit, a GSK proprietary suite of applications for SAR data analysis, based on the Daylight Toolkit<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and embedded within Spotfire DecisionSite.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A highly versatile fragmentation tool defines the core portion of the molecules and the specific substituents (R-groups) within the set of molecules of interest (e.g., RG-Core, RG-R1, and RG-R2). Pairs of compounds which differ only in one R-group are then automatically identified, and the activity of the compound with an R-group chosen as reference is compared with that of a molecule carrying a replacement R-group. To assess whether the change is beneficial or detrimental for activity, a D-score is calculated as the average difference in activity across all the pairs of compounds carrying respectively the R-group of interest and the reference R-group and differing only by that R-group. All the compounds reported here constituted the original data set. Compound <b>37</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> was used as a reference structure. Using the right-hand side of the molecule as core structure and making use of the pendant substituents on the [3.1.0] scaffold as RG-R2, it appears quite clear from Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> that in this specific subseries more lipophilic substituents seem to boost the DA D<sub>3</sub> activity. It is interesting to note that bulky substituents in the ortho position of the aromatic system (e.g., −CF<sub>3</sub><b>65</b>, −CH<sub>3</sub><b>75</b>) were less tolerated in this specific subseries. This is probably due to a conformational effect as the o-F derivative <b>74</b> (the fluorine atom being slightly less bulky than the hydrogen one), which is instead well tolerated. These results were confirmed by the general trend of the DA D<sub>3</sub> activity vs Daylight’s ClogD, which is reported in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B. Among the few outliers which can be observed in this plot, derivatives <b>65</b> and <b>75</b> are endowed with RG-R2s carrying a bulky substituent in ortho (their Hansch’s MR values are respectively 5.02 and 5.65), while all the other compounds have either a hydrogen or a fluorine in the ortho positions (with their Hansch MR values equal to 1.03 and 0.92, respectively). Derivative <b>17</b> contains a <i>p</i>-cyano-phenyl in RG-R2. Although the global polarity of the compound, as expressed by tPSA, is not much higher than that for the other molecules in the data set, this substituent is by far the most polar RG-R2. Potentially, very polar substituents might not be tolerated in this precise position in this specific series, although this hypothesis must be further explored. Finally, for derivative <b>9</b>, the theory previously discussed about a potential steric clash might be invoked; nonetheless, at the current status of the exploration, it is not possible to exclude any a priori hypothesis, including a potentially slightly different binding mode to the receptor within the subseries. As far as derivative <b>7</b> is concerned, the lack of substituents on the aryl ring, also in this case, might lead to a slightly different behavior.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Pie chart for RG-R2 fragmentation. See text for a comprehensive explanation of the technique. (B) General trend of DA D3 fp<i>K</i><sub>i</sub> vs whole molecule lipophilicity expressed as ACD logD 7.4. Ver 11. Dots are color coded according to RG-R1: yellow, quinoline series (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>); blue, oxazolo series (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>); red, other substituents (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). (C) RG-R2 D-scores for hERG vs RG-R2 D-scores for D<sub>3</sub>. Labels beneath the substituents are respectively D-score hERG, D-score D<sub>3</sub>. RG-R2 groups positioned above the unity line have on average a greater effect on D<sub>3</sub> than on hERG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When the analysis was repeated with respect to the hERG activity, it was evident that substituents on the right-hand side which were very efficient in boosting the DA D<sub>3</sub> activity (e.g., the furan and the 2-methyl-5-quinoline) were unfortunately also good at increasing hERG. However, the RG-R2 plot suggests that there was slight room for a divergent SAR for the two targets as reported in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C. The selection of the few compounds along the screening cascade and the use of receptor modeling techniques confirmed this possibility.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Further Characterization of Derivatives <b>27</b>, <b>28</b>, <b>32</b>, <b>35</b>, <b>51</b>, and <b>74</b></h3><div class="NLM_p">In agreement with the screening cascade, these selected compounds underwent a further in vitro characterization enlarging the selectivity panel using both in-house testing and a selectivity screen available at Cerep as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Because the compounds showed at least 100-fold selectivity over a wide range of receptors and enzymes, they were submitted to a patch clamp hERG electrophysiology assay<a onclick="showRef(event, 'ref7 ref16'); return false;" href="javascript:void(0);" class="ref ref7 ref16">(7, 16)</a> to assess their overall activity for this K<sup>+</sup> channel. The results of the experiments are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Results from Patch Clamp hERG Electrophysiology Assay for the Selected Derivatives<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char="."><b>27</b></th><th align="center" char="."><b>28</b></th><th align="center" char="."><b>32</b></th><th align="center" char="."><b>35</b></th><th align="center" char="."><b>51</b></th><th align="center" char="."><b>74</b></th></tr></thead><tbody><tr valign="top"><td align="left">affinity at the hERG channel (μM)</td><td align="char" char=".">0.39</td><td align="char" char=".">0.47</td><td align="char" char=".">0.35</td><td align="char" char=".">0.20</td><td align="char" char=".">0.11</td><td align="char" char=".">0.46</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Results are expressed in μM values.</p></div></div></div><div class="NLM_p">On the basis of these new generated data, which considered the affinity at the DA D<sub>3</sub> receptor, the overall in vitro and in vivo PK properties of these derivatives and the in vivo efficacy of DA D<sub>3</sub> receptor antagonists in animal models of addiction<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> combined with our previous experience,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> it was decided to temporarily remove derivatives <b>35</b> and <b>51</b> from further progression and to assess the efficacy of the remaining compounds in the expression of either nicotine or cocaine-induced conditioned place preference<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (CPP).</div><div class="NLM_p">Prior to these in vivo experiments, and for a better final interpretation of the results, it was also decided to generate affinity data in rat native tissues using [<sup>125</sup>I]-7-OH-PIPAT in competition binding assays on brain homogenates from rat nucleus accumbens and olfactory tubercles; results from these experiments are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Profile of the Selected Derivatives in [<sup>125</sup>I]-7-OH-PIPAT Competition Binding Assay on Brain Homogenates from Rat Brain</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center" char="."><b>27</b></th><th class="rowsep1" align="center" char="."><b>28</b></th><th class="rowsep1" align="center" char="."><b>32</b></th><th class="rowsep1" align="center" char="."><b>35</b></th><th class="rowsep1" align="center"><b>51</b></th><th class="rowsep1" align="center" char="."><b>74</b></th></tr></thead><tbody><tr valign="top"><td align="left">r DA D<sub>3</sub> rat native tissue p<i>K</i><sub>i</sub></td><td align="char" char=".">9.01</td><td align="char" char=".">8.70</td><td align="char" char=".">9.19</td><td align="char" char=".">9.05</td><td align="left">NT</td><td align="char" char=".">8.38</td></tr></tbody></table></div></div><div class="NLM_p">In the CPP paradigm, animals are given an injection of a drug or vehicle and confined or “paired” to a specific environment with distinct cues. This pairing of the animal with specific cues after being given vehicle or drug is repeated. Subsequently, on the test day, animals are not given any treatment (drug-free state) and are allowed to freely explore the CPP apparatus to determine if they prefer an environment in which they previously received drug compared to an environment in which they previously received vehicle. If the animals approach and spend a significantly greater amount of time in the drug-paired environment, one can reasonably infer that the drug was rewarding. Further details on this paradigm can be found in the experimental part.</div><div class="NLM_p">Separate studies were performed to investigate the effects of the acute administration of derivatives <b>27</b>, <b>28</b>, <b>32</b>, and <b>74</b> compared to vehicle on the expression of nicotine CPP in male Sprague−Dawley rats. All the compounds were administered ip (0.05, 0.1, 0.3, 1.0, 3.0 mg/kg) and the amount of time spent in each chamber was determined using an automated timing system. The results are reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>−<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effect of a Single ip Administration of Vehicle and <b>27</b> (0.05, 0.1, 0.3, 1, 3 mg/kg) on the Expression of the Conditioned Place Preference Response to 0.6 mg/kg sc of (−)-Nicotine or Vehicle (1 mL/kg sc) in Adult Male Sprague−Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th class="rowsep1" colspan="2" align="center" char="±">time spent in compartments (min) ± SEM</th></tr><tr valign="top"><th align="left">treatment pairings</th><th align="left">drug given on test day</th><th align="center" char="±">paired</th><th align="center" char="±">unpaired</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle/vehicle</td><td align="left">vehicle</td><td align="char" char="±">7.51 ± 0.3</td><td align="char" char="±">7.49 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left">vehicle</td><td align="char" char="±">9.81 ± 0.3<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td align="char" char="±">5.19 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>27</b> (0.05 mg/kg)</td><td align="char" char="±">9.73 ± 0.4</td><td align="char" char="±">5.27 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>27</b> (0.1 mg/kg)</td><td align="char" char="±">9.87 ± 0.4</td><td align="char" char="±">5.13 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>27</b> (0.3 mg/kg)</td><td align="char" char="±">9.55 ± 0.4</td><td align="char" char="±">5.45 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>27</b> (1.0 mg/kg)</td><td align="char" char="±">7.91 ± 0.3<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td align="char" char="±">7.09 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>27</b> (3.0 mg/kg)</td><td align="char" char="±">7.77 ± 0.4<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td align="char" char="±">7.23 ± 0.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last"><i>P</i> < 0.0001 vs vehicle/vehicle/vehicle.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last"><i>P</i> < 0.0001 vs vehicle/nicotine/vehicle.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effect of a Single ip Administration of Vehicle and <b>28</b> (0.05, 0.1, 0.3, 1, 3 mg/kg) on the Expression of the Conditioned Place Preference Response to 0.6 mg/kg sc of (−)-Nicotine or Vehicle (1 mL/kg sc) in Adult Male Sprague−Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th class="rowsep1" colspan="2" align="center" char="±">time spent in compartments (min) ± SEM</th></tr><tr valign="top"><th align="left">treatment pairings</th><th align="left">drug given on test day</th><th align="center" char="±">paired</th><th align="center" char="±">unpaired</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle/vehicle</td><td align="left">vehicle</td><td align="char" char="±">7.51 ± 0.4</td><td align="char" char="±">7.49 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left">vehicle</td><td align="char" char="±">9.87 ± 0.4<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td align="char" char="±">5.13 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>28</b> (0.05 mg/kg)</td><td align="char" char="±">9.59 ± 0.4</td><td align="char" char="±">5.41 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>28</b> (0.1 mg/kg)</td><td align="char" char="±">9.14 ± 0.4</td><td align="char" char="±">5.86 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>28</b> (0.3 mg/kg)</td><td align="char" char="±">8.49 ± 0.4<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td align="char" char="±">6.51 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>28</b> (1.0 mg/kg)</td><td align="char" char="±">7.65 ± 0.4<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td align="char" char="±">7.35 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>28</b> (3.0 mg/kg)</td><td align="char" char="±">7.10 ± 0.3<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td align="char" char="±">7.90 ± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last"><i>P</i> < 0.0001 vs vehicle/vehicle/vehicle.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last"><i>P</i> < 0.001 vs vehicle/nicotine/vehicle.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last"><i>P</i> < 0.0001 vs vehicle/nicotine/vehicle.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effect of a Single ip Administration of Vehicle and <b>32</b> (0.05, 0.1, 0.3, 1, 3 mg/kg) on the Expression of the Conditioned Place Preference Response to 0.6 mg/kg sc of (−)-Nicotine or Vehicle (1 mL/kg sc) in Adult Male Sprague−Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th class="rowsep1" colspan="2" align="center" char="±">time spent in compartments (min) ± SEM</th></tr><tr valign="top"><th align="left">treatment pairings</th><th align="left">drug given on test day</th><th align="center" char="±">paired</th><th align="center" char="±">unpaired</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle/vehicle</td><td align="left">vehicle</td><td align="char" char="±">7.41 ± 0.4</td><td align="char" char="±">7.49 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left">vehicle</td><td align="char" char="±">9.82 ± 0.3<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td align="char" char="±">5.18 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>32</b> (0.05 mg/kg)</td><td align="char" char="±">9.58 ± 0.3</td><td align="char" char="±">5.42 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>32</b> (0.1 mg/kg)</td><td align="char" char="±">9.16 ± 0.2</td><td align="char" char="±">5.84 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>32</b> (0.3 mg/kg)</td><td align="char" char="±">8.23 ± 0.2<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td align="char" char="±">6.77 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>32</b> (1.0 mg/kg)</td><td align="char" char="±">7.54 ± 0.3<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td align="char" char="±">7.46 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>32</b> (3.0 mg/kg)</td><td align="char" char="±">7.16 ± 0.3<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td align="char" char="±">7.84 ± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last"><i>P</i> < 0001 vs vehicle/vehicle/vehicle.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last"><i>P</i> < 001 vs vehicle/nicotine/vehicle.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last"><i>P</i> < 0001 vs. vehicle/nicotine/vehicle.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Effect of a Single ip Administration of Vehicle and <b>74</b> (0.05, 0.1, 0.3, 1, 3 mg/kg) on the Expression of the Conditioned Place Preference Response to 0.6 mg/kg sc of (−)-Nicotine or Vehicle (1 mL/kg sc) in Adult Male Sprague−Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="left"> </th><th class="rowsep1" align="left"> </th><th class="rowsep1" colspan="2" align="center" char="±">time spent in compartments (min) ± SEM</th></tr><tr valign="top"><th align="left">treatment pairings</th><th align="left">drug given on test day</th><th align="center" char="±">paired</th><th align="center" char="±">unpaired</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle/vehicle</td><td align="left">vehicle</td><td align="char" char="±">7.51 ± 0.3</td><td align="char" char="±">7.49 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left">vehicle</td><td align="char" char="±">9.39 ± 0.4<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></td><td align="char" char="±">5.61 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>74</b> (0.05 mg/kg)</td><td align="char" char="±">8.68 ± 0.3</td><td align="char" char="±">6.32 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>74</b> (0.1 mg/kg)</td><td align="char" char="±">8.07 ± 0.3<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td align="char" char="±">6.93 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>74</b> (0.3 mg/kg)</td><td align="char" char="±">7.42 ± 0.3<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td align="char" char="±">7.58 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>74</b> (1.0 mg/kg)</td><td align="char" char="±">7.26 ± 0.2<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td align="char" char="±">7.84 ± 0.2</td></tr><tr valign="top"><td align="left">vehicle/nicotine</td><td align="left"><b>74</b> (3.0 mg/kg)</td><td align="char" char="±">7.05 ± 0.2<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td align="char" char="±">7.95 ± 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last"><i>P</i> < 0001 vs vehicle/vehicle/vehicle.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last"><i>P</i> < 001 vs vehicle/nicotine/vehicle.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last"><i>P</i> < 0001 vs vehicle/nicotine/vehicle.</p></div></div></div><div class="NLM_p">In addition, to further strengthen the available results<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> indicating that antagonism at the DA D<sub>3</sub> receptor is efficacious in attenuating the rewarding/reinforcing properties of different drugs of abuse, two of these four derivatives (namely <b>28</b> and <b>74</b>), were also tested to investigate their acute effects on the expression of cocaine CPP in male Sprague−Dawley rats. Both compounds were given ip (0.05, 0.1, 0.3, 1.0, 3.0 mg/kg). The results of these experiments are reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a> and <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Effect of a Single ip Administration of Vehicle and <b>28</b> (0.05, 0.1, 0.3, 1, 3 mg/kg) on the Expression of the Conditioned Place Preference Response to 15 mg/kg ip of (−)-Cocaine or Vehicle (1 mL/kg sc) in Adult Male Sprague−Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th class="rowsep1" colspan="2" align="center" char="±">time spent in compartments (min) ± SEM</th></tr><tr valign="top"><th align="left">treatment pairings</th><th align="left">drug given on test day</th><th align="center" char="±">paired</th><th align="center" char="±">unpaired</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle/vehicle</td><td align="left">vehicle</td><td align="char" char="±">7.11 ± 0.4</td><td align="char" char="±">7.90 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left">vehicle</td><td align="char" char="±">10.83 ± 0.5<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td align="char" char="±">4.17 ± 0.5</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>28</b> (0.05 mg/kg)</td><td align="char" char="±">9.79 ± 0.3<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td align="char" char="±">5.21 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>28</b> (0.1 mg/kg)</td><td align="char" char="±">9.36 ± 0.4<a class="ref internalNav" href="#t10fn3" aria-label="c">c</a></td><td align="char" char="±">5.64 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>28</b> (0.3 mg/kg)</td><td align="char" char="±">8.70 ± 0.5<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></td><td align="char" char="±">6.30 ± 0.5</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>28</b> (1.0 mg/kg)</td><td align="char" char="±">7.89 ± 0.3<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></td><td align="char" char="±">7.11 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>28</b> (3.0 mg/kg)</td><td align="char" char="±">7.36 ± 0.3<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></td><td align="char" char="±">7.64 ± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last"><i>P</i> < 0001 vs vehicle/vehicle/vehicle.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last"><i>P</i> < 05 vs vehicle/cocaine/vehicle.</p></div><div class="footnote" id="t10fn3"><sup>c</sup><p class="last"><i>P</i> < 01 vs vehicle/nicotine/vehicle.</p></div><div class="footnote" id="t10fn4"><sup>d</sup><p class="last"><i>P</i> < 0001 vs vehicle/nicotine/vehicle.</p></div></div></div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Effect of a Single ip Administration of Vehicle and <b>74</b> (0.05, 0.1, 0.3, 1, 3 mg/kg) on the Expression of the Conditioned Place Preference Response to 15 mg/kg ip of (−)-Cocaine or Vehicle (1 mL/kg sc) in Adult Male Sprague−Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th class="rowsep1" colspan="2" align="center" char="±">time spent in compartments (min) ± SEM</th></tr><tr valign="top"><th align="left">treatment pairings</th><th align="left">drug given on test day</th><th align="center" char="±">paired</th><th align="center" char="±">unpaired</th></tr></thead><tbody><tr valign="top"><td align="left">vehicle/vehicle</td><td align="left">vehicle</td><td align="char" char="±">7.06 ± 0.4</td><td align="char" char="±">7.94 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left">vehicle</td><td align="char" char="±">10.81 ± 0.5<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></td><td align="char" char="±">4.19 ± 0.5</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>74</b> (0.05 mg/kg)</td><td align="char" char="±">10.44 ± 0.4</td><td align="char" char="±">4.56 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>74</b> (0.1 mg/kg)</td><td align="char" char="±">9.01 ± 0.4<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a></td><td align="char" char="±">5.89 ± 0.4</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>74</b> (0.3 mg/kg)</td><td align="char" char="±">8.23 ± 0.3<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td align="char" char="±">6.87 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>74</b> (1.0 mg/kg)</td><td align="char" char="±">7.56 ± 0.3<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td align="char" char="±">7.34 ± 0.3</td></tr><tr valign="top"><td align="left">vehicle/cocaine</td><td align="left"><b>74</b> (3.0 mg/kg)</td><td align="char" char="±">7.10 ± 0.3<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td align="char" char="±">7.90 ± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last"><i>P</i> < 0001 vs vehicle/vehicle/vehicle.</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last"><i>P</i> < 001 vs vehicle/nicotine/vehicle.</p></div><div class="footnote" id="t11fn3"><sup>c</sup><p class="last"><i>P</i> < 0001 vs vehicle/nicotine/vehicle.</p></div></div></div><div class="NLM_p">A one-way ANOVA revealed a significant main effect of dose on the time spent in the nicotine or cocaine-paired compartments, and the results clearly show that all the compounds tested significantly reduced both nicotine- (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>−<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a><a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>) and cocaine-induced CPP (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>−<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>) in a dose-dependent manner.</div><div class="NLM_p">Additional experiments were performed to assess whether or not these derivatives produced nonspecific behavioral effects. Subsequently, the acute effects of these compounds up to high exposure (i.e., 10 mg/kg ip) were determined using spontaneous locomotor activity and motor coordination using the accelerating rotarod. For locomotor activity assessment, rats were treated with either saline or the test compounds (1, 3, 10 mg/kg ip). All rats were subsequently placed in an AccuScan locomotor apparatus. Their locomotor activity was measured for a 30 min period. An overall ANOVA revealed that there was no significant effect of treatment and no significant treatment × time interval interaction (data not shown).</div><div class="NLM_p">For motor coordination assessment, rats were trained on the accelerating rotarod (4−40 rpm over 270s; 7750, Ugo Basile, Italy) twice daily for 3 consecutive days. On the test day (day 4), rats were treated with vehicle, the four selected compounds (1, 3, 10 mg/kg ip), or haloperidol (1 mg/kg ip) as a positive control (<i>n</i> = 8 rats/group). Rats were then repeatedly tested for their endurance performance on the rotarod 30, 60, and 120 min after these treatments. Rotarod latencies were measured with a 270 s cutoff time. Pretreatment with haloperidol significantly decreased the time that rats spent on the rotarod. In contrast, the selected derivatives (<b>27</b>, <b>28</b>, <b>32</b>, <b>74</b>) did not affect endurance performance at any of the posttreatment times tested (data not shown).</div><div class="NLM_p">A final important point to be assessed in this quest for new and developable selective DA D<sub>3</sub> receptor antagonist, as it was done for the previously reported BAZ system,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> was related to the demonstration of the lack of QTc prolongation in vivo. It is well-known that an undesirable feature of some drugs is their ability to delay cardiac repolarization, an effect that can be measured as prolongation of the QT interval on the surface electrocardiogram (ECG).<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Because of its inverse relationship to heart rate, the QT interval is routinely transformed (normalized) by means of various formulas into a heart rate independent “corrected” value known as the QTc interval. The QTc interval is intended to represent the QT interval at a standardized heart rate of 60 bpm.</div><div class="NLM_p last">In agreement with our screening cascade, derivatives <b>27</b>, <b>28</b>, <b>32</b>, and <b>74</b> were all evaluated for their ability to determine QTc prolongation in vivo when assessed in the anesthetized guinea pig model.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> All of the compounds were administered intravenously in escalating doses from 0.5 to 15 mg/kg. Despite the very high exposure reached at the top dose of 15 mg/kg (<i>C</i><sub>max</sub> = 6237, 9577, 8322, and 8635 ng/mL for <b>27</b>, <b>28</b>, <b>32</b>, and <b>74</b>, respectively), the QTc interval was not significantly increased in the guinea pig model by any of the derivatives. Thus, there is a large window between the efficacy and the potential side effects that was obtained in preclinical species for these derivatives.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting from the potent and selective DA D<sub>3</sub> receptor antagonists previously reported (<b>1</b>−<b>4</b>), a new series of 1,2,4-triazol-yl azabicyclo[3.1.0]hexanes was identified. Rational design and computational tools helped to design a number of products endowed with high affinity and selectivity for the DA D<sub>3</sub> receptor. In addition, selected compounds of this family series proved to have appropriate developability characteristics (P450, Cl<sub>i</sub>, <i>F</i>%) and good CNS penetration. As described, a number of these compounds were also active in the CPP model and were endowed with a large selectivity window with respect to their affinity at the hERG channel, leading to a total lack of QTc when assessed in vivo in the anesthetized guinea pig model.</div><div class="NLM_p last">Provided that in vivo preclinical evidence can be extrapolated to human, selective DA D<sub>3</sub> receptor antagonists belonging to this new chemical series show high promise for the treatment of drug addiction.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Biological Test Methods</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> In Vitro Studies</h4><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> [<sup>35</sup>S] GTPγS Functional Binding Assay in Cell Membranes Expressing hD<sub>3</sub> Receptors</h5><div class="NLM_p">In vitro functional studies were performed according to the following [<sup>35</sup>S]-GTPγS protocol. Cells used in the study are Chinese hamster ovary (CHO) cells.</div><div class="NLM_p">Cell membranes were prepared as follows. Cell pellets were resuspended in 10 volumes of 50 mM HEPES, 1 mM EDTA pH 7.4, using KOH. On the day, the following proteases were added to the buffer just prior to giving the homogenization buffer.</div><div class="NLM_p">10−6 M leupeptin (Sigma L2884) − 5000 × stock = 5 mg/mL in buffer.</div><div class="NLM_p">25μg/mL bacitracin (Sigma B0125) − 1000 × stock = 25 mg/mL in buffer.</div><div class="NLM_p">1 mM PMSF − 1000 × stock = 17 mg/mL in 100% ethanol.</div><div class="NLM_p">2 × 10<sup>−6</sup> M pepstain A − 1000 × stock = 2 mM in 100% DMSO.</div><div class="NLM_p">The cells were homogenized by 2 × 15 s bursts in a 1 L glass Waring blender in a class two biohazard cabinet. The resulting suspension was spun at 500<i>g</i> for 20 min (Beckman T21 centrifuge: 1550 rpm). The supernatant was withdrawn with a 25 mL pipet, aliquotted into prechilled centrifuge tubes, and spun at 48000<i>g</i> to pellet membrane fragments (Beckman T1270: 23000 rpm for 30 min). The final 48000<i>g</i> pellet was resuspended in homogenization buffer (4× the volume of the original cell pellet). The 48000<i>g</i> pellet was resuspended by vortexing for 5 s and homogenized in a dounce homogenizer 10−15 stokes. The prep was distributed into appropriate sized aliquots (200−1000 μL) in polypropylene tubes and store at −800 °C. Protein content in the membrane preparations was evaluated with the Bradford protein assay.</div><div class="NLM_p">The final top concentration of test drug was 3 μM in the assay, and 11 points serial dilution curves 1:4 in 100% DMSO were carried out using a Biomek FX. The test drug at 1% total assay volume (TAV) was added to a solid, white, 384-well assay plate. 50%TAV of precoupled (for 90 min at 4 °C) membranes, 5 μg/well, and wheatgerm agglutinin polystyrene scintillation proximity assay beads (RPNQ0260, Amersham), 0.25 mg/well, in 20 mM HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl<sub>2</sub>, 60 μg/mL saponin, and 30 μM GDP is added. The third addition was a 20% TAV addition of either buffer (agonist format) or EC<sub>80</sub> final assay concentration of agonist, Quinelorane, prepared in assay buffer (antagonist format). The assay was started by the addition of 29%TAV of GTPγ[35S] 0.38 nM final (37 MBq/mL, 1160 Ci/mmol, Amersham). After all additions assay plates were spun down for 1 min at 1000 rpm, assay plates were counted on a Viewlux, 613/55 filter, for 5 min, between 2 and 6 h after the final addition.</div><div class="NLM_p last">The effect of the test drug over the basal generates EC<sub>50</sub> value by an iterative least-squares curve fitting program, expressed in the table as pEC<sub>50</sub> (i.e., −logEC<sub>50</sub>). The ratio between the maximal effect of the test drug and the maximal effect of full agonist, Quinelorane, generated the intrinsic activity (IA) value (i.e., IA = 1 full agonist, IA < 1 partial agonist). fp<i>K</i><sub>i</sub> values of test drug were calculated from the IC<sub>50</sub> generated by “antagonist format” experiment using Cheng and Prusoff equation: f<i>K</i><sub>i</sub> = IC<sub>50</sub>/1 + ([A]/EC<sub>50</sub>), where [A] is the concentration of the agonist in the assay and EC<sub>50</sub> is the agonist EC<sub>50</sub> value obtained in the same experiment. fp<i>K</i><sub>i</sub> is defined as −logf<i>K</i><sub>i</sub>.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> [<sup>125</sup>I]-7-OH-PIPAT Competition Bbinding Assay on Brain Homogenates from Rat Brain</h5><div class="NLM_p">Homogenates from frozen nucleus accumbens and olfactory tubercles were prepared as described by Burris et al. (1994).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In saturation experiments, increasing concentrations of [<sup>125</sup>I]-7-OH-PIPAT (15 pM−2 nM) were incubated with 12 μg/well of homogenates for 45 min at 37 °C in a final volume of 200 μL of 50 mM Tris-HCl (pH7.0), 50 mM NaCl, 100 μM Gpp(NH)p, and 0.02%BSA, i.e., conditions which inhibit [<sup>125</sup>I]-7-OH-PIPAT binding to D<sub>2</sub> and 5HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Nonspecific binding was determined by the presence of 1 μM <b>1</b>. In competition binding experiments, increasing concentrations of <b>35</b> (17 pM−1 μM) were incubated as above in the presence of 0.1 nM [<sup>125</sup>I]-7-OH-PIPAT.</div><div class="NLM_p">Reactions were stopped by filtration through GF/C 96-well filter plates presoaked in 0.3% polyethylenimine using a cell harvester. Filters were washed 3 times with 1 mL of ice-cold 50 mM Tris-HCl (pH7.7), and radioactivity was counted in a microplate scintillation counter (Top Count, Perkin-Elmer).</div><div class="NLM_p">Radioligand binding data were analyzed by nonlinear regression analysis using GraphPad Prism 4.0 (GraphPad Software, CA). Determination of <i>K</i><sub>D</sub> and <i>B</i><sub>max</sub> of [<sup>125</sup>I]-7-OH-PIPAT from saturation experiments was assessed by using one-site binding (hyperbola) equation. Curve fitting from competition-binding experiments was determined by using one site competition equation after checking with <i>F</i> test (<i>P</i> < 0.05) that Hill slope in the four parameter logistic equation was not statistically different from 1.0. In this condition, IC<sub>50</sub> values were converted to <i>K</i><sub>i</sub> using the Cheng−Prusoff equation.<sup>33</sup> Results are expressed as mean p<i>K</i><sub>i</sub> ± SEM.</div><div class="NLM_p last">[<sup>125</sup>I]-7-OH-PIPAT ([<sup>125</sup>I](<i>R</i>)-<i>trans</i>-7-hydroxy-2-[<i>N</i>-propyl-<i>N</i>-(3′-iodo-2′-propenyl)amino] tetralin, 81.4 TBq/mmol) was purchased from PerkinElmer Life and Analytical Sciences. Haloperidol and Gpp(NH)p (guanylyl-5′-imidodiphosphate) were obtained from Sigma Chemicals.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> hERG-<sup>3</sup>H Dofetilide Binding Assay</h3><div class="NLM_p last">hERG activity was measured using <sup>3</sup>H dofetilide binding in a scintillation proximity assay (SPA) format. The activity was measured with a PerkinElmer Viewlux imager.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> H1-FLIPR Assay</h3><div class="NLM_p last">A functional response in CHO-hH1 cells was measured using cytoplasmic calcium indicator, Fluo-4. The change in cell fluorescence was measured in a FLIPR (λ<sub>ex</sub> = 488 nm, λ<sub>EM</sub> = 540 nm, Molecular Devices, UK).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> P450 CYPEX Assay</h3><div class="NLM_p last">Inhibition (IC<sub>50</sub>) of human CYP1A2, 2C9, 2C19, 2D6, and 3A4 was determined using Cypex Bactosomes expressing the major human P450s. A range of concentrations (0.1, 0.2, 0.4, 1, 2, 4, and 10 μM) of test compound were prepared in methanol and preincubated at 37 °C for 10 min in 50 mM potassium phosphate buffer (pH 7.4) containing recombinant human CYP450 microsomal protein (0.1 mg/mL; Cypex Limited, Dundee, UK) and probe-fluorescent substrate. The final concentration of solvent was between 3 and 4.5% of the final volume. Following preincubation, NADPH regenerating system (7.8 mg glucose 6-phosphate, 1.7 mg NADP, and 6 units glucose-6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO3; 25 μL) was added to each well to start the reaction. Production of fluorescent metabolite was then measured over a 10 min time-course using a Spectrafluor plus plate reader. The rate of metabolite production (AFU/min) was determined at each concentration of compound and converted to a percentage of the mean control rate using Magellan (Tecan software). The inhibition (IC<sub>50</sub>) of each compound was determined from the slope of the plot using Grafit v5 (Erithacus software, UK). Miconazole was added as a positive control to each plate. CYP450 isoform substrates used were ethoxyresorufin (ER; 1A2; 0.5 μM), 7-methoxy-4-triflouromethylcoumarin-3-acetic acid (FCA; 2C9; 50 μM), 3-butyryl-7-methoxycoumarin (BMC; 2C19; 10 μM), 4-methylaminomethyl-7-methoxycoumarin (MMC; 2D6; 10 μM), diethoxyflourescein (DEF; 3A4; 1 μM), and 7-benzyloxyquinoline (7-BQ; 3A4; 25 μM). The test was performed in three replicates.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Intrinsic Clearance (Cl<sub>i</sub>) Assay</h3><div class="NLM_p last">Intrinsic clearance (CL<sub>i</sub>) values were determined in rat and human liver microsomes. Test compounds (0.5 μM) were incubated at 37 °C for 30 min in 50 mM potassium phosphate buffer (pH 7.4) containing 0.5 mg microsomal protein/mL. The reaction was started by addition of cofactor (NADPH; 8 mg/mL). The final concentration of solvent was 1% of the final volume. At 0, 3, 6, 9, 15, and 30 min, an aliquot (50 μL) was taken, quenched with acetonitrile containing an appropriate internal standard, and analyzed by HPLC-MS/MS. The intrinsic clearance (CL<sub>i</sub>) was determined from the first-order elimination constant by nonlinear regression using Grafit v5 (Erithacus software, UK), corrected for the volume of the incubation and assuming 52.5 mg microsomal protein/g liver for all species. Values for CL<sub>i</sub> were expressed as mL/min/g liver. The lower limit of quantification of clearance was determined to be when <15% of the compound had been metabolized by 30 min and this corresponded to a CL<sub>i</sub> value of 0.5 mL/min/g liver. The upper limit was 50 mL/min/g liver.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Patch Clamp hERG Electrophysiology Assay</h3><div class="NLM_p">On the days of experimentation, a weighed amount of the test substance was formulated in dimethyl sulfoxide (DMSO, lot no. U10781; Sigma-Aldrich, UK) by shaking to give a stock concentration of 10 mM of the test compound. The 10 mM stock solution was serially diluted in DMSO to give further stock solutions of 1 and 0.1 mM. Aliquots of these stock solutions were added to bath solution to achieve final perfusion concentrations of 0.1, 1, and 10 μM test compound. The corresponding vehicle concentration in all test substance perfusion solutions was 0.1% DMSO. Test substance stock formulations were freshly prepared on each day of experimentation, stored at room temperature, and protected from light.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Reference Substance</h4><div class="NLM_p last">E-4031 (batch no. MLE9446; Wako Pure Chemical Industries Ltd.). Stock solutions of E-4031 (100 μM) were prepared in reverse osmosis water, aliquoted, and stored at approximately −20 °C until use. On the day of use, the 100 μM stock solution was added to bath solution to give a final perfusion concentration of 100 nM.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Bath and Pipette Solutions</h4><div class="NLM_p last">The composition of bath solution was (mM): NaCl 137, KCl 4, CaCl<sub>2</sub> 1.8, MgCl<sub>2</sub> 1.0, <span class="smallcaps smallerCapital">d</span>-glucose 10, <i>N</i>-2-hydroxyethylpiperazine-<i>N</i>′-2-ethanesulfonic acid (HEPES) 10, pH 7.4 with 1 M NaOH. Pipette solution was prepared in batches, aliquoted, and stored frozen until the day of use. The composition of pipet solution was (mM): KCl 130, MgCl<sub>2</sub> 1.0, ethylene glycol-bis(ss-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA) 5, MgATP 5, HEPES 10, pH 7.2, with 1 M KOH.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Study Design</h4><div class="NLM_p last">Cells (passage number: 48) were transferred to the recording chamber and continuously perfused (at approximately 1−2 mL/min) with bath solution at room temperature. High resistance seals (seal resistances >1.5 GΩ) were formed between the patch electrodes (resistance range: 1.4−5.5 MΩ) and individual cells. The membrane across the electrode tip was then ruptured and the whole-cell patch-clamp configuration was established. Once a stable patch had been achieved, recording commenced in voltage-clamp mode, with the cell initially clamped at −80 mV. Currents were evoked by stepping the membrane potential to +20 mV and then to −50 mV (tail current). Test compound at 10, 1, and 0.1 μM was used to produce (if any) inhibition of hERG tail current and therefore to investigate the concentration−response relationship (<i>n</i> = 3 cells/concentration). The effect of the vehicle (0.1% DMSO) was investigated in 3 cells. The effect of 100 nM E-4031 was investigated in 2 of the vehicle treated cells to confirm the sensitivity of the test system to an agent known to block hERG current. All perfusion solutions were applied for approximately 10 min.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Anesthetized Guinea Pig Model for the Assessment of QT Prolongation</h3><div class="NLM_p">Prior to the experiment, six male Hartley guinea pigs (Charles River, France) weighing between 564 and 605 g on the day of the test were anaesthetised with urethane (1−1.5 g/kg ip), tracheotomized, artificially ventilated with a tidal volume of approximately 1 mL/100 g at a rate of 54 cycles/min, and surgically prepared for the experiment (i.e., insertion of catheters in appropriate blood vessels, see below, and placement of surface electrodes for lead II electrocardiogram recording). The animal's temperature was kept constant between 36.8 and 38.0 °C. Once physiological parameters were stabilized (approximately 30 min following surgery), each animal was given either the vehicle (5% w/v dextrose in aqueous 0.9 w/v sodium chloride) or test compound by the intravenous route (via the jugular vein) over 15 min/treatment.</div><div class="NLM_p">The following parameters were recorded: arterial pressure (via the carotid artery), heart rate, electrocardiography (i.e., RR, PQ, QRS, and QT interval duration; the QT interval was corrected for heart rate changes according to Fridericia, Bazett and Van de Water's formula). Parameters were recorded prior to dosing to establish baseline measurements and continuously during the infusion period but data were reported every 5 min during each infusion period. In addition, blood samples (0.3 mL) were collected via the femoral artery at the end of each infusion period for toxicokinetic evaluations.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> In Vivo Studies</h4><div class="NLM_p">All experiments were prereviewed and approved by a local animal care committee in accordance with the guidelines of the “Principles of Laboratory Animal Care” (NIH publication no. 86-23, revised 1985) and with a project license that was obtained according to Italian law (Art. 7, Legislative Decree no. 116, 27 January 1992), which acknowledges European Directive 86/609/EEC on the care and welfare of laboratory animals.</div><div id="sec5_7_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Nicotine CPP</h5><div class="NLM_p">Male Sprague−Dawley rats (200 g at the start of the pairings, Taconic Farms, Germantown, NY) were used in all experiments. Animals were housed two per cage, and there was no more than a 5% difference in body weight between the cagemates. Animals were kept on a 12 h lights on/12 h lights off schedule (lights on at 09.00 h). Food and water were freely available. The conditioning and testing of all animals was carried out between 11.00−18.00 h. All rats were naive and used only once.</div><div class="NLM_p">An automated, two-chambered, Plexiglas CPP apparatus was used as previously described,<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> with modifications. Briefly, the two pairing chambers of the apparatus were identical in dimensions (25 cm × 14 cm × 36 cm) and were separated by removable Plexiglas guillotine doors. The pairing chambers were composed of distinct visual and tactile cues. The walls of one of the pairing chambers were white, with cage bedding on the floor and the walls of the second chamber consisted of alternating white and black boxes (1.2 cm × 1.8 cm) in a chessboard pattern and a Plexiglas floor. The two pairing chambers were separated by a third, neutral connecting tunnel, with one-half of the wall white and the other half with black and white boxes.</div><div class="NLM_p">Expression studies with the compounds reported in the tables or vehicle were divided into four phases: acclimation, handling, conditioning, and testing. The animals were not exposed to the chambers prior to the start of the pairings. During days 1−3, animals were acclimated to the animal facility. During handling (days 4−6), animals were transported to the laboratory and handled for 5 min each. During conditioning (days 7−14), animals were exposed to once-daily conditioning sessions. For each conditioning session, animals (10 rats per group) were injected with nicotine (0.6 mg/kg sc in a volume of 1 mL/kg) or vehicle (1 mL/kg sc) and then immediately confined for 30 min in an appropriate cue-specific chamber. During conditioning, nicotine was always paired with 1 cue-specific environment, and vehicle was paired with the other; nicotine or vehicle exposure (and appropriate environmental pairing) alternated from day to day. This was done over an 8-day period, i.e., animals were given four pairings with nicotine and there was a 24 h separation between exposure to vehicle and nicotine. The animals in each group were randomly assigned to a 2 × 2 factorial design, with one factor being the pairing chamber and the other factor being the order of conditioning. In the counterbalanced procedure, the animals were randomly assigned to one of the two pairing chambers so that half of the subjects received the drug in one compartment (white walls with bedding on the floor) and the other half in the other compartment (alternating black and white boxes with a smooth chamber floor). This procedure resulted in the animals receiving equal exposure to the two compartments and due to random assignment controlled for their side preference. Another group of 10 animals were paired with vehicle in both chambers of the apparatus. On the test day (day 15), animals were randomly divided into five groups of 10 and received the test compounds or vehicle (10% 2-hydroxypropyl-β-cyclodextrin) in the home cage 30 min before they were placed in the apparatus and allowed free access to both chambers for 15 min. The amount of time spent in each chamber was determined using an automated timing system.</div><div class="NLM_p last">(−)-Nicotine (+)-bitartrate salt was used in all experiments (Sigma-Aldrich Corporation, Saint Louis, MO) and was dissolved in sterile physiological saline and the pH adjusted to 7.4 with NaOH. The doses of nicotine were expressed as free base. 2-Hydroxypropyl-β-cyclodextrin was purchased from Tocris-Cookson Chemical (St. Louis, MO). Data were analyzed with a 1-way ANOVA with a main factor of dose. Statistical significance was set at a probability level of <i>P</i> < 0.05.</div></div><div id="sec5_7_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Cocaine CPP</h5><div class="NLM_p last">The cocaine CPP procedure was identical to the one described for nicotine except that (1) only four pairings were used and (2) for each conditioning session, animals were injected with (−)-cocaine HCl (15 mg/kg ip in a volume of 1 mL/kg) or vehicle (1 mL/kg ip of deionized, distilled water). (−)-Cocaine HCl was purchased from Sigma Chemicals (St. Louis, MO).</div></div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Chemical Procedures. General</h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Experimental</h4><div class="NLM_p">NMR spectra were obtained on Varian INOVA spectrometers (300, 400, and 500 MHz). Chemical shifts are expressed in δ (ppm) units and peak multiplicity are expressed as follows: singlet (s), doublet (d), doublet of doublets (dd), triplet (t), multiplet (m), broad singlet (br s), broad multiplet (br m). All mass spectrometric measurements were performed using a Micromass Platform LCZ (Waters, Manchester, UK) mass spectrometer operated in positive electrospray ionization mode. When LC/MS detection was performed, analytical conditions were used as reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>.</div><div class="NLM_table-wrap" id="tbl12">Table 12<div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="left" /></col></colgroup><tbody><tr valign="top"><td>analytical column</td><td align="left">Zorbax SB-C18, 4.6 mm × 50 mm (1.8 μ)</td></tr><tr valign="top"><td>mobile phase</td><td align="left">amm acet, 5 mM + 0.1% formic acid/acetonitrile + 0.1% formic acid</td></tr><tr valign="top"><td>gradient</td><td align="left">97/3 → 36/64 v/v in 3.5 min → 10/90 in 3.5 min</td></tr><tr valign="top"><td>flow rate</td><td align="left">2.0 mL/min</td></tr><tr valign="top"><td>detection</td><td align="left">DAD, 210−350 nm</td></tr><tr valign="top"><td>MS</td><td align="left">ES+</td></tr></tbody></table></div></div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Synthetic Procedures</h3><div class="NLM_p">Appropriate 4-methyl-5-aryl-2,4-dihydro-3<i>H</i>-1,2,4-triazole-3-thiones, prepared by the aryl acid in agreement with literature procedures, were suspended in acetone and potassium carbonate and 1-bromo-3-chloropropane was added. The so obtained 3-[(3-chloropropyl)thio]-4-methyl-5-aryl-4<i>H</i>-1,2,4-triazoles were suspended/dissolved in dry acetonitrile or DMF and added (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>) or (1<i>S</i>,5<i>R</i>) aryl azabicyclo[3.1.0]hexanes in presence of potassium carbonate according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><div class="NLM_p">Crudes were evaporated and purified by column chromatography. The solids were taken up with dichloromethane and a 1.0 M HCl solution in diethylether was added; the solvent was removed under reduced pressure to give product compounds as hydrochloride salts.</div><div class="NLM_p">Where no specific details are given, the retention times reported refer to the following general analytical chromatographic conditions of method A: column, X Terra MS C18 5 mm, 50 mm × 4.6 mm; mobile phase: A = NH<sub>4</sub>HCO<sub>3</sub> soln 10n mM, pH 10; B = CH<sub>3</sub>CN; gradient, 10% (B) for 1 min, from 10% (B) to 95% (B) in 12 min, 95% (B) for 3 min. Flow rate: 1 mL/min. UV wavelength range: 210−350 nm. Mass range: 100−900 amu. Ionization method: ES+</div><div class="NLM_p">The enantiomeric purity of each single enantiomer obtained after preparative chromatography on chiral columns was always verified on analytical column. For example, enatiomeric excess has been measured on the separated enantiomers by means of SFC analytical techniques. Typical conditions were derived from Chiralpak AD-H column (25 cm × 0.46 cm) with ethanol (+0.1% isopropylamine) 15% as modifier, flow rate 2.5 mL/min, <i>P</i> = 180 bar at 35 °C with detection at 220 nm.</div><div class="NLM_p last">The purity of the compounds reported in the manuscript was established through HPLC methodology. All the compounds reported in the manuscript have a purity >95%.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Methyl-5-[4-methyl-5-({3-[(1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-phenyl-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4<i>H</i>-1,2,4-triazol-3-yl]quinoline Hydrochloride (<b>5</b>)</h3><div class="NLM_p">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (1H, DMSO-<i>d</i><sub>6</sub>): δ: 10.4 (bs,1H), 8.3 (bs, 1H), 8.2 (d, 1H), 7.9 (t, 1H), 7.8 (d, 1H), 7.6 (bd, 1H), 7.4−7.3 (m, 5H), 4.0−3.5 (m/m, 2H), 3.7−3.45 (m/m, 2H), 3.5−3.3 (m, 7H), 2.73 (s, 3H), 2.3 (m, 3H), 1.60,1.1 (t,t 2H). MS: <i>m</i>/<i>z</i> 456 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Derivative <b>5</b> was separated to give the separated enantiomers by semipreparative HPLC. Retention times given were obtained using an analytical HPLC using a chiral column Chiralcel OD 5 μm, 250 mm × 4.6 mm; eluent A: <i>n</i>-hexane; B: 2-propanol, gradient isocratic 25% B, flow rate 1 mL/min, detection UV at 200−400 nm. Enantiomer <b>6</b> retention time = 39.2 min; enantiomer <b>7</b> retention time = 43.4 min.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-[5-({3-[(1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]-2-methylquinoline Hydrochloride (<b>8</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid (70% yield). <sup>1</sup>H NMR (1H, DMSO-<i>d</i><sub>6</sub>) δ: 10.46 (bs,1H), 8.58 (s, 1H), 7.4−7.2 (m, 5H), 4.04 (dd, 1H), 3.73 (m, 1H), 3.7 (s, 3H), 3.7−3.4 (m, 2H), 3.4−3.2 (m + t, 4H), 2.39 (s, 3H), 2.17 (m, 3H), 1.64,1.1 (2t, 2H). MS: <i>m</i>/<i>z</i> 562 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-[5-({3-[(1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(4-<i>tert</i>-Butylphenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]-2-methylquinoline Hydrochloride (<b>11</b>)</h3><div class="NLM_p">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (1H, DMSO-<i>d</i><sub>6</sub>): δ: 10.16 (bs,1H), 8.15 (dd, 2H), 7.89 (t, 1H), 7.76 (d, 1H), 7.49 (d, 1H), 7.36 (d, 2H), 7.23 (d, 2H), 4.05 (dd, 1H), 3.77 (dd, 1H), 3.58 (m, 2H), 3.44 (s, 3H), 2.7 (bm, 4H), 2.34 (s, 3H), 2.23 (t, 2H), 2.15 (t, 1H), 1.51 (t, 1H), 1.27 (s, 9H), 1.14 (m, 1H). MS: <i>m</i>/<i>z</i> 512 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Derivative <b>11</b> was separated to give the separated enantiomers by chiral chromatography. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 20% (ethanol + 0.1% 2-propanol), flow rate 2.5 mL/min, <i>P</i> 194 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>12</b> retention time = 7.0 min; enantiomer <b>13</b> retention time = 7.8 min.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-[5-({3-[(1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(4-Bromophenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]-2-methylquinoline Hydrochloride (<b>14</b>)</h3><div class="NLM_p">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (1H, DMSO-<i>d</i><sub>6</sub>) δ: 10.28 (bs,1H), 8.16 (dd, 2H), 7.89 (dd, 1H), 7.76 (d, 1H), 7.55 (d, 2H), 7.49 (d, 1H), 7.28 (d, 2H), 4.06 (bm, 1H), 3.77 (bm, 1H), 3.6 (bm, 2H), 3.44 (s, 3H), 3.5−3.2 (bm, 4H), 2.71 (s, 3H), 2.23 (m, 3H), 1.58/1.14 (t/m, 2H). MS: <i>m</i>/<i>z</i> 534 [M + H]<sup>+</sup>.</div><div class="NLM_p">Derivative <b>14</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralcel OJ-H, 25 cm × 0.46 cm, eluent CO2 containing 10% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 196 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>15</b> retention time = 56.8 min; enantiomer <b>16</b>. Retention time = 62.5 min. The absolute configuration of enantiomer <b>15</b> was assigned using comparative VCD and comparative OR analyses of the corresponding free base to be 5-[5-({3-[(1<i>R</i>,5<i>S</i>)-1-(4-bromophenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]-2-methylquinoline. The absolute configuration of enantiomer <b>16</b> was assigned as described above to be 5-[5-({3-[(1<i>S</i>,5<i>R</i>)-1-(4-bromophenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]-2-methylquinoline.</div><div class="NLM_p">Enantiomer <b>15</b>: specific optical rotation of the corresponding free base [α]D = +47° (CHCl<sub>3</sub>, <i>T</i> = 20 °C, <i>c</i> = 0.066 g/mL).</div><div class="NLM_p last">Enantiomer <b>16</b>: specific optical rotation of the corresponding free base [α]D = −42° (CHCl<sub>3</sub>, <i>T</i> = 20 °C, <i>c</i> = 0.065 g/mL).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-[(1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(2-methylquinolin-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hex-1-yl]benzonitrile Hydrochloride (<b>17</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (1H, DMSO-<i>d</i><sub>6</sub>) δ: 10.45 (bs,1H), 8.26 (bd, 1H), 8.17 (d, 1H), 7.93 (t, 1H), 7.8 (d/d, 3H), 7.5 (d, 1H), 7.46 (d, 2H), 4.09 (d, 1H), 3.76 (d, 1H), 3.67 (t, 1H), 3.6−3.2 (bm, 5H), 3.43 (s, 3H), 2.73 (s, 3H), 2.34 (m, 1H), 2.25 (quint., 2H),1.71/1.22 (dt, 2H). MS: <i>m</i>/<i>z</i> 481[M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-[5-({3-[(1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(4-Methoxyphenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4H-1,2,4-triazol-3-yl]-2-methylquinoline Hydrochloride (<b>18</b>)</h3><div class="NLM_p">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (1H, DMSO-<i>d</i><sub>6</sub>) δ: 10.57 (bs,1H), 8.28 (bs, 1H), 8.2 (d, 1H), 7.94 (t, 1H), 7.82 (d, 1H), 7.56 (d, 1H), 7.25 (d, 2H), 6.91 (d, 2H), 4.01 (dd, 1H), 3.7 (m, 1H), 3.74 (s, 3H), 3.6−3.2 (m, 6H), 3.42 (s, 3H), 2.75 (s, 3H), 2.24 (quint, 2H), 2.08 (quint, 1H), 1.62/1.05 (t/t, 2H). MS: <i>m</i>/<i>z</i> 486 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Derivative <b>18</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO2 containing 20% (ethanol + 0.1% isopropyl alcohol), flow rate 2.5 mL/min, <i>P</i> 194 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>19</b> retention time = 39.2 min; enantiomer <b>20</b> retention time = 43.4 min.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-[5-({3-[(1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-1-(4-Chlorophenyl)-3-azabicyclo[3.1.0]hex-3-yl]propyl}thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]-2-methylquinoline Hydrochloride (<b>21</b>)</h3><div class="NLM_p">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.95 (d,1H), 8.39 (d, 1H), 8.28 (t, 1H), 8.13 (d, 1H), 7.96 (d, 1H), 7.37 (m, 4H), 4.17 (d, 1H), 3.93 (d, 1H), 3.71 (m, 2H), 3.62 (s, 3H), 3.5 (2 m, 4H), 3.04 (s, 3H), 2.37 (m, 2H), 2.27 (m, 1H), 1.55 (m, 1H), 1.31 (m, 1H). MS: <i>m</i>/<i>z</i> 490 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Derivative <b>21</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 25% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>22</b>. Retention time = 24.3 min; enantiomer <b>23</b> retention time = 26.5 min.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-Methyl-5-{4-methyl-5-[(3-{(1<i>S</i>,5<i>R</i>)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hex-3-yl}propyl)thio]-4<i>H</i>-1,2,4-triazol-3-yl}quinoline Hydrochloride (<b>24</b>)</h3><div class="NLM_p last">MS: <i>m</i>/<i>z</i> 490 [M + H]<sup>+</sup>. Retention time = 10.12 min (method A).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Methyl-6-{4-methyl-5-[(3-{(1<i>S</i>,5<i>R</i>)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hex-3-yl}propyl)thio]-4<i>H</i>-1,2,4-triazol-3-yl}quinoline Hydrochloride (<b>25</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.41 (bs, HCl), 8.67 (bs, 1H), 8.47 (s, 1H), 8.2 (s, 2H), 7.72 (m, 1H), 7.68 (m, 2H), 7.49 (m, 2H), 4.07 (m, 1H), 3.74 (dd, 1H), 3.72 (s, 3H), 3.64 (dd, 1H), 3.51 (m, 1H), 3.3 (m, 4H), 2.81 (s, 3H), 2.28 (m, 1H), 2.19 (m, 2H), 1.72 (t, 1H), 1.19 (t, 1H). MS: <i>m</i>/<i>z</i> 524 [M + H]<sup>+</sup>. Retention time = 10.17 min (method A).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (1<i>S</i>,5<i>R</i>)-3-{3-[(4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>26</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.3 (bs,), 7.7 (m, 4H), 7.57 (m, 4H), 7.49 (m, 1H), 4.11 (d, 1H), 3.76 (d, 1H), 3.66 (m, 1H), 3.61 (s, 3H), 3.52 (m, 1H), 3.30 (m, 4H), 2.29 (m, 1H), 2.17 (m, 2H), 1.63 (m, 1H), 1.22 (m, 1H). MS: <i>m</i>/<i>z</i> 459 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(2-methyl-3-pyridinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>27</b>)</h3><div class="NLM_p last">The compound was obtained as a whitish, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.84 (bs, HCl), 8.77 (dd, 1H), 8.19 (bd, 1H), 7.71 (d, 2H), 7.66 (m, 1H), 7.51 (d, 2H), 4.08 (dd, 1H), ca. 3.8 (s, 3H), 3.8−3.3 (m, 7H), 2.54 (s, 3H), 2.30 (m, 1H), 2.22 (m, 2H), 1.83 (m, 1H), 1.20 (m, 1H). NMR (<sup>19</sup>F, DMSO): δ −60.8. MS: <i>m</i>/<i>z</i> 474 [M + H]<sup>+</sup>. Retention time = 9.35 min (method A).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(4-pyridazinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>28</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.24 (bs, HCl), 9.56 (m, 1H), 9.39 (m, 1H), 8.01 (s, 1H), 7.64 (m, 2H), 7.44 (m, 2H), 4.08 (m, 1H), 3.68 (s, 3H), 3.58 (bm, 1H), 3.7−3.3 (m, 6H), 2.26 (m, 1H), 2.13 (m, 2H), 1.58 (t, 1H), 1.14 (t, 1H). MS: <i>m</i>/<i>z</i> 461 [M + H]<sup>+</sup>. Retention time = 8.84 min (method A).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(5-pyrimidinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hhydrochloride (<b>29</b>)</h3><div class="NLM_p last">The compound was obtained as a off-white, slightly hygroscopic, solid. MS: <i>m</i>/<i>z</i> 461 [M + H]<sup>+</sup>. Retention time = 8.92 min (method A).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(3-methyl-2-furanyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>30</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub><i>6</i></sub>) δ: 10.56 (bs, HCl), 7.85 (d, 1H), 7.71 (d, 2H), 7.51 (d, 2H), 6.64 (d, 1H), 4.08 (dd, 1H), 3.75 (dd, 1H), 3.71 (s, 3H), 3.7−3.3 (m, 4H), 3.27 (t, 2H), 2.31 (m, 1H), 2.28 (s, 3H), 2.18 (m, 2H), 1.74 (t, 1H), 1.21 (t, 1H). MS: <i>m</i>/<i>z</i> 463 [M + H]<sup>+</sup>. Retention time = 10.72 min (method A).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(6-methyl-3-pyridinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>31</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. MS: <i>m</i>/<i>z</i> 474 [M + H]<sup>+</sup>. Retention time = 9.47 min (method A).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (1<i>S</i>,5<i>R</i>)-3-(3-{[5-(2,4-Dimethyl-1,3-thiazol-5-yl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hhydrochloride (<b>32</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.61 (bs, 1H), 7.69 (d, 2H), 7.49 (d, 2H), 4.06 (d, 1H), 3.72 (t, 1H), 3.63 (d, 1H), 3.52 (t, 1H), 3.48 (s, 3H), 3.34 (t, 2H), 3.27 (t, 2H), 2.68 (s, 3H), 2.33 (m, 3H), 2.28 (m, 1H), 2.18 (m, 2H), 1.73 (t, 1H), 1.18 (t, 1H). MS: <i>m</i>/<i>z</i> 494 [M + H]<sup>+</sup>. Retention time = 9.79 min (method A).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(5-methyl-2-pyrazinyl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>33</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.41 (bs, HCl), 9.11 (bs, 1H), 8.63 (bs, 1H), 7.66 (d, 2H), 7.44 (d, 2H), 4.02 (dd, 1H), 3.83 (s, 3H), 3.68 (d, 1H), 3.6−3.2 (m, 6H), 2.54 (s, 3H), 2.25 (m, 1H), 2.14 (m, 2H), 1.65 (m, 1H), 1.14 (m, 1H). MS: <i>m</i>/<i>z</i> 475 [M + H]<sup>+</sup>. Retention time = 10.15 min (method A).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>34</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.16 (bs, 1H), 8.58 (s, 1H), 7.72 (d, 2H), 7.51 (d, 2H), 4.1 (dd, 1H), 3.78 (dd, 1H), 3.70 (s, 3H), 3.66 (m, 2H), 3.29 (t, 2H), 2.5 (bm, 2H), 2.39 (s, 3H), 2.33 (quint, 2H), 2.19 (m, 1H), 1.62/1.23 (t/t, 2H). MS: <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>35</b>)</h3><div class="NLM_p last">The compound was obtained as a off white solid, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.16 (bs, 1H), 8.58 (s, 1H), 7.72 (d, 2H), 7.51 (d, 2H), 4.1 (dd, 1H), 3.78 (dd, 1H), 3.70 (s, 3H), 3.66 (m, 2H), 3.29 (t, 2H), 2.5 (bm, 2H), 2.39 (s, 3H), 2.33 (quint, 2H), 2.19 (m, 1H), 1.62/1.23 (t/t, 2H). MS: <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (1<i>R</i>,5<i>S</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>36</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.16 (bs, 1H), 8.58 (s, 1H), 7.72 (d, 2H), 7.51 (d, 2H), 4.1 (dd, 1H), 3.78 (dd, 1H), 3.70 (s, 3H), 3.66 (m, 2H), 3.29 (t, 2H), 2.5 (bm, 2H), 2.39 (s, 3H), 2.33 (quint, 2H), 2.19 (m, 1H), 1.62/1.23 (t/t, 2H). MS: <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>37</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.46 (bs,1H), 8.58 (s, 1H), 7.4−7.2 (m, 5H), 4.04 (dd, 1H), 3.73 (m, 1H), 3.7 (s, 3H), 3.7−3.4 (m, 2H), 3.4−3.2 (m + t, 4H), 2.39 (s, 3H), 2.17 (m, 3H), 1.64,1.1 (2t, 2H). MS: <i>m</i>/<i>z</i> 396 [M + H]<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(4-<i>tert</i>-Butylphenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>38</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.4 (s, 1H), 7.42 (d, 2H), 7.28 (d, 2H), 4.11 (d, 1H), 3.88 (d, 1H), 3.8 (s, 3H), 3.65 (m, 2H), 3.43 (t, 2H), 3.39 (t, 2H), 2.47 (s, 3H), 2.29 (m, 2H), 2.21 (m, 1H), 1.44 (m, 1H), 1.33 (s, 9H), 1.3 (m, 1H). MS: <i>m</i>/<i>z</i> 452 [M + H]<sup>+</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (1<i>R</i>,5<i>S</i>)-1-(4-<i>tert</i>-Butylphenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>39</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.4 (s, 1H), 7.42 (d, 2H), 7.28 (d, 2H), 4.11 (d, 1H), 3.88 (d, 1H), 3.8 (s, 3H), 3.65 (m, 2H), 3.43 (t, 2H), 3.39 (t, 2H), 2.47 (s, 3H), 2.29 (m, 2H), 2.21 (m, 1H), 1.44 (m, 1H), 1.33 (s, 9H), 1.3 (m, 1H). MS: <i>m</i>/<i>z</i> 452 [M + H]<sup>+</sup>.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (1<i>S</i>,5<i>R</i>)-1-(4-<i>tert</i>-Butylphenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>40</b>)</h3><div class="NLM_p last">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.4 (s, 1H), 7.42 (d, 2H), 7.28 (d, 2H), 4.11 (d, 1H), 3.88 (d, 1H), 3.8 (s, 3H), 3.65 (m, 2H), 3.43 (t, 2H), 3.39 (t, 2H), 2.47 (s, 3H), 2.29 (m, 2H), 2.21 (m, 1H), 1.44 (m, 1H), 1.33 (s, 9H), 1.3 (m, 1H). MS: <i>m</i>/<i>z</i> 452 [M + H]<sup>+</sup>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(4-Bromophenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>41</b>)</h3><div class="NLM_p">The compound was obtained as a white, slightly hygroscopic, solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.29 (bs,1H), 8.58 (s, 1H), 7.55 (dd, 2H), 7.27 (dd, 2H), 4.03 (dd, 1H), 3.73 (dd, 1H), 3.7 (s, 3H), 3.55 (m, 2H), 3.5−3.2/3.28 (m + t, 4H), 2.39 (s, 3H), 2.19 (m, 3H), 1.59/1.12 (2t, 2H). MS: <i>m</i>/<i>z</i> 474 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>41</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO2 containing 10% (ethanol + 0.1% isopropyilamine), flow rate 2.5 mL/min, <i>P</i> 199 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>42</b> retention time = 22.2 min. Specific optical rotation of the corresponding free base: [α]D = −51° (CHCl<sub>3</sub>, <i>T</i> = 20 °C, <i>c</i> = 0.00913 g/mL); enantiomer 43 retention time = 30.8 min. Specific optical rotation of the corresponding free base: enantiomer 2, specific optical rotation of the corresponding free base [α]D = +27° (CHCl<sub>3</sub>, <i>T</i> = 20 °C, <i>c</i> = 0.0113 g/mL).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(4-Methoxyphenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>44</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.18 (bs, 1H), 8.58 (s, 1H), 7.24 (d, 2H), 6.91 (d, 2H), 3.97 (dd, 1H), 3.74 (s, 3H), 3.7 (s, 3H), 3.7 (m, 1H), 3.6−3.2 (m, 4H), 3.27 (t, 2H), 2.39 (s, 3H), 2.15 (quint, 2H), 2.07 (quint, 1H), 1.49/1.05 (2t, 2H). MS: <i>m</i>/<i>z</i> 426 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>44</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO2 containing 8% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 190 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>45</b> retention time = 28.7 min; enantiomer <b>46</b> retention time = 36.4 min.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[3-(methyloxy)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>47</b>)</h3><div class="NLM_p">The title compound was obtained as a white, slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.16 (bs,1H), 8.58 (d, 1H), 7.26 (dd, 1H), 6.85 (m, 3H), 4.03 (dd, 1H), 3.77 (s, 3H), 3.72 (dd, 1H), 3.7 (s, 3H), 3.6−3.3 (bm, 4H), 3.28 (t/m, 2H), 2.39 (s, 3H), 2.18 (m, 3H), 1.53−1.1 (t/m, 2H). MS: <i>m</i>/<i>z</i> 426 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>47</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralcel OJ-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 13% (2-propanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>48</b> retention time = 24.2 min; enantiomer <b>49</b> retention time = 26.8 min.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-1-(4-Chlorophenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>50</b>)</h3><div class="NLM_p">The title compound was obtained as a white, slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: δ 9.93(bs,1H), 8.58 (s, 1H), 7.42 (d, 2H), 7.33 (d, 2H), 4.04 (dd, 1H), 3.75 (dd, 1H), 3.7 (s, 3H), 3.5 (m, 2H), 3.3 (bm, 4H), 2.39 (s, 3H), 2.2 (m, 1H), 2.15 (m, 2H), 1.47−1.14 (2t, 2H). MS: <i>m</i>/<i>z</i> 431 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>50</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 15% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 190 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>51</b> retention time = 7.8 min. Specific optical rotation of the corresponding free base: [α]D = −25° (CHCl<sub>3</sub>, <i>T</i> = 20 °C, <i>c</i> = 0.0066 g/mL). Enantiomer <b>52</b> retention time = 9.7 min. Specific optical rotation of the corresponding free base: [α]D = +29° (CHCl<sub>3</sub>, <i>T</i> = 20 °C, <i>c</i> = 0.0068 g/mL)</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-1-(3-Chlorophenyl)-5-methyl-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>53</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 9.88 (bs,1H), 8.58 (s, 1H), 7.43 (d, 1H), 7.4−7.2 (m, 3H), 4.06 (dd, 1H), 3.75 (dd, 1H), 3.7 (s, 3H), 3.62−3.54 (t/m, 2H), 3.5−3.3 (bm, 4H), 2.39 (s, 3H), 2.25 (m, 1H), 2.15 (m, 2H), 1.46−1.19 (2 m, 2H). MS: <i>m</i>/<i>z</i> 431 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>53</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 15% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>54</b> retention time = 29.6 min; enantiomer <b>55</b> retention time = 32.0 min.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-1-(4-Fluorophenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>56</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.06 (bs,1H), 8.58 (s, 1H), 7.36 (dd, 2H), 7.19 (t, 2H), 4.02 (dd, 1H), 3.74 (dd, 1H), 3.7 (s, 3H), 3.55 (m, 2H), 3.5−3.2 (bm, 4H), 2.39 (s, 3H), 2.15 (m, 3H), 1.49−1.1 (2t, 2H). MS: <i>m</i>/<i>z</i> 414 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>56</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 6% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 190 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>57</b> retention time = 26.2 min; enantiomer <b>58</b> retention time = 32.4 min</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-1-(3-Fluorophenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>59</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.21 (bs,1H), 8.58 (d, 1H), 7.4 (m, 1H), 7.2−7.0 (m, 3H), 4.03 (dd, 1H), 3.75 (dd, 1H), 3.7 (s, 3H), 3.61 (t/m, 1H), 3.52 (m, 1H), 3.3 (m, 2H), 3.28 (t, 2H), 2.38 (s, 3H), 2.25 (m, 1H), 2.16 (m, 2H), 1.57−1.17 (t/m, 2H). MS: <i>m</i>/<i>z</i> 414 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>59</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 6% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 190 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>60</b> retention time = 24.6 min; enantiomer <b>61</b> retention time = 26.0 min</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[3-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>62</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.5 (bs,1H), 8.58 (s, 1H), 7.7−7.5 (m, 4H), 4.09 (m, 1H), 3.8−3.2 (m, 8H), 3.29 (t, 2H), 2.39 (s, 3H), 2.3 (m, 1H), 2.18 (m, 2H), 1.68 (t, 1H), 1.21 (t, 1H). MS: <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>62</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 10% (ethanol + 0.1% 2-propanol), flow rate 22 mL/min, <i>P</i> 190 bar, <i>T</i> 36 °C, detection UV at 220 nm. Enantiomer <b>63</b> retention time = 17.6 min; enantiomer <b>64</b> retention time = 18.4 min</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[2-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>65</b>)</h3><div class="NLM_p last">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.48 (bs,1H), 8.55 (s, 1H), 7.9−7.6 (m, 4H), 3.9−3.1 (bm, 8H), 3.68 (s, 3H), 2.36 (s, 3H), 2.13 (m, 2H), 1.66 (m, 1H), 1.2 (m, 1H), 1.1 (m, 1H). MS: <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-{4-[(trifluoromethyl)oxy]phenyl}-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>66</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.33 (bs,1H), 8.58 (s, 1H), 7.43 (d, 2H), 7.36 (d, 2H), 4.04 (dd, 1H), 3.73 (dd, 1H), 3.7 (s, 3H), 3.6−3.2 (bm, 6H), 2.39 (s, 3H), 2.2 (m, 3H), 1.61−1.16 (2t, 2H). MS: <i>m</i>/<i>z</i> 480 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>66</b> was separated to give the separated enantiomers. Retention times given were obtained using chiral column Chiracel OD, 25 cm × 0.46 cm, eluent A: <i>n</i>-hexane; B: 2-propanol, gradient isocratic 10% B v/v, flow rate 1 mL/min, detection UV at 220 nm. Enantiomer <b>67</b> retention time = 28.3 min; enantiomer <b>68</b> retention time = 50.6 min.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(3,4-Dichlorophenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>69</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.11 (vbs, 1H), 8.58 (s, 1H), 7.6 (d + d, 2H), 6.29 (dd, 1H), 4.04/3.74 (2dd, 2H), 3.7 (s, 3H), 3.6−3.2 (m, 4H), 3.28 (t, 2H), 2.39 (s, 3H), 2.26 (quint, 1H), 2.15 (quint, 2H), 1.53/1.2 (2t, 2H). MS: <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>69</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 8% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 190 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>70</b> retention time = 38.0 min; enantiomer <b>71</b> retention time = 40.8 min.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[2-Fluoro-4-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>72</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.28 (bs,1H), 8.58 (s, 1H), 7.73 (d, 1H), 7.6 (m, 2H), 4/ 3.57 (d/m, 2H), 3.79 (d, 1H), 3.69 (s, 3H), 3.5−3.2 (vbm, 1H), 3.27 (t, 2H), 2.5 (m, 2H), 2.4 (m, 1H), 2.38 (s, 3H), 2.14 (quint, 2H), 1.62/1.16 (2t, 2H). MS: <i>m</i>/<i>z</i> 481 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>72</b> was separated to give the separated. Retention times given were obtained using an analytical HPLC using a chiral column Chiralpak AD-H 5 μm, 250 mm × 4.6 mm, eluent A, <i>n</i>-hexane; B, 2-propanol, gradient isocratic 15% B, flow rate 0.8 mL/min, detection UV at 200−400 nm. Enantiomer <b>73</b> retention time = 15.4 min; enantiomer <b>74</b> retention time = 16.3 min.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (1<i>S</i>,5<i>R</i>/1<i>R</i>,5<i>S</i>)-3-(3-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-[2-methyl-4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>75</b>)</h3><div class="NLM_p last">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.25 (bs,1H), 8.58 (s, 1H), 7.6 (m, 3H), 3.97−3.7 (dd/m, 2H), 3.79/3.4 (dd/m, 2H), 3.69 (s, 3H), 3.27 (t, 2H), 2.5 (m, 2H), 2.48 (s, 3H), 2.38 (s, 3H), 2.2 (m, 1H), 2.13 (quint, 2H), 1.61−1.01 (2t, 2H). MS: <i>m</i>/<i>z</i> 478 [M + H]<sup>+</sup>.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[4-Fluoro-3-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>76</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 10.2 (bs, 1H), 8.58 (s, 1H), 7.75 (dm, 1H), 7.72 (m, 1H), 7.53 (t, 1H), 4.06 (dd, 1H), 3.74 (dd, 1H), 3.7 (s, 3H), 3.6 (m, 2H), 3.4 (m, 2H), 3.28 (t, 2H), 2.39 (s, 3H), 2.26 (m, 1H), 2.18 (m, 2H), 1.54 (t, 1H), 1.22 (dd, 1H). MS: <i>m</i>/<i>z</i> 481 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>76</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AS-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 8% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>77</b> retention time = 25.9 min; enantiomer <b>78</b> retention time = 28.3 min.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[2-Fluoro-5-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>79</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.41 (s,1H), 7.8 (m, 1H), 7.74 (m, 1H), 7.39 (t, 1H), 4.13 (d, 1H), 3.95 (d, 1H), 3.81 (s, 3H), 3.73 (bd, 1H), 3.54 (d, 1H), 3.48 (m, 2H), 3.41 (m, 2H), 2.48 (s, 3H), 2.39 (m, 1H), 2.28 (q, 2H), 1.58 (m, 1H), 1.35 (m, 1H). MS: <i>m</i>/<i>z</i> 482 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>79</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 7% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>80</b> retention time = 21.2 min; enantiomer <b>81</b> retention time = 22.7 min.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[2-Fluoro-3-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-azabicyclo[3.1.0]hexane Hydrochloride (<b>82</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.46 (s,1H), 7.75−7.65 (m, 2H), 7.38 (t, 1H), 4.1 (d, 1H), 3.93 (d, 1H), 3.78 (s, 3H), 3.71 (d, 1H), 3.54 (d, 1H), 3.48 (t, 2H), 3.38 (t, 2H), 2.45 (s, 3H), 2.36 (m, 1H), 2.25 (m, 2H), 1.54 (m, 1H), 1.34 (m, 1H). MS: <i>m</i>/<i>z</i> 481 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>82</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AD-H, 250 mm × 4.6 mm, eluent <i>n</i>-hexane/ethanol 88/12 (isocratic), flow rate 1 mL/min, <i>P</i> 200−400 bar, <i>T</i> 36 °C, detection UV at 200−400 nm. Enantiomer <b>83</b> retention time = 20.4 min; enantiomer <b>84</b> retention time = 23.0 min.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[3-Fluoro-4-(trifluoromethyl)phenyl]-5-methyl-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>85</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.4 (s, 1H), 7.55 (t, 1H), 7.37 (d, 1H), 7.32 (d, 1H), 4.2 (d, 1H), 3.91 (d, 1H), 3.81 (s, 3H), 3.76 (d, 1H), 3.67 (d, 1H), 3.51 (t, 2H), 3.43 (t, 2H), 2.47 (s, 3H), 2.41 (m, 1H), 2.31 (m, 2H), 1.61 (t, 1H), 1.45 (t, 1H). MS: <i>m</i>/<i>z</i> 496 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>85</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 10% (ethanol + 0.1% isopropylamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>86</b> retention time = 27.1 min; enantiomer <b>87</b> retention time = 31.0 min.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[3-Fluoro-5-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-azabicyclo[3.1.0]hexane Hydrochloride (<b>88</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.46 (s,1H), 7.54 (bs, 1H), 7.47 (bd, 1H), 7.41 (bd, 1H), 4.19 (d, 1H), 3.09 (d, 1H), 3.87 (s, 3H), 3.71 (m, 2H), 3.51 (t, 2H), 3.46 (t, 2H), 2.49 (s, 3H), 2.33 (m, 3H), 1.67 (m, 1H), 1.39 (m, 1H). MS: <i>m</i>/<i>z</i> 482 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>88</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 10% (ethanol + 0.1% isopropyilamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>89</b> retention time = 12.6 min; enantiomer <b>90</b> retention time = 14.7 min.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-(2-Fluoro-4-methylphenyl)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>91</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.39 (s, 1H), 7.26 (t, 1H), 7.01 (m, 2H), 3.93 (m,1H), 3.77 (m, 4H), 3.61 (m, 1H), 3.41−3.38 (m, 5H), 2.47 (s, 3H), 2.36 (s, 3H), 2.23 (m, 2H), 2.19 (m, 1H), 1.45 (t, 1H), 1.21 (t, 1H). MS: <i>m</i>/<i>z</i> 428 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>91</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 25% (ethanol + 0.1% isopropyilamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>92</b> retention time = 13.7 min; enantiomer <b>93</b> retention time = 16.2 min.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[4-(4-Chloro-2-fluorophenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-azabicyclo[3.1.0]hexane Hydrochloride (<b>94</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.27 (s, 1H), 7.3 (t, 1H), 7.1 (m, 2H), 3.95 (d, 1H), 3.8 (d, 1H), 3.67 (s, 3H), 3.56 (dd, 1H), 3.4−3.2 (m, 5H), 2.34 (s, 3H), 2.15 (m, 3H), 1.4 (t, 1H), 1.18 (t, 1H). MS: <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>94</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical HPLC using a chiral column Chiralpak AD-H 5 μm, 250 mm × 21 mm; eluent A, <i>n</i>-hexane; B, ethanol + 0.1% isopropylamine, gradient isocratic 20% B, flow rate 6 mL/min, detection UV at 225 nm. Enantiomer <b>95</b> retention time = 18.7 min; enantiomer <b>96</b> retention time = 20.6 min.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (1R,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[4-(Methyloxy)-5-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-azabicyclo[3.1.0]hexane Hydrochloride (<b>97</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.37 (s,1H), 7.57 (m, 2H), 7.17 (d, 1H) 3.9 (m, 4H), 3.77 (s, 3H), 3.74 (m, 1H), 3.65−3.30 (m, 6H), 2.44 (s, 3H), 2.21 (m, 2H), 2.13 (m, 1H), 1.43 (t, 1H), 1.24 (m, 1H). MS: <i>m</i>/<i>z</i> 494 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>97</b> was separated to give the separated. Retention times given were obtained using an analytical supercritical fluid chromatography (Gilson) using a chiral column Chiralpak AD-H, 250 mm × 4.6 mm, eluent <i>n</i>-hexane/ethanol 70/30 (isocratic), flow rate 0.8 mL/min, detection UV at 200−400 nm. Enantiomer <b>98</b> retention time = 15.5 min; enantiomer <b>99</b> retention time = 17.5 min.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[3-Chloro-4-(methyloxy)phenyl]-3-(2-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>100</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.4 (s,1H), 7.35 (m, 1H), 7.1 (m, 2H), 4.01 (m,1H), 3.89 (m,4H), 3.8 (s, 3H), 3.6−3.3 (m, 6H), 2.47 (s, 3H), 2.23 (m, 2H), 2.19 (m, 1H), 1.4 (m, 1H), 1.2 (m, 1H). MS: <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>100</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 25% (ethanol + 0.1% isopropyilamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>101</b> retention time = 13.7 min; enantiomer <b>102</b> retention time = 16.2 min.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (1<i>R</i>,5<i>S</i>/1<i>S</i>,5<i>R</i>)-1-[3-(2-{[4-Methyl-5-(4-methyl-1,3-oxazol-5-yl)-4<i>H</i>-1,2,4-triazol-3-yl]thio}propyl)-1-{3-[(trifluoromethyl)oxy]phenyl}-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>103</b>)</h3><div class="NLM_p">The title compound was obtained as a white slightly hygroscopic solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 8.41 (s, 1H), 7.49 (t, 1H), 7.3 (s, 1H), 7.37 (d, 1H), 7.24 (m,1H), 4.17 (d,1H), 3.9 (d, 1H), 3.8 (s, 3H), 3.69 (d, 2H), 3.51 (t, 2H), 3.42 (t, 2H), 2.47 (s, 3H), 2.3 (m, 3H), 1.57 (dd, 1H), 1.36 (t, 1H). MS: <i>m</i>/<i>z</i> 480 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>103</b> was separated to give the separated enantiomers. Retention times given were obtained using an analytical supercritical fluid chromatography (Berger) using a chiral column Chiralpak AD-H, 25 cm × 0.46 cm, eluent CO<sub>2</sub> containing 12% (ethanol + 0.1% isopropyilamine), flow rate 2.5 mL/min, <i>P</i> 180 bar, <i>T</i> 35 °C, detection UV at 220 nm. Enantiomer <b>104</b> retention time = 10.7 min; enantiomer <b>105</b> retention time = 12.0 min.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Computational Modeling</h3><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Construction of the hERG Models</h4><div class="NLM_p">The closed state of the hERG channel was modeled based on its homology with the bacterial Kcsa structure from <i>Streptococcus lividans</i>, solved in 1998 by McKinnon et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Alignment of the pore region and the S6 helix is obvious from the key GYG motif (GFG in hERG) and the key hinge glycine in S6. The alignment of the S5 helices of hERG and Kcsa, however, was not obvious. This was based finally on the observation of a highly conserved glutamate at the extracellular side of S5, which is found in most potassium channels. An NMR structure of the S5-SS1 loop peptide has been published,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> which suggests that this region is largely helical. This was added to the model as a helix-turn-β-strand motif. The tetrameric ensemble was fully minimized using the CHARMm program,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> with an initial 500 steps of Steepest Descent, followed by 5000 steps of ABNR, and a constant dielectric of 5. Helical H-bonding distance constraints were used to maintain the overall fold of the bundle.</div><div class="NLM_p last">An open state model was also built using the rat Kv1.2 structure as a template.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The same S5 glutamate, pore GYG, and S6 glycine residues were used to generate the alignment. Use was made of the S5-SS1 loop model constructed for the closed state structure and the same CHARMm conditions were used for final refinement.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Construction of the Dopamine D<sub>3</sub> Receptor Models</h4><div class="NLM_p last">The model of the dopamine D<sub>3</sub> receptor was built using our “in house” program GPCR_Builder.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This is an automated 7TM receptor homology modeling program which incorporates a database of all known human and rodent Family A receptor sequences and a prealigned set of transmembrane domains for these. The models are based on the TM domain taken from the crystal structure of bovine rhodopsin.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> A special set of optimized 3D templates are used to add the extracellular loops. An internal rotamer library is then applied to all residue side chains except those conserved residues known to be involved in an important functional role (e.g., the asparagines in TM1 and TM7, the aspartate on TM2, and the DRY motif on TM3). The program automatically generates a CHARMm script, which can be used for model optimization and ligand docking. Typically, the same set of conditions as those described for the hERG models above were used during the minimization stage. A strict alignment between rhodopsin and dopamine D<sub>3</sub> gives rise to a very short loop length (2 residues) between the disulfide bonded cysteine in the second extracellular loop and the top of TM5. During the optimization some unfolding of the extracellular side of TM5 is therefore allowed by relaxing the helical distance constraints in this region. This is in keeping with the reported SCAM results carried out by Javitch et al. on the D<sub>2</sub> receptor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Automated Docking of Ligands in the Receptor and Channel Models</h4><div class="NLM_p">Partial atomic charges fitted to the electrostatic potential derived from semiempirical wave functions (MNDO) were calculated with MOPAC.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> All calculations were performed in vacuum.</div><div class="NLM_p">Automatic docking experiments were performed with Monte Carlo sampling followed by energy minimization (MCEM) using MacroModel routines and AMBER* force field. Subsequently poses were ranked according to their interaction energy defined as the difference between the energy of the complex (<i>E</i><sub>complex</sub>) and the energy of the ligand (<i>E</i><sub>ligand</sub>) and that of the protein (<i>E</i><sub>protein</sub>):</div><span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/jm-2009-01319p_m001.gif" alt="" /></img></span><div class="NLM_p last">Poses were visually inspected within Maestro and evaluated for their consistency with with SAR data generated within the same structural class.</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Micheli</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d395b2b1a1baa9babcfd96fd9ebab0bbb6bfba93b4a0b8fdb0bcbe"><span class="__cf_email__" data-cfemail="32745350405b485b5d1c771c7f5b515a575e5b725541591c515d5f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Arista</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute Research, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Bonanomi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank E. Blaney</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Medicines Research Centre, NFSP, Harlow, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Braggio</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Maria Capelli</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Checchia</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Damiani</span> - <span class="hlFld-Affiliation affiliation">European Patent Office, Munich, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romano Di-Fabio</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Fontana</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriella Gentile</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristiana Griffante</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Hamprecht</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim, Milan, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla Marchioro</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manolo Mugnaini</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqui Piner</span> - <span class="hlFld-Affiliation affiliation">Safety Assessment</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Medicines Research Centre, NFSP, Harlow, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emiliangelo Ratti</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Medicines Research Centre, NFSP, Harlow, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Tedesco</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Tarsi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Terreni</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence</span>; 
    <span class="hlFld-Affiliation affiliation"> GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Worby</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Medicines Research Centre, NFSP, Harlow, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles R. Ashby</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Saint John’s University, Jamaica, New York 11439</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Heidbreder</span> - <span class="hlFld-Affiliation affiliation">Reckitt Benckiser Pharmaceuticals, Richmond, Virginia 23235</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901319p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank all the colleagues who helped in generating the data reported in this manuscript, Drs. Caterina Mazzoni, Chiara Savoia, and Maria Pilla, and Enzo Valerio. We also thank in particular Drs. Anne Andorn and Barbara Bertani for the fruitful discussion during the preparation of this manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z-X</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanos, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">The role of central DA D<sub>3</sub> receptors in drug addiction: a review of pharmacological evidence</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.1016%2Fj.brainresrev.2004.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=15960988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Ghu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=77-105&author=C.+A.+Heidbrederauthor=E.+L.+Gardnerauthor=Z-X+Xiauthor=P.+K.+Thanosauthor=M.+Mugnainiauthor=J.+J.+Haganauthor=C.+R.+Ashby&title=The+role+of+central+DA+D3+receptors+in+drug+addiction%3A+a+review+of+pharmacological+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence</span></div><div class="casAuthors">Heidbreder, Christian A.; Gardner, Eliot L.; Xi, Zheng-Xiong; Thanos, Panayotis K.; Mugnaini, Manolo; Hagan, Jim J.; Ashby, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-105</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cDNA for the dopamine D3 receptor was isolated and characterized in 1990.  Subsequent studies have indicated that D3 receptors, as well as D3 receptor mRNA, are primarily localized in limbic regions in mammals.  This finding led to the postulate that D3 receptors may be involved in drug dependence and addiction.  However, this hypothesis has been difficult to test due to the lack of compds. with high selectivity for central D3 receptors.  The interpretation of results from studies using mixed D2/D3 agonists and/or antagonists is problematic because these agents have low selectivity for D3 over D2 receptors and it is likely that their actions are primarily related to D2 receptor antagonism and possibly interaction with other neurotransmitter receptors.  Currently, with the synthesis and characterization of new highly selective D3 receptor antagonists such as SB-277011-A this difficulty has been surmounted.  The purpose of the present article is to review, for the first time, the effects of various putative D3 receptor selective compds. in animal models of drug dependence and addiction.  The results obtained with highly selective D3 receptor antagonists such as SB-277011-A, SB-414796, and NGB-2904 indicate that central D3 receptors may play an important role in drug-induced reward, drug-taking, and cue-, drug-, and stress-induced reinstatement of drug-seeking behavior.  Provided these results can be extrapolated to human drug addicts, they suggest that selective DA D3 receptor antagonists may prove effective as potential pharmacotherapeutic agents to manage drug dependence and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwzEJPprm60rVg90H21EOLACvtfcHk0liqfvuRIJQKAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Ghu7k%253D&md5=3e5948e0f94515fd240d1e3d18812028</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2004.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2004.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DXi%26aufirst%3DZ-X%26aulast%3DThanos%26aufirst%3DP.%2BK.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3DThe%2520role%2520of%2520central%2520DA%2520D3%2520receptors%2520in%2520drug%2520addiction%253A%2520a%2520review%2520of%2520pharmacological%2520evidence%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D49%26spage%3D77%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Joyce, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">DA D3 receptor antagonists as therapeutic agents</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=917-925&author=J.+N.+Joyceauthor=M.+J.+Millan&title=DA+D3+receptor+antagonists+as+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDA%2520D3%2520receptor%2520antagonists%2520as%2520therapeutic%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D917%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective DA D3 receptor antagonists: A review 2001−2005</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=271-288&author=F.+Micheliauthor=C.+Heidbreder&title=Selective+DA+D3+receptor+antagonists%3A+A+review+2001%E2%88%922005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520DA%2520D3%2520receptor%2520antagonists%253A%2520A%2520review%25202001%25E2%2588%25922005%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D271%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">DA D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3663</span><span class="NLM_x">–</span> <span class="NLM_lpage">3679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040190e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3663-3679&author=A.+H.+Newmanauthor=P.+Grundtauthor=M.+A.+Nader&title=DA+D3+receptor+partial+agonists+and+antagonists+as+potential+drug+abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm040190e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040190e%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDA%2520D3%2520receptor%2520partial%2520agonists%2520and%2520antagonists%2520as%2520potential%2520drug%2520abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3663%26epage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span> </span><span class="NLM_article-title">Selective Dopamine D3 Receptor Antagonists; 1997−2007: A Decade of Progress</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.1517%2F13543776.18.8.821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlagsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=821-840&author=F.+Micheliauthor=C.+A.+Heidbreder&title=Selective+Dopamine+D3+Receptor+Antagonists%3B+1997%E2%88%922007%3A+A+Decade+of+Progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective dopamine D3 receptor antagonists. A decade of progress: 1997 - 2007</span></div><div class="casAuthors">Micheli, Fabrizio; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">821-840</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: A growing no. of patent applications on dopamine (DA) D3 receptors have been filed over the last 10 years.  The increased interest in this target correlates with evidence that implicates the DA D3 receptor in the control of drug-seeking behavior and in the pathophysiol. of some impulse control disorders and schizophrenia.  Objectives: This manuscript provides an overview of the most recent literature in support of the biol. rationale for the use of selective DA D3 receptor antagonists for neuropsychiatric indications, and reviews > 80 patents that reflect 10-yr advances in the discovery of these compds. by pharmaceutical companies, national research institutes and academic groups.  Methods: Anal. of > 100 primary literature and 80 patent refs. of the last 10 years.  Conclusions: The recent synthesis and profiling of new highly potent and selective DA D3 receptor antagonists over the last 10 years has permitted the testing of these compds. in a wide range of preclin. animal models of neuropsychiatric diseases.  Clin. trials have now been initiated and clin. proof-of-concept is expected in the forthcoming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosoJQzC1c8ALVg90H21EOLACvtfcHk0liPV1KkujQZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlagsb0%253D&md5=aba421201368477a4e3c9961a31305f9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.8.821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.8.821%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26atitle%3DSelective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%253B%25201997%25E2%2588%25922007%253A%2520A%2520Decade%2520of%2520Progress%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D821%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span> <span class="citation_source-journal">CNS Neurol. Disord. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.2174%2F187152708786927822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=19128200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=410-421&author=C.+Heidbreder&title=Selective+antagonism+at+dopamine+D3+receptors+as+a+target+for+drug+addiction+pharmacotherapy%3A+a+review+of+preclinical+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span></div><div class="casAuthors">Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-421</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The focal distribution of the dopamine (DA) D3 receptor in brain regions implicated in emotional and cognitive functions has made this target a main focus of drug discovery efforts.  This paper will review the most recent lines of research in support of the use of selective DA D3 receptor antagonists for the pharmacotherapeutic management of drug addiction: (1) expression of the DA D3 receptor in the rodent and human brain; (2) changes in expression of the DA D3 receptor following exposure to drugs of abuse, and (3) efficacy of selective DA D3 receptor antagonists in preclin. paradigms assessing the behavioral effects of drugs such as cocaine, nicotine, alc., methamphetamine, and heroin.  This manuscript, however, will not review the effects of nonselective DA D2/D3 receptor antagonists or partial D3 receptor agonists.  Growing evidence suggests that selective DA D3 receptor antagonists do not affect the primary reinforcing effects of drugs of abuse, but rather seem to regulate the motivation to self-administer drugs under schedules of reinforcement that require an increase in work demand.  In addn., selective antagonism at DA D3 receptors appears to disrupt significantly the responsiveness to drug-assocd. stimuli that play a key role in reinstatement of drug-seeking behavior.  These preclin. findings will be discussed in the context of translational research relevant to the design of early clin. trials and hypothesis testing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcM0jWAd6GHrVg90H21EOLACvtfcHk0lhIPz9y9BLaGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D&md5=8f187ba70d486dc49f745562fe3f9408</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F187152708786927822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927822%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520antagonism%2520at%2520dopamine%2520D3%2520receptors%2520as%2520a%2520target%2520for%2520drug%2520addiction%2520pharmacotherapy%253A%2520a%2520review%2520of%2520preclinical%2520evidence%26jtitle%3DCNS%2520Neurol.%2520Disord.%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D410%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curcuruto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di-Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarsi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecoraro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perini, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valerio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacroix, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D3 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5076</span><span class="NLM_x">–</span> <span class="NLM_lpage">5089</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0705612" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5076-5089&author=F.+Micheliauthor=G.+Bonanomiauthor=F.+E.+Blaneyauthor=S.+Braggioauthor=A.+M.+Capelliauthor=A.+Checchiaauthor=O.+Curcurutoauthor=F.+Damianiauthor=R.+Di-Fabioauthor=D.+Donatiauthor=G.+Gentileauthor=A.+Gribbleauthor=D.+Hamprechtauthor=G.+Tedescoauthor=S.+Terreniauthor=L.+Tarsiauthor=A.+Lightfootauthor=M.+Pecoraroauthor=M.+Petroneauthor=O.+Periniauthor=J.+Pinerauthor=T.+Rossiauthor=A.+Worbyauthor=M.+Pillaauthor=E.+Valerioauthor=C.+Griffanteauthor=M.+Mugnainiauthor=M.+Woodauthor=C.+Scottauthor=M.+Andreoliauthor=L.+Lacroixauthor=A.+Schwarzauthor=A.+Gozziauthor=A.+Bifoneauthor=C.+R.+Ashbyauthor=J.+J.+Haganauthor=C.+Heidbreder&title=1%2C2%2C4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines%3A+a+series+of+potent+and+selective+dopamine+D3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0705612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705612%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DChecchia%26aufirst%3DA.%26aulast%3DCurcuruto%26aufirst%3DO.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi-Fabio%26aufirst%3DR.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DGribble%26aufirst%3DA.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DLightfoot%26aufirst%3DA.%26aulast%3DPecoraro%26aufirst%3DM.%26aulast%3DPetrone%26aufirst%3DM.%26aulast%3DPerini%26aufirst%3DO.%26aulast%3DPiner%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DT.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DPilla%26aufirst%3DM.%26aulast%3DValerio%26aufirst%3DE.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DScott%26aufirst%3DC.%26aulast%3DAndreoli%26aufirst%3DM.%26aulast%3DLacroix%26aufirst%3DL.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DGozzi%26aufirst%3DA.%26aulast%3DBifone%26aufirst%3DA.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines%253A%2520a%2520series%2520of%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5076%26epage%3D5089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celestini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagliardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">New fused benzazepine as selective D<sub>3</sub> receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=901-907&author=F.+Micheliauthor=G.+Bonanomiauthor=S.+Braggioauthor=A.+M.+Capelliauthor=P.+Celestiniauthor=F.+Damianiauthor=R.+Di+Fabioauthor=D.+Donatiauthor=S.+Gagliardiauthor=G.+Gentileauthor=D.+Hamprechtauthor=M.+Petroneauthor=S.+Radaelliauthor=G.+Tedescoauthor=S.+Terreniauthor=A.+Worbyauthor=C.+Heidbreder&title=New+fused+benzazepine+as+selective+D3+receptor+antagonists.+Synthesis+and+biological+evaluation.+Part+one%3A+%5Bh%5D-fused+tricyclic+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DCelestini%26aufirst%3DP.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGagliardi%26aufirst%3DS.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DPetrone%26aufirst%3DM.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DNew%2520fused%2520benzazepine%2520as%2520selective%2520D3%2520receptor%2520antagonists.%2520Synthesis%2520and%2520biological%2520evaluation.%2520Part%2520one%253A%2520%255Bh%255D-fused%2520tricyclic%2520systems%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D901%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celestini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagliardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perini, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">New fused benzazepine as selective D<sub>3</sub> receptor antagonists. Synthesis and biological evaluation. Part two: [g]-fused and hetero fused systems</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=908-912&author=F.+Micheliauthor=G.+Bonanomiauthor=S.+Braggioauthor=A.+M.+Capelliauthor=P.+Celestiniauthor=F.+Damianiauthor=R.+Di+Fabioauthor=D.+Donatiauthor=S.+Gagliardiauthor=G.+Gentileauthor=D.+Hamprechtauthor=O.+Periniauthor=M.+Petroneauthor=S.+Radaelliauthor=G.+Tedescoauthor=S.+Terreniauthor=A.+Worbyauthor=C.+Heidbreder&title=New+fused+benzazepine+as+selective+D3+receptor+antagonists.+Synthesis+and+biological+evaluation.+Part+two%3A+%5Bg%5D-fused+and+hetero+fused+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DCelestini%26aufirst%3DP.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGagliardi%26aufirst%3DS.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DPerini%26aufirst%3DO.%26aulast%3DPetrone%26aufirst%3DM.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DNew%2520fused%2520benzazepine%2520as%2520selective%2520D3%2520receptor%2520antagonists.%2520Synthesis%2520and%2520biological%2520evaluation.%2520Part%2520two%253A%2520%255Bg%255D-fused%2520and%2520hetero%2520fused%2520systems%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D908%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bonanomi, G.; Checchia, A.; Fazzolari, E.; Hamprecht, D.; Micheli, F.; Tarsi, L.; Terreni, S.</span><span> </span><span class="NLM_article-title">3-(1,2,4-Triazol-3-ylalkyl) azabiciclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors</span>. Patent WO 2006108701,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=G.+Bonanomi&author=A.+Checchia&author=E.+Fazzolari&author=D.+Hamprecht&author=F.+Micheli&author=L.+Tarsi&author=S.+Terreni&title=3-%281%2C2%2C4-Triazol-3-ylalkyl%29+azabiciclo+%5B3.1.0%5D+hexane+derivatives+as+modulators+of+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonanomi%26aufirst%3DG.%26atitle%3D3-%25281%252C2%252C4-Triazol-3-ylalkyl%2529%2520azabiciclo%2520%255B3.1.0%255D%2520hexane%2520derivatives%2520as%2520modulators%2520of%2520dopamine%2520D3%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Arista, L.; Cardullo, F.; Checchia, A.; Hamprecht, D.; Micheli, F.; Tedesco, G.; Terreni, S..</span><span> </span><span class="NLM_article-title">Preparation of 3-azabicyclo[3.1.0]hexanes as selective modulators of dopamine D3 receptors</span>. Patent WO 2006133946,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=L.+Arista&author=F.+Cardullo&author=A.+Checchia&author=D.+Hamprecht&author=F.+Micheli&author=G.+Tedesco&author=S..+Terreni&title=Preparation+of+3-azabicyclo%5B3.1.0%5Dhexanes+as+selective+modulators+of+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArista%26aufirst%3DL.%26atitle%3DPreparation%2520of%25203-azabicyclo%255B3.1.0%255Dhexanes%2520as%2520selective%2520modulators%2520of%2520dopamine%2520D3%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">The research complied with national legislation and with company policy on the Care and Use of Animals and with related codes of practice.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Atkinson, F.; Bravi, G.</span>The SAR Toolkit, <span class="NLM_conf-name">UK-QSAR and ChemoInformatics Group Meeting</span>, <span class="NLM_conf-date">October 2007</span>; Abstract (<a href="http://www.iainm.demon.co.uk/ukqsar/meetings/2007-10-11.html#abstract_e013ca26c3a3c590184b907a3d2668c2" class="extLink">http://www.iainm.demon.co.uk/ukqsar/meetings/2007-10-11.html#abstract_e013ca26c3a3c590184b907a3d2668c2</a>) and presentation (<a href="http://www.documentarea.com/qsar/Francis_Atkinson07.pdf" class="extLink">http://www.documentarea.com/qsar/Francis_Atkinson07.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Atkinson%2C+F.%3B+Bravi%2C+G.The+SAR+Toolkit%2C+UK-QSAR+and+ChemoInformatics+Group+Meeting%2C+October+2007%3B+Abstract+%28http%3A%2F%2Fwww.iainm.demon.co.uk%2Fukqsar%2Fmeetings%2F2007-10-11.html%23abstract_e013ca26c3a3c590184b907a3d2668c2%29+and+presentation+%28http%3A%2F%2Fwww.documentarea.com%2Fqsar%2FFrancis_Atkinson07.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DF.%26jtitle%3DThe%2520SAR%2520Toolkit" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Daylight v4.92; <span class="NLM_publisher-name">Chemical Information Systems Inc.</span>: <span class="NLM_publisher-loc">Aliso Viejo, CA</span>, <a href="http://www.daylight.com" class="extLink">http://www.daylight.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Daylight+v4.92%3B+Chemical+Information+Systems+Inc.%3A+Aliso+Viejo%2C+CA%2C+http%3A%2F%2Fwww.daylight.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDaylight%2520v4.92%26pub%3DChemical%2520Information%2520Systems%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>Spotfire Decision Site 8.2.1; available from <a href="http://www.spotfire.com/" class="extLink">http://www.spotfire.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Spotfire+Decision+Site+8.2.1%3B+available+from+http%3A%2F%2Fwww.spotfire.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DSpotfire%2520Decision%2520Site%25208.2.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_publisher-name">Aptuit Limited</span>, <span class="NLM_publisher-loc">3 Simpson Parkway, Livingston,West Lothian, EH54 7BH, Scotland</span>, <a href="http://www.aptuit.uk" class="extLink">www.aptuit.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aptuit+Limited%2C+3+Simpson+Parkway%2C+Livingston%2CWest+Lothian%2C+EH54+7BH%2C+Scotland%2C+www.aptuit.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DAptuit%2520Limited" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">A structural basis for drug-induced long QT syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci.U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">12329</span><span class="NLM_x">–</span> <span class="NLM_lpage">12333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.1073%2Fpnas.210244497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=11005845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=12329-12333&author=J.+S.+Mitchesonauthor=J.+Chenauthor=M.+Linauthor=C.+Culbersonauthor=M.+C.+Sanguinetti&title=A+structural+basis+for+drug-induced+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A structural basis for drug-induced long QT syndrome</span></div><div class="casAuthors">Mitcheson, John S.; Chen, Jun; Lin, Monica; Culberson, Chris; Sanguinetti, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12329-12333</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the HERG K+ channel gene cause inherited long QT syndrome (LQT), a disorder of cardiac repolarization that predisposes affected individuals to lethal arrhythmias.  Acquired LQT is far more common and is most often caused by block of cardiac HERG K+ channels by commonly used medications.  It is unclear why so many structurally diverse compds. block HERG channels, but this undesirable side effect now is recognized as a major hurdle in the development of new and safe drugs.  Here we use alanine-scanning mutagenesis to det. the structural basis for high-affinity drug block of HERG channels by MK-499, a methanesulfonanilide antiarrhythmic drug.  The binding site, corroborated with homol. modeling, is comprised of amino acids located on the S6 transmembrane domain (G648, Y652, and F656) and pore helix (T623 and V625) of the HERG channel subunit that face the cavity of the channel.  Other compds. that are structurally unrelated to MK-499, but cause LQT, also were studied.  The antihistamine terfenadine and a gastrointestinal prokinetic drug, cisapride, interact with Y652 and F656, but not with V625.  The arom. residues of the S6 domain that interact with these drugs (Y652 and F656) are unique to eag/erg K+ channels.  Other voltage-gated K+ (Kv) channels have lle and Val (lle) in the equiv. positions.  These findings suggest a possible structural explanation for how so many commonly used medications block HERG but not other Kv channels and should facilitate the rational design of drugs devoid of HERG channel binding activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczBuinwjCZrVg90H21EOLACvtfcHk0ljVlA5AkUTioQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D&md5=595505ebd987ee7a4af280016c03ea35</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.210244497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.210244497%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DA%2520structural%2520basis%2520for%2520drug-induced%2520long%2520QT%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.U.S.A.%26date%3D2000%26volume%3D97%26spage%3D12329%26epage%3D12333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug-hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-124&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug-hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug-hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_publisher-name">CERB</span>, <span class="NLM_publisher-loc">Chemin de Montifault, 18800 Baugy, France</span><a href="http://www.cerb.fr" class="extLink">www.cerb.fr</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CERB%2C+Chemin+de+Montifault%2C+18800+Baugy%2C+Francewww.cerb.fr."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DCERB" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Burris, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filtz, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumpradit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulon, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinoff, P. B.</span><span> </span><span class="NLM_article-title">Characterization of [<sup>125</sup>I](<i>R</i>)-<i>trans</i>-7-hydroxy-2-[<i>N</i>-propyl-<i>N</i>-(3′-iodo-2′-propenyl)amino] tetralin binding to dopamine D<sub>3</sub> receptors in rat olfactory tubercle</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=8114008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADyaK2cXitVynu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1994&pages=935-942&author=K.+D.+Burrisauthor=T.+M.+Filtzauthor=S.+Chumpraditauthor=M.+P.+Kungauthor=C+Foulonauthor=J.+G.+Henslerauthor=H.+F.+Kungauthor=P.+B.+Molinoff&title=Characterization+of+%5B125I%5D%28R%29-trans-7-hydroxy-2-%5BN-propyl-N-%283%E2%80%B2-iodo-2%E2%80%B2-propenyl%29amino%5D+tetralin+binding+to+dopamine+D3+receptors+in+rat+olfactory+tubercle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin binding to dopamine D3 receptors in rat olfactory tubercle</span></div><div class="casAuthors">Burris, Kevin D.; Filtz, Theresa M.; Chumpradit, Sumalee; Kung, Mei Ping; Foulon, Catherine; Hensler, Julie G.; Kung, Hank F.; Molinoff, Perry B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">935-42</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">[125I](R,S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin {[125I](R,S)-trans-7-OH-PIPAT} has been shown to bind with high affinity to dopamine D3 receptors expressed in Spodoptera frugiperda cells.  No specific binding was seen in S. frugiperda cells expressing a high d. of D2 receptors.  It was therefore, suggested that [125I](R,S)-trans-7-OH-PIPAT selectively labels D3 receptors.  In the present study, satn. binding of [125I](R)-trans-7-OH-PIPAT to membranes from rat olfactory tubercle resulted in markedly curvilinear Scatchard plots, suggesting that the radioligand was binding to more than one receptor class or affinity state.  [125I](R)-trans-7-OH-PIPAT bound with high affinity to membranes from human embryonic kidney-293 cells expressing transfected D2 or D3 receptors and to membranes from Chinese hamster ovary cells expressing serotonin1A receptors.  Binding of [125I](R)-trans-7-OH-PIPAT to serotonin1A and D2 receptors was decreased or eliminated in the presence of NaCl and/or guanylylimidodiphosphate [Gpp(NH)p].  In the presence of Gpp(NH)p and NaCl, a linear Scatchard plot with a Kd value of 0.4 nM and a d. of 100 fmol/mg of protein was obtained in membranes from rat olfactory tubercle.  Agonists and antagonists inhibited binding of [125I](R)-trans-7-OH-PIPAt with a rank order of potency consistent with an interaction at D3 receptors.  These results suggest that, in the presence of Gpp(NH)p and NaCl, [125I](R)-trans-7-OH-PIPAT specifically labels D3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-V0z3zdC1jbVg90H21EOLACvtfcHk0lhIu_1tVS6EBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitVynu7w%253D&md5=5b4a38e09888fe1b2c5b742ee445901e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DK.%2BD.%26aulast%3DFiltz%26aufirst%3DT.%2BM.%26aulast%3DChumpradit%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DFoulon%26aufirst%3DC%26aulast%3DHensler%26aufirst%3DJ.%2BG.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DMolinoff%26aufirst%3DP.%2BB.%26atitle%3DCharacterization%2520of%2520%255B125I%255D%2528R%2529-trans-7-hydroxy-2-%255BN-propyl-N-%25283%25E2%2580%25B2-iodo-2%25E2%2580%25B2-propenyl%2529amino%255D%2520tetralin%2520binding%2520to%2520dopamine%2520D3%2520receptors%2520in%2520rat%2520olfactory%2520tubercle%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D268%26spage%3D935%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dewey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerasimov, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">A pharmacologic strategy for the treatment of nicotine addiction</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1999&pages=76-86&author=S.+L.+Deweyauthor=J.+D.+Brodieauthor=M+Gerasimovauthor=B+Horanauthor=E.+L.+Gardnerauthor=C.+R.+Ashby&title=A+pharmacologic+strategy+for+the+treatment+of+nicotine+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDewey%26aufirst%3DS.%2BL.%26aulast%3DBrodie%26aufirst%3DJ.%2BD.%26aulast%3DGerasimov%26aufirst%3DM%26aulast%3DHoran%26aufirst%3DB%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3DA%2520pharmacologic%2520strategy%2520for%2520the%2520treatment%2520of%2520nicotine%2520addiction%26jtitle%3DSynapse%26date%3D1999%26volume%3D31%26spage%3D76%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Horan, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepore, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">(−)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1997&pages=93-94&author=B+Horanauthor=M+Smithauthor=E.+L.+Gardnerauthor=M+Leporeauthor=C.+R.+Ashby&title=%28%E2%88%92%29-Nicotine+produces+conditioned+place+preference+in+Lewis%2C+but+not+Fischer+344+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DB%26aulast%3DSmith%26aufirst%3DM%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DLepore%26aufirst%3DM%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3D%2528%25E2%2588%2592%2529-Nicotine%2520produces%2520conditioned%2520place%2520preference%2520in%2520Lewis%252C%2520but%2520not%2520Fischer%2520344%2520rats%26jtitle%3DSynapse%26date%3D1997%26volume%3D26%26spage%3D93%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Horan, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (−)-nicotine in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">R1</span><span class="NLM_x">–</span> <span class="NLM_lpage">R2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2001&pages=R1-R2&author=B+Horanauthor=E.+L.+Gardnerauthor=S.+L.+Deweyauthor=J.+D.+Brodieauthor=C.+R.+Ashby&title=The+selective+sigma%281%29+receptor+agonist%2C+1-%283%2C4-dimethoxyphenethyl%29-4-%28phenylpropyl%29piperazine+%28SA4503%29%2C+blocks+the+acquisition+of+the+conditioned+place+preference+response+to+%28%E2%88%92%29-nicotine+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DB%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DDewey%26aufirst%3DS.%2BL.%26aulast%3DBrodie%26aufirst%3DJ.%2BD.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3DThe%2520selective%2520sigma%25281%2529%2520receptor%2520agonist%252C%25201-%25283%252C4-dimethoxyphenethyl%2529-4-%2528phenylpropyl%2529piperazine%2520%2528SA4503%2529%252C%2520blocks%2520the%2520acquisition%2520of%2520the%2520conditioned%2520place%2520preference%2520response%2520to%2520%2528%25E2%2588%2592%2529-nicotine%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D426%26spage%3DR1%26epage%3DR2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kaab, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuckelmann, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, G. F.</span><span> </span><span class="NLM_article-title">Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=1383-1393&author=S.+Kaabauthor=J.+Dixonauthor=J.+Ducauthor=D.+Ashenauthor=M.+Nabauerauthor=D.+J.+Beuckelmannauthor=G.+Steinbeckauthor=D.+McKinnonauthor=G.+F.+Tomaselli&title=Molecular+basis+of+transient+outward+potassium+current+downregulation+in+human+heart+failure%3A+a+decrease+in+Kv4.3+mRNA+correlates+with+a+reduction+in+current+density"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaab%26aufirst%3DS.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DDuc%26aufirst%3DJ.%26aulast%3DAshen%26aufirst%3DD.%26aulast%3DNabauer%26aufirst%3DM.%26aulast%3DBeuckelmann%26aufirst%3DD.%2BJ.%26aulast%3DSteinbeck%26aufirst%3DG.%26aulast%3DMcKinnon%26aufirst%3DD.%26aulast%3DTomaselli%26aufirst%3DG.%2BF.%26atitle%3DMolecular%2520basis%2520of%2520transient%2520outward%2520potassium%2520current%2520downregulation%2520in%2520human%2520heart%2520failure%253A%2520a%2520decrease%2520in%2520Kv4.3%2520mRNA%2520correlates%2520with%2520a%2520reduction%2520in%2520current%2520density%26jtitle%3DCirculation%26date%3D1998%26volume%3D98%26spage%3D1383%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Torres, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauskin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewood, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuchel, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, J. I.</span><span> </span><span class="NLM_article-title">Structure of the HERG K<sup>+</sup> Channel S5P Extracellular Linker: Role of an Amphipathic alpha-Helix in C-Type Inactivation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">42136</span><span class="NLM_x">–</span> <span class="NLM_lpage">42148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=42136-42148&author=A.+M.+Torresauthor=P.+S.+Bansalauthor=M.+Sundeauthor=C.+E.+Clarkeauthor=J.+A.+Bursillauthor=D.+J.+Smithauthor=A.+Bauskinauthor=S.+N.+Breitauthor=T.+J.+Campbellauthor=P.+F.+Alewoodauthor=P.+W.+Kuchelauthor=J.+I.+Vandenberg&title=Structure+of+the+HERG+K%2B+Channel+S5P+Extracellular+Linker%3A+Role+of+an+Amphipathic+alpha-Helix+in+C-Type+Inactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DA.%2BM.%26aulast%3DBansal%26aufirst%3DP.%2BS.%26aulast%3DSunde%26aufirst%3DM.%26aulast%3DClarke%26aufirst%3DC.%2BE.%26aulast%3DBursill%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BJ.%26aulast%3DBauskin%26aufirst%3DA.%26aulast%3DBreit%26aufirst%3DS.%2BN.%26aulast%3DCampbell%26aufirst%3DT.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26aulast%3DKuchel%26aufirst%3DP.%2BW.%26aulast%3DVandenberg%26aufirst%3DJ.%2BI.%26atitle%3DStructure%2520of%2520the%2520HERG%2520K%252B%2520Channel%2520S5P%2520Extracellular%2520Linker%253A%2520Role%2520of%2520an%2520Amphipathic%2520alpha-Helix%2520in%2520C-Type%2520Inactivation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D42136%26epage%3D42148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><a href="http://www.accelrys.com" class="extLink">www.accelrys.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.accelrys.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Magis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Du, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charbonnier, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulain, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuniasse, P.</span><span> </span><span class="NLM_article-title">Structure-Based Secondary Structure-Independent Approach To Design Protein Ligands: Application to the Design of Kv1..2 Potassium Channel Blockers</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">16190</span><span class="NLM_x">–</span> <span class="NLM_lpage">16205</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0646491" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16190-16205&author=C.+Magisauthor=D.+Gaspariniauthor=A.+Lecoqauthor=M.+H.+Le+Duauthor=E.+Sturaauthor=J.+B.+Charbonnierauthor=G.+Mourierauthor=J.-C.+Boulainauthor=L.+Pardoauthor=A.+Caruanaauthor=A.+Jolyauthor=M.+Lefrancauthor=M.+Masellaauthor=A.+Menezauthor=P.+Cuniasse&title=Structure-Based+Secondary+Structure-Independent+Approach+To+Design+Protein+Ligands%3A+Application+to+the+Design+of+Kv1..2+Potassium+Channel+Blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja0646491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0646491%26sid%3Dliteratum%253Aachs%26aulast%3DMagis%26aufirst%3DC.%26aulast%3DGasparini%26aufirst%3DD.%26aulast%3DLecoq%26aufirst%3DA.%26aulast%3DLe%2BDu%26aufirst%3DM.%2BH.%26aulast%3DStura%26aufirst%3DE.%26aulast%3DCharbonnier%26aufirst%3DJ.%2BB.%26aulast%3DMourier%26aufirst%3DG.%26aulast%3DBoulain%26aufirst%3DJ.-C.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DCaruana%26aufirst%3DA.%26aulast%3DJoly%26aufirst%3DA.%26aulast%3DLefranc%26aufirst%3DM.%26aulast%3DMasella%26aufirst%3DM.%26aulast%3DMenez%26aufirst%3DA.%26aulast%3DCuniasse%26aufirst%3DP.%26atitle%3DStructure-Based%2520Secondary%2520Structure-Independent%2520Approach%2520To%2520Design%2520Protein%2520Ligands%253A%2520Application%2520to%2520the%2520Design%2520of%2520Kv1..2%2520Potassium%2520Channel%2520Blockers%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D16190%26epage%3D16205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Blaney, F. E.; Tennant, M.</span><span class="NLM_x"> (</span><span class="NLM_year">1996</span><span class="NLM_x">) </span><span> </span><span class="NLM_article-title">Computational tools and results in the construction of G protein-coupled receptor models</span>. In  <span class="citation_source-book">Membrane Protein Models</span>; <span class="NLM_contrib-group">Findlay, J. B. C.</span>, Ed.; <span class="NLM_publisher-name">Bios Scientific Publishers Ltd.</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">161</span>− <span class="NLM_lpage">176</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=161-176&author=F.+E.+Blaney&author=M.+Tennantauthor=J.+B.+C.+Findlay&title=Membrane+Protein+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26date%3D1996%26atitle%3DComputational%2520tools%2520and%2520results%2520in%2520the%2520construction%2520of%2520G%2520protein-coupled%2520receptor%2520models%26btitle%3DMembrane%2520Protein%2520Models%26aulast%3DFindlay%26aufirst%3DJ.%2BB.%2BC.%26pub%3DBios%2520Scientific%2520Publishers%2520Ltd%26date%3D1996%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Polczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of rhodopsin: a G protein-coupled receptor</span>.  <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span>− <span class="NLM_lpage">745</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=739-745&author=K.+Polczewski&author=T.+Kumasaka&author=T.+Hori&author=C.+A.+Behnke&author=H.+Motoshima&author=B.+A.+Fox&author=I.+Le+Trong&author=D.+C.+Teller&author=T.+Okada&author=R.+E.+Stenkamp&author=M.+Yamamoto&author=M.+Miyano&title=Crystal+structure+of+rhodopsin%3A+a+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolczewski%26aufirst%3DK.%26atitle%3DCrystal%2520structure%2520of%2520rhodopsin%253A%2520a%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A..</span><span> </span><span class="NLM_article-title">The First Transmembrane Segment of the Dopamine D2 Receptor: Accessibility in the Binding-Site Crevice and Position in the Transmembrane Bundle</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">12339</span><span class="NLM_x">–</span> <span class="NLM_lpage">12348</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi011204a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=12339-12348&author=L.+Shiauthor=M.+M.+Simpsonauthor=J.+A.+Ballesterosauthor=J.+A..+Javitch&title=The+First+Transmembrane+Segment+of+the+Dopamine+D2+Receptor%3A+Accessibility+in+the+Binding-Site+Crevice+and+Position+in+the+Transmembrane+Bundle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi011204a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011204a%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSimpson%26aufirst%3DM.%2BM.%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DJavitch%26aufirst%3DJ.%2BA..%26atitle%3DThe%2520First%2520Transmembrane%2520Segment%2520of%2520the%2520Dopamine%2520D2%2520Receptor%253A%2520Accessibility%2520in%2520the%2520Binding-Site%2520Crevice%2520and%2520Position%2520in%2520the%2520Transmembrane%2520Bundle%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D12339%26epage%3D12348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><a href="http://www.openmopac.com" class="extLink">www.openmopac.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.openmopac.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':[],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Qingtong Zhou, Wenzhong Yan, Jian Sun, Alan P. Kozikowski, Suwen Zhao, Xi-Ping Huang, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4579-4602. <a href="https://doi.org/10.1021/acs.jmedchem.9b01835" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBitopic%252B2-Phenylcyclopropylmethylamine%252B%252528PCPMA%252529%252BDerivatives%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%26aulast%3DTan%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18112019%26date%3D23042020%26date%3D13042020%26volume%3D63%26issue%3D9%26spage%3D4579%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean W.  Reilly</span>, <span class="hlFld-ContribAuthor ">Suzy  Griffin</span>, <span class="hlFld-ContribAuthor ">Michelle  Taylor</span>, <span class="hlFld-ContribAuthor ">Kristoffer  Sahlholm</span>, <span class="hlFld-ContribAuthor ">Chi-Chang  Weng</span>, <span class="hlFld-ContribAuthor ">Kuiying  Xu</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Jacome</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, and <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9905-9910. <a href="https://doi.org/10.1021/acs.jmedchem.7b01248" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01248%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BDopamine%252BD3%252BReceptor%252BAntagonists%252Bwith%252BArylated%252BDiazaspiro%252BAlkane%252BCores%26aulast%3DReilly%26aufirst%3DSean%2BW.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23082017%26date%3D21112017%26date%3D14122017%26date%3D10112017%26volume%3D60%26issue%3D23%26spage%3D9905%26epage%3D9910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Alessia  Bacchi</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Laura  Castelletti</span>, <span class="hlFld-ContribAuthor ">Palmina  Cavallini</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Susanna  Cremonesi</span>, <span class="hlFld-ContribAuthor ">Michele  Dal Cin</span>, <span class="hlFld-ContribAuthor ">Aldo  Feriani</span>, <span class="hlFld-ContribAuthor ">Sylvie  Gehanne</span>, <span class="hlFld-ContribAuthor ">Mahmud  Kajbaf</span>, <span class="hlFld-ContribAuthor ">Luciano  Marchió</span>, <span class="hlFld-ContribAuthor ">Selena  Nola</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Annalisa  Pellacani</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Perdonà</span>, <span class="hlFld-ContribAuthor ">Anna  Sava</span>, <span class="hlFld-ContribAuthor ">Teresa  Semeraro</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Tomelleri</span>, <span class="hlFld-ContribAuthor ">Andrea  Wong</span>, <span class="hlFld-ContribAuthor ">Filippo  Visentini</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span>, and <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>  . </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8549-8576. <a href="https://doi.org/10.1021/acs.jmedchem.6b00972" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00972%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazolyl%252B5-Azaspiro%25255B2.4%25255Dheptanes%25253A%252BLead%252BIdentification%252Band%252BEarly%252BLead%252BOptimization%252Bof%252Ba%252BNew%252BSeries%252Bof%252BPotent%252Band%252BSelective%252BDopamine%252BD3%252BReceptor%252BAntagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08072016%26date%3D09092016%26date%3D22092016%26date%3D26082016%26volume%3D59%26issue%3D18%26spage%3D8549%26epage%3D8576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">William S.  John</span>, <span class="hlFld-ContribAuthor ">Paul W.  Czoty</span>, <span class="hlFld-ContribAuthor ">Michael A.  Nader</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (14)
                                     , 5361-5380. <a href="https://doi.org/10.1021/jm501512b" title="DOI URL">https://doi.org/10.1021/jm501512b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501512b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501512b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentifying%252BMedication%252BTargets%252Bfor%252BPsychostimulant%252BAddiction%25253A%252BUnraveling%252Bthe%252BDopamine%252BD3%252BReceptor%252BHypothesis%26aulast%3DKeck%26aufirst%3DThomas%2BM.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01102014%26date%3D31032015%26date%3D23072015%26volume%3D58%26issue%3D14%26spage%3D5361%26epage%3D5380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subramaniam  Ananthan</span>, <span class="hlFld-ContribAuthor ">Surendra K.  Saini</span>, <span class="hlFld-ContribAuthor ">Guangyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Judith V.  Hobrath</span>, <span class="hlFld-ContribAuthor ">Indira  Padmalayam</span>, <span class="hlFld-ContribAuthor ">Ling  Zhai</span>, <span class="hlFld-ContribAuthor ">J. Robert  Bostwick</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Shea  McDowell</span>, <span class="hlFld-ContribAuthor ">Eunie  Cho</span>, <span class="hlFld-ContribAuthor ">Leah  McAleer</span>, <span class="hlFld-ContribAuthor ">Michelle  Taylor</span>, and <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure–Activity Relationship Studies of a Series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines: Insights into Structural Features Contributing to Dopamine D3 versus D2 Receptor Subtype Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (16)
                                     , 7042-7060. <a href="https://doi.org/10.1021/jm500801r" title="DOI URL">https://doi.org/10.1021/jm500801r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500801r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500801r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252Ba%252BSeries%252Bof%252B%25255B4-%2525284-Carboxamidobutyl%252529%25255D-1-arylpiperazines%25253A%252BInsights%252Binto%252BStructural%252BFeatures%252BContributing%252Bto%252BDopamine%252BD3%252Bversus%252BD2%252BReceptor%252BSubtype%252BSelectivity%26aulast%3DAnanthan%26aufirst%3DSubramaniam%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23052014%26date%3D15082014%26date%3D28082014%26volume%3D57%26issue%3D16%26spage%3D7042%26epage%3D7060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingbo  Xiao</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Elena  Barnaeva</span>, <span class="hlFld-ContribAuthor ">Jennie L.  Conroy</span>, <span class="hlFld-ContribAuthor ">Trevor  Doyle</span>, <span class="hlFld-ContribAuthor ">Brittney  Miller</span>, <span class="hlFld-ContribAuthor ">Marthe  Bryant-Genevier</span>, <span class="hlFld-ContribAuthor ">Mercedes K.  Taylor</span>, <span class="hlFld-ContribAuthor ">Xin  Hu</span>, <span class="hlFld-ContribAuthor ">Andrés E.  Dulcey</span>, <span class="hlFld-ContribAuthor ">Noel  Southall</span>, <span class="hlFld-ContribAuthor ">Marc  Ferrer</span>, <span class="hlFld-ContribAuthor ">Steve  Titus</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>, and <span class="hlFld-ContribAuthor ">Juan J.  Marugan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery, Optimization, and Characterization of Novel D2 Dopamine Receptor Selective Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (8)
                                     , 3450-3463. <a href="https://doi.org/10.1021/jm500126s" title="DOI URL">https://doi.org/10.1021/jm500126s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500126s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500126s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BOptimization%25252C%252Band%252BCharacterization%252Bof%252BNovel%252BD2%252BDopamine%252BReceptor%252BSelective%252BAntagonists%26aulast%3DXiao%26aufirst%3DJingbo%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23012014%26date%3D10042014%26date%3D24042014%26date%3D25032014%26volume%3D57%26issue%3D8%26spage%3D3450%26epage%3D3463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "><span class="perennialReviewAddition">Na</span><span class="perennialReviewAddition">Ye</span></span>, <span class="hlFld-ContribAuthor ">John L.  Neumeyer</span>, <span class="hlFld-ContribAuthor ">Ross J.  Baldessarini</span>, <span class="hlFld-ContribAuthor "><span class="perennialReviewAddition">Xuechu</span><span class="perennialReviewAddition">Zhen</span></span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (5)
                                     , PR123-PR178. <a href="https://doi.org/10.1021/cr300113a" title="DOI URL">https://doi.org/10.1021/cr300113a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr300113a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr300113a%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DUpdate%252B1%252Bof%25253A%252BRecent%252BProgress%252Bin%252BDevelopment%252Bof%252BDopamine%252BReceptor%252BSubtype-Selective%252BAgents%25253A%252BPotential%252BTherapeutics%252Bfor%252BNeurological%252Band%252BPsychiatric%252BDisorders%26aulast%3DYe%26aufirst%3DNa%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D16032012%26date%3D08052013%26volume%3D113%26issue%3D5%26spage%3DPR123%26epage%3DPR178%3Cspan+class%3D%22perennialReviewAddition%22%3E%3C%2Fspan%3E%3Cspan+class%3D%22perennialReviewAddition%22%3E%3C%2Fspan%3E%3Cspan+class%3D%22perennialReviewAddition%22%3E%3C%2Fspan%3E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyong  Chen</span>, <span class="hlFld-ContribAuthor ">Gregory T.  Collins</span>, <span class="hlFld-ContribAuthor ">Beth  Levant</span>, <span class="hlFld-ContribAuthor ">James  Woods</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Deschamps</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (8)
                                     , 620-625. <a href="https://doi.org/10.1021/ml200100t" title="DOI URL">https://doi.org/10.1021/ml200100t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200100t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200100t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCJ-1639%25253A%252BA%252BPotent%252Band%252BHighly%252BSelective%252BDopamine%252BD3%252BReceptor%252BFull%252BAgonist%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D19042011%26date%3D19062011%26date%3D28062011%26date%3D11082011%26volume%3D2%26issue%3D8%26spage%3D620%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashwini K.  Banala</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Levy</span>, <span class="hlFld-ContribAuthor ">Sameer S.  Khatri</span>, <span class="hlFld-ContribAuthor ">Cheryse A.  Furman</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Roof</span>, <span class="hlFld-ContribAuthor ">Yogesh  Mishra</span>, <span class="hlFld-ContribAuthor ">Suzy A.  Griffin</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">N-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as Selective Dopamine D3 Receptor Ligands: Critical Role of the Carboxamide Linker for D3 Receptor Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (10)
                                     , 3581-3594. <a href="https://doi.org/10.1021/jm200288r" title="DOI URL">https://doi.org/10.1021/jm200288r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200288r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200288r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-%2525283-Fluoro-4-%2525284-%2525282-methoxy%252Bor%252B2%25252C3-dichlorophenyl%252529piperazine-1-yl%252529butyl%252529arylcarboxamides%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%25253A%252BCritical%252BRole%252Bof%252Bthe%252BCarboxamide%252BLinker%252Bfor%252BD3%252BReceptor%252BSelectivity%26aulast%3DBanala%26aufirst%3DAshwini%2BK.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D11032011%26date%3D02052011%26date%3D26052011%26date%3D15042011%26volume%3D54%26issue%3D10%26spage%3D3581%26epage%3D3594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Massari</span>, <span class="hlFld-ContribAuthor ">Laura  Panelli</span>, <span class="hlFld-ContribAuthor ">Mark  Hughes</span>, <span class="hlFld-ContribAuthor ">Federica  Stazi</span>, <span class="hlFld-ContribAuthor ">William  Maton</span>, <span class="hlFld-ContribAuthor ">Pieter  Westerduin</span>, <span class="hlFld-ContribAuthor ">Federico  Scaravelli</span>, and <span class="hlFld-ContribAuthor ">Sergio  Bacchi</span>. </span><span class="cited-content_cbyCitation_article-title">A Mechanistic Insight into a Simple C−N Bond Formation via SN2 Displacement: A Synergistic Kinetics and Design of Experiment Approach. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2010,</strong> <em>14 </em>
                                    (6)
                                     , 1364-1372. <a href="https://doi.org/10.1021/op100176u" title="DOI URL">https://doi.org/10.1021/op100176u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op100176u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop100176u%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BMechanistic%252BInsight%252Binto%252Ba%252BSimple%252BC%2525E2%252588%252592N%252BBond%252BFormation%252Bvia%252BSN2%252BDisplacement%25253A%252BA%252BSynergistic%252BKinetics%252Band%252BDesign%252Bof%252BExperiment%252BApproach%26aulast%3DMassari%26aufirst%3DLuca%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D24%252006%25202010%26date%3D04102010%26date%3D19112010%26volume%3D14%26issue%3D6%26spage%3D1364%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Luca  Arista</span>, <span class="hlFld-ContribAuthor ">Barbara  Bertani</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Capelli</span>, <span class="hlFld-ContribAuthor ">Susanna  Cremonesi</span>, <span class="hlFld-ContribAuthor ">Romano  Di-Fabio</span>, <span class="hlFld-ContribAuthor ">Giacomo  Gelardi</span>, <span class="hlFld-ContribAuthor ">Gabriella  Gentile</span>, <span class="hlFld-ContribAuthor ">Carla  Marchioro</span>, <span class="hlFld-ContribAuthor ">Alessandra  Pasquarello</span>, <span class="hlFld-ContribAuthor ">Stefano  Provera</span>, <span class="hlFld-ContribAuthor ">Giovanna  Tedesco</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Terreni</span>, <span class="hlFld-ContribAuthor ">Angela  Worby</span>, and <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploration of the Amine Terminus in a Novel Series of 1,2,4-Triazolo-3-yl-azabicyclo[3.1.0]hexanes as Selective Dopamine D3 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 7129-7139. <a href="https://doi.org/10.1021/jm100832d" title="DOI URL">https://doi.org/10.1021/jm100832d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100832d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100832d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bthe%252BAmine%252BTerminus%252Bin%252Ba%252BNovel%252BSeries%252Bof%252B1%25252C2%25252C4-Triazolo-3-yl-azabicyclo%25255B3.1.0%25255Dhexanes%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BAntagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D05072010%26date%3D14092010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D7129%26epage%3D7139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siqi  Wang</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Filatov</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Lozovskiy</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Shmakov</span>, <span class="hlFld-ContribAuthor ">Olesya V.  Khoroshilova</span>, <span class="hlFld-ContribAuthor ">Anna G.  Larina</span>, <span class="hlFld-ContribAuthor ">Stanislav I.  Selivanov</span>, <span class="hlFld-ContribAuthor ">Vitali M.  Boitsov</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Stepakov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of Spiro[3-azabicyclo[3.1.0]hexanes] via 1,3-Dipolar Cycloaddition of 1,2-Diphenylcyclopropenes to Ninhydrin-Derived Azomethine Ylides. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (12)
                                     , 2114-2132. <a href="https://doi.org/10.1055/a-1360-9716" title="DOI URL">https://doi.org/10.1055/a-1360-9716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1360-9716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1360-9716%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DConstruction%252Bof%252BSpiro%25255B3-azabicyclo%25255B3.1.0%25255Dhexanes%25255D%252Bvia%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252B1%25252C2-Diphenylcyclopropenes%252Bto%252BNinhydrin-Derived%252BAzomethine%252BYlides%26aulast%3DWang%26aufirst%3DSiqi%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D12%26spage%3D2114%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tadashi  Honda</span>, <span class="hlFld-ContribAuthor ">Iwao  Ojima</span>. </span><span class="cited-content_cbyCitation_article-title">Curious effects of fluorine on medicinally active compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 241-276. <a href="https://doi.org/10.1016/B978-0-12-819874-2.00008-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-819874-2.00008-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819874-2.00008-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819874-2.00008-4%26sid%3Dliteratum%253Aachs%26atitle%3DCurious%252Beffects%252Bof%252Bfluorine%252Bon%252Bmedicinally%252Bactive%252Bcompounds%26aulast%3DHonda%26aufirst%3DTadashi%26date%3D2021%26spage%3D241%26epage%3D276%26pub%3DElsevier%26atitle%3DThe%252BCurious%252BWorld%252Bof%252BFluorinated%252BMolecules%26date%3D2021%26volume%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Béla  Kiss</span>, <span class="hlFld-ContribAuthor ">István  Laszlovszky</span>, <span class="hlFld-ContribAuthor ">Balázs  Krámos</span>, <span class="hlFld-ContribAuthor ">András  Visegrády</span>, <span class="hlFld-ContribAuthor ">Amrita  Bobok</span>, <span class="hlFld-ContribAuthor ">György  Lévay</span>, <span class="hlFld-ContribAuthor ">Balázs  Lendvai</span>, <span class="hlFld-ContribAuthor ">Viktor  Román</span>. </span><span class="cited-content_cbyCitation_article-title">Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 104. <a href="https://doi.org/10.3390/biom11010104" title="DOI URL">https://doi.org/10.3390/biom11010104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11010104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11010104%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DNeuronal%252BDopamine%252BD3%252BReceptors%25253A%252BTranslational%252BImplications%252Bfor%252BPreclinical%252BResearch%252Band%252BCNS%252BDisorders%26aulast%3DKiss%26aufirst%3DB%25C3%25A9la%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine antagonists for the treatment of drug addiction: PF-4363467 and related compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 84-90. <a href="https://doi.org/10.5155/eurjchem.11.1.84-90.1970" title="DOI URL">https://doi.org/10.5155/eurjchem.11.1.84-90.1970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5155/eurjchem.11.1.84-90.1970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5155%2Feurjchem.11.1.84-90.1970%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Chemistry%26atitle%3DDopamine%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bdrug%252Baddiction%25253A%252BPF-4363467%252Band%252Brelated%252Bcompounds%26aulast%3DMartinez%26aufirst%3DAna%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D84%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Bree A.  Humburg</span>, <span class="hlFld-ContribAuthor ">Eric B.  Thorndike</span>, <span class="hlFld-ContribAuthor ">Anver Basha  Shaik</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, <span class="hlFld-ContribAuthor ">Michael H.  Baumann</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Charles W.  Schindler</span>. </span><span class="cited-content_cbyCitation_article-title">Newly Developed Dopamine D
              3
              Receptor Antagonists,
              R
              -VK4-40 and
              R
              -VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>371 </em>
                                    (3)
                                     , 602-614. <a href="https://doi.org/10.1124/jpet.119.259390" title="DOI URL">https://doi.org/10.1124/jpet.119.259390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.259390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.259390%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DNewly%252BDeveloped%252BDopamine%252BD%252B3%252BReceptor%252BAntagonists%25252C%252BR%252B-VK4-40%252Band%252BR%252B-VK4-116%25252C%252BDo%252BNot%252BPotentiate%252BCardiovascular%252BEffects%252Bof%252BCocaine%252Bor%252BOxycodone%252Bin%252BRats%26aulast%3DJordan%26aufirst%3DChloe%2BJ.%26date%3D2019%26date%3D2019%26volume%3D371%26issue%3D3%26spage%3D602%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Tadashi  Honda</span>, <span class="hlFld-ContribAuthor ">Lori  Fitz</span>, <span class="hlFld-ContribAuthor ">Iwao  Ojima</span>. </span><span class="cited-content_cbyCitation_article-title">Case studies of fluorine in drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 181-211. <a href="https://doi.org/10.1016/B978-0-12-812733-9.00004-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-812733-9.00004-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812733-9.00004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812733-9.00004-0%26sid%3Dliteratum%253Aachs%26atitle%3DCase%252Bstudies%252Bof%252Bfluorine%252Bin%252Bdrug%252Bdiscovery%26aulast%3DXing%26aufirst%3DLi%26date%3D2019%26spage%3D181%26epage%3D211%26pub%3DElsevier%26atitle%3DFluorine%252Bin%252BLife%252BSciences%25253A%252BPharmaceuticals%25252C%252BMedicinal%252BDiagnostics%25252C%252Band%252BAgrochemicals%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR studies on 1,2,4-triazolyl 5-azaspiro [2.4]-heptanes as D 3 R antagonists. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2018,</strong> <em>704 </em>, 11-20. <a href="https://doi.org/10.1016/j.cplett.2018.05.022" title="DOI URL">https://doi.org/10.1016/j.cplett.2018.05.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2018.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2018.05.022%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3D3D-QSAR%252Bstudies%252Bon%252B1%25252C2%25252C4-triazolyl%252B5-azaspiro%252B%25255B2.4%25255D-heptanes%252Bas%252BD%252B3%252BR%252Bantagonists%26aulast%3DZhang%26aufirst%3DXin%26date%3D2018%26volume%3D704%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel, Selective, and Developable Dopamine D
              3
              Antagonists with a Modified “Amino” Region. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (16)
                                     , 1254-1260. <a href="https://doi.org/10.1002/cmdc.201700148" title="DOI URL">https://doi.org/10.1002/cmdc.201700148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700148%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%25252C%252BSelective%25252C%252Band%252BDevelopable%252BDopamine%252BD%252B3%252BAntagonists%252Bwith%252Ba%252BModified%252B%2525E2%252580%25259CAmino%2525E2%252580%25259D%252BRegion%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D16%26spage%3D1254%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre  Sokoloff</span>, <span class="hlFld-ContribAuthor ">Bernard  Le Foll</span>, . </span><span class="cited-content_cbyCitation_article-title">The dopamine D3 receptor, a quarter century later. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Neuroscience</span><span> <strong>2017,</strong> <em>45 </em>
                                    (1)
                                     , 2-19. <a href="https://doi.org/10.1111/ejn.13390" title="DOI URL">https://doi.org/10.1111/ejn.13390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ejn.13390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fejn.13390%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Neuroscience%26atitle%3DThe%252Bdopamine%252BD3%252Breceptor%25252C%252Ba%252Bquarter%252Bcentury%252Blater%26aulast%3DSokoloff%26aufirst%3DPierre%26date%3D2017%26date%3D2016%26volume%3D45%26issue%3D1%26spage%3D2%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuele  Maramai</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Stefania  Butini</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00451" title="DOI URL">https://doi.org/10.3389/fnins.2016.00451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00451%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DDopamine%252BD3%252BReceptor%252BAntagonists%252Bas%252BPotential%252BTherapeutics%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurological%252BDiseases%26aulast%3DMaramai%26aufirst%3DSamuele%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoni  Cortés</span>, <span class="hlFld-ContribAuthor ">Estefanía  Moreno</span>, <span class="hlFld-ContribAuthor ">Mar  Rodríguez-Ruiz</span>, <span class="hlFld-ContribAuthor ">Enric I.  Canela</span>, <span class="hlFld-ContribAuthor ">Vicent  Casadó</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the dopamine D3 receptor: an overview of drug design strategies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , 641-664. <a href="https://doi.org/10.1080/17460441.2016.1185413" title="DOI URL">https://doi.org/10.1080/17460441.2016.1185413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1185413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1185413%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DTargeting%252Bthe%252Bdopamine%252BD3%252Breceptor%25253A%252Ban%252Boverview%252Bof%252Bdrug%252Bdesign%252Bstrategies%26aulast%3DCort%25C3%25A9s%26aufirst%3DAntoni%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D7%26spage%3D641%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Andrea  Bernardelli</span>, <span class="hlFld-ContribAuthor ">Federica  Bianchi</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Laura  Castelletti</span>, <span class="hlFld-ContribAuthor ">Palmina  Cavallini</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Susanna  Cremonesi</span>, <span class="hlFld-ContribAuthor ">Michele Dal  Cin</span>, <span class="hlFld-ContribAuthor ">Aldo  Feriani</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Teresa  Semeraro</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Tomelleri</span>, <span class="hlFld-ContribAuthor ">Andrea  Wong</span>, <span class="hlFld-ContribAuthor ">Filippo  Visentini</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span>, <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1619-1636. <a href="https://doi.org/10.1016/j.bmc.2016.02.031" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazolyl%252Boctahydropyrrolo%25255B2%25252C3-b%25255Dpyrroles%25253A%252BA%252Bnew%252Bseries%252Bof%252Bpotent%252Band%252Bselective%252Bdopamine%252BD3%252Breceptor%252Bantagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1619%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Susanna  Cremonesi</span>, <span class="hlFld-ContribAuthor ">Teresa  Semeraro</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Tomelleri</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Perdonà</span>, <span class="hlFld-ContribAuthor ">Anna  Sava</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span>, <span class="hlFld-ContribAuthor ">Aldo  Feriani</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>. </span><span class="cited-content_cbyCitation_article-title">Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (4)
                                     , 1329-1332. <a href="https://doi.org/10.1016/j.bmcl.2015.12.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bmorpholine%252Bscaffolds%252Bas%252Bselective%252Bdopamine%252B%252528DA%252529%252BD3%252Breceptor%252Bantagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1329%26epage%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan M.  Appel</span>, <span class="hlFld-ContribAuthor ">Shou-Hua  Li</span>, <span class="hlFld-ContribAuthor ">Tyson H.  Holmes</span>, <span class="hlFld-ContribAuthor ">Jane B.  Acri</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D
              3
              Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2015,</strong> <em>354 </em>
                                    (3)
                                     , 484-492. <a href="https://doi.org/10.1124/jpet.115.224121" title="DOI URL">https://doi.org/10.1124/jpet.115.224121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.115.224121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.115.224121%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DDopamine%252BD%252B3%252BReceptor%252BAntagonist%252B%252528GSK598809%252529%252BPotentiates%252Bthe%252BHypertensive%252BEffects%252Bof%252BCocaine%252Bin%252BConscious%25252C%252BFreely-Moving%252BDogs%26aulast%3DAppel%26aufirst%3DNathan%2BM.%26date%3D2015%26date%3D2015%26volume%3D354%26issue%3D3%26spage%3D484%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 290-333. <a href="https://doi.org/10.1002/9781118943670.refs" title="DOI URL">https://doi.org/10.1002/9781118943670.refs</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118943670.refs&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118943670.refs%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2014%26date%3D2014%26spage%3D290%26epage%3D333%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%252Bfor%252Bthe%252BTreatment%252Bof%252BAddiction%26aulast%3DFulton%26aufirst%3DBrian%2BS.%26date%3D2014%26volume%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-Heon  Song</span>. </span><span class="cited-content_cbyCitation_article-title">A Synthesis of Novel Sulfur-Linked Fused Thienotriazolopyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>58 </em>
                                    (4)
                                     , 423-427. <a href="https://doi.org/10.5012/jkcs.2014.58.4.423" title="DOI URL">https://doi.org/10.5012/jkcs.2014.58.4.423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/jkcs.2014.58.4.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fjkcs.2014.58.4.423%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DA%252BSynthesis%252Bof%252BNovel%252BSulfur-Linked%252BFused%252BThienotriazolopyrimidine%252BDerivatives%26aulast%3DSong%26aufirst%3DYang-Heon%26date%3D2014%26volume%3D58%26issue%3D4%26spage%3D423%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Massimo  Bani</span>, <span class="hlFld-ContribAuthor ">Anne  Andorn</span>, <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologically, are smokers the same as non-smokers?. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2014,</strong> <em>14 </em>, 42-49. <a href="https://doi.org/10.1016/j.coph.2013.11.003" title="DOI URL">https://doi.org/10.1016/j.coph.2013.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2013.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2013.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DPharmacologically%25252C%252Bare%252Bsmokers%252Bthe%252Bsame%252Bas%252Bnon-smokers%25253F%26aulast%3DBani%26aufirst%3DMassimo%26date%3D2014%26volume%3D14%26spage%3D42%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Caitlin  Burzynski</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond Small-Molecule SAR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 267-300. <a href="https://doi.org/10.1016/B978-0-12-420118-7.00007-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-420118-7.00007-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420118-7.00007-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420118-7.00007-X%26sid%3Dliteratum%253Aachs%26atitle%3DBeyond%252BSmall-Molecule%252BSAR%26aulast%3DKeck%26aufirst%3DThomas%2BM.%26date%3D2014%26spage%3D267%26epage%3D300%26pub%3DElsevier%26atitle%3DEmerging%252BTargets%252B%252526%252BTherapeutics%252Bin%252Bthe%252BTreatment%252Bof%252BPsychostimulant%252BAbuse%26date%3D2014%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neil E.  Paterson</span>, <span class="hlFld-ContribAuthor ">Frank  Vocci</span>, <span class="hlFld-ContribAuthor ">Rajkumar J.  Sevak</span>, <span class="hlFld-ContribAuthor ">Eric  Wagreich</span>, <span class="hlFld-ContribAuthor ">Edythe D.  London</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. </span><span class="cited-content_cbyCitation_journal-name">The American Journal of Drug and Alcohol Abuse</span><span> <strong>2014,</strong> <em>40 </em>
                                    (1)
                                     , 1-9. <a href="https://doi.org/10.3109/00952990.2013.858723" title="DOI URL">https://doi.org/10.3109/00952990.2013.858723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00952990.2013.858723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00952990.2013.858723%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520American%2520Journal%2520of%2520Drug%2520and%2520Alcohol%2520Abuse%26atitle%3DDopamine%252BD3%252Breceptors%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bmethamphetamine%252Bdependence%26aulast%3DPaterson%26aufirst%3DNeil%2BE.%26date%3D2014%26date%3D2013%26volume%3D40%26issue%3D1%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. A.  Rzhevskii</span>, <span class="hlFld-ContribAuthor ">N. P.  Gerasimova</span>, <span class="hlFld-ContribAuthor ">Zh. V.  Chirkova</span>, <span class="hlFld-ContribAuthor ">S. I.  Filimonov</span>, <span class="hlFld-ContribAuthor ">S. I.  Firgang</span>, <span class="hlFld-ContribAuthor ">G. A.  Stashina</span>, <span class="hlFld-ContribAuthor ">K. Yu.  Suponitsky</span>. </span><span class="cited-content_cbyCitation_article-title">Structure of reaction products of substituted [1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-ones with amines and hydrazines. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>49 </em>
                                    (11)
                                     , 1680-1685. <a href="https://doi.org/10.1134/S1070428013110201" title="DOI URL">https://doi.org/10.1134/S1070428013110201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428013110201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428013110201%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStructure%252Bof%252Breaction%252Bproducts%252Bof%252Bsubstituted%252B%25255B1%25252C3%25255Dthiazolo%25255B3%25252C2-b%25255D%25255B1%25252C2%25252C4%25255Dtriazol-6%2525285H%252529-ones%252Bwith%252Bamines%252Band%252Bhydrazines%26aulast%3DRzhevskii%26aufirst%3DA.%2BA.%26date%3D2013%26date%3D2013%26volume%3D49%26issue%3D11%26spage%3D1680%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Insua</span>, <span class="hlFld-ContribAuthor ">Mario  Alvarado</span>, <span class="hlFld-ContribAuthor ">Christian F.  Masaguer</span>, <span class="hlFld-ContribAuthor ">Alba  Iglesias</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">María I.  Loza</span>, <span class="hlFld-ContribAuthor ">Laura  Carro</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (20)
                                     , 5586-5591. <a href="https://doi.org/10.1016/j.bmcl.2013.08.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbinding%252Baffinity%252Bof%252Bnew%252B1%25252C4-disubstituted%252Btriazoles%252Bas%252Bpotential%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DInsua%26aufirst%3DIgnacio%26date%3D2013%26volume%3D23%26issue%3D20%26spage%3D5586%26epage%3D5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Du</span>, <span class="hlFld-ContribAuthor ">Lili  Xu</span>, <span class="hlFld-ContribAuthor ">Jiye  Huang</span>, <span class="hlFld-ContribAuthor ">Kunqian  Yu</span>, <span class="hlFld-ContribAuthor ">Rui  Zhao</span>, <span class="hlFld-ContribAuthor ">Bo  Gao</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Weili  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Indolebutylamines as a Novel Class of Selective Dopamine D3 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2013,</strong> <em>82 </em>
                                    (3)
                                     , 326-335. <a href="https://doi.org/10.1111/cbdd.12158" title="DOI URL">https://doi.org/10.1111/cbdd.12158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12158%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BIndolebutylamines%252Bas%252Ba%252BNovel%252BClass%252Bof%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%26aulast%3DDu%26aufirst%3DPeng%26date%3D2013%26date%3D2013%26volume%3D82%26issue%3D3%26spage%3D326%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerhard  Gross</span>, <span class="hlFld-ContribAuthor ">Karsten  Wicke</span>, <span class="hlFld-ContribAuthor ">Karla U.  Drescher</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Naunyn-Schmiedeberg's Archives of Pharmacology</span><span> <strong>2013,</strong> <em>386 </em>
                                    (2)
                                     , 155-166. <a href="https://doi.org/10.1007/s00210-012-0806-3" title="DOI URL">https://doi.org/10.1007/s00210-012-0806-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00210-012-0806-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00210-012-0806-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Archives%2520of%2520Pharmacology%26atitle%3DDopamine%252BD3%252Breceptor%252Bantagonism%2525E2%252580%252594still%252Ba%252Btherapeutic%252Boption%252Bfor%252Bthe%252Btreatment%252Bof%252Bschizophrenia%26aulast%3DGross%26aufirst%3DGerhard%26date%3D2013%26date%3D2012%26volume%3D386%26issue%3D2%26spage%3D155%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manolo  Mugnaini</span>, <span class="hlFld-ContribAuthor ">Laura  Iavarone</span>, <span class="hlFld-ContribAuthor ">Palmina  Cavallini</span>, <span class="hlFld-ContribAuthor ">Cristiana  Griffante</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Chiara  Savoia</span>, <span class="hlFld-ContribAuthor ">John  Beaver</span>, <span class="hlFld-ContribAuthor ">Eugenii A  Rabiner</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>, <span class="hlFld-ContribAuthor ">Anne  Andorn</span>, <span class="hlFld-ContribAuthor ">Emilio  Merlo Pich</span>, <span class="hlFld-ContribAuthor ">Massimo  Bani</span>. </span><span class="cited-content_cbyCitation_article-title">Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2013,</strong> <em>38 </em>
                                    (2)
                                     , 302-312. <a href="https://doi.org/10.1038/npp.2012.171" title="DOI URL">https://doi.org/10.1038/npp.2012.171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/npp.2012.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnpp.2012.171%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DOccupancy%252Bof%252BBrain%252BDopamine%252BD3%252BReceptors%252Band%252BDrug%252BCraving%25253A%252BA%252BTranslational%252BApproach%26aulast%3DMugnaini%26aufirst%3DManolo%26date%3D2013%26date%3D2012%26volume%3D38%26issue%3D2%26spage%3D302%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Altomonte</span>, <span class="hlFld-ContribAuthor ">Matteo  Zanda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic chemistry and biological activity of pentafluorosulphanyl (SF5) organic molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2012,</strong> <em>143 </em>, 57-93. <a href="https://doi.org/10.1016/j.jfluchem.2012.06.030" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2012.06.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2012.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2012.06.030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSynthetic%252Bchemistry%252Band%252Bbiological%252Bactivity%252Bof%252Bpentafluorosulphanyl%252B%252528SF5%252529%252Borganic%252Bmolecules%26aulast%3DAltomonte%26aufirst%3DStefano%26date%3D2012%26volume%3D143%26spage%3D57%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyong  Chen</span>, <span class="hlFld-ContribAuthor ">Beth  Levant</span>, <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">High-affinity and selective dopamine D3 receptor full agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5612-5617. <a href="https://doi.org/10.1016/j.bmcl.2012.07.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHigh-affinity%252Band%252Bselective%252Bdopamine%252BD3%252Breceptor%252Bfull%252Bagonists%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5612%26epage%3D5617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reet  Reinart-Okugbeni</span>, <span class="hlFld-ContribAuthor ">Kerti  Ausmees</span>, <span class="hlFld-ContribAuthor ">Kadri  Kriis</span>, <span class="hlFld-ContribAuthor ">Franz  Werner</span>, <span class="hlFld-ContribAuthor ">Ago  Rinken</span>, <span class="hlFld-ContribAuthor ">Tõnis  Kanger</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoenzymatic synthesis and evaluation of 3-azabicyclo[3.2.0]heptane derivatives as dopaminergic ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>, 255-261. <a href="https://doi.org/10.1016/j.ejmech.2012.07.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.07.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.07.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemoenzymatic%252Bsynthesis%252Band%252Bevaluation%252Bof%252B3-azabicyclo%25255B3.2.0%25255Dheptane%252Bderivatives%252Bas%252Bdopaminergic%252Bligands%26aulast%3DReinart-Okugbeni%26aufirst%3DReet%26date%3D2012%26volume%3D55%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Dopamine D3 Receptor Antagonists: a Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2011,</strong> <em>6 </em>
                                    (7)
                                     , 1152-1162. <a href="https://doi.org/10.1002/cmdc.201000538" title="DOI URL">https://doi.org/10.1002/cmdc.201000538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201000538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201000538%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BDopamine%2525E2%252580%252585D3%252BReceptor%252BAntagonists%25253A%252Ba%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2011%26date%3D2011%26volume%3D6%26issue%3D7%26spage%3D1152%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Ortega</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, <span class="hlFld-ContribAuthor ">Christian F.  Masaguer</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatic ring functionalization of benzolactam derivatives: New potent dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (9)
                                     , 2670-2674. <a href="https://doi.org/10.1016/j.bmcl.2010.12.083" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.12.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.12.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.12.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAromatic%252Bring%252Bfunctionalization%252Bof%252Bbenzolactam%252Bderivatives%25253A%252BNew%252Bpotent%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DOrtega%26aufirst%3DRaquel%26date%3D2011%26volume%3D21%26issue%3D9%26spage%3D2670%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Löber</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Nuska  Tschammer</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2011,</strong> <em>32 </em>
                                    (3)
                                     , 148-157. <a href="https://doi.org/10.1016/j.tips.2010.12.003" title="DOI URL">https://doi.org/10.1016/j.tips.2010.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2010.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2010.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsearch%252Bfor%252BD3-%252Band%252BD4-selective%252Bdrugs%25253A%252Bprobes%25252C%252Bmodels%252Band%252Bcandidates%26aulast%3DL%25C3%25B6ber%26aufirst%3DStefan%26date%3D2011%26volume%3D32%26issue%3D3%26spage%3D148%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">New and unusual scaffolds in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2011,</strong> <em>40 </em>
                                    (11)
                                     , 5514. <a href="https://doi.org/10.1039/c1cs15119c" title="DOI URL">https://doi.org/10.1039/c1cs15119c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1cs15119c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1cs15119c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DNew%252Band%252Bunusual%252Bscaffolds%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2011%26volume%3D40%26issue%3D11%26spage%3D5514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Dieter  Hamprecht</span>, <span class="hlFld-ContribAuthor ">Giorgio  Bonanomi</span>, <span class="hlFld-ContribAuthor ">Romano  Di Fabio</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Gabriella  Gentile</span>, <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>, <span class="hlFld-ContribAuthor ">Adolfo  Prandi</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Terreni</span>. </span><span class="cited-content_cbyCitation_article-title">[3-Azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (18)
                                     , 5491-5494. <a href="https://doi.org/10.1016/j.bmcl.2010.07.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.07.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.07.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.07.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%25255B3-Azabicyclo%25255B3.1.0%25255Dhex-1-yl%25255Dphenyl-benzenesulfonamides%252Bas%252Bselective%252Bdopamine%252BD3%252Bantagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2010%26volume%3D20%26issue%3D18%26spage%3D5491%26epage%3D5494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Daniele  Andreotti</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Anna  Checchia</span>. </span><span class="cited-content_cbyCitation_article-title">A specific and direct comparison of the trifluoromethyl and pentafluoro sulfanyl groups on the selective dopamine D3 antagonist 3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane template. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (15)
                                     , 4566-4568. <a href="https://doi.org/10.1016/j.bmcl.2010.06.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bspecific%252Band%252Bdirect%252Bcomparison%252Bof%252Bthe%252Btrifluoromethyl%252Band%252Bpentafluoro%252Bsulfanyl%252Bgroups%252Bon%252Bthe%252Bselective%252Bdopamine%252BD3%252Bantagonist%252B3-%2525283-%25257B%25255B4-methyl-5-%2525284-methyl-1%25252C3-oxazol-5-yl%252529-4H-1%25252C2%25252C4-triazol-3-yl%25255Dthio%25257Dpropyl%252529-1-phenyl-3-azabicyclo%25255B3.1.0%25255Dhexane%252Btemplate%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2010%26volume%3D20%26issue%3D15%26spage%3D4566%26epage%3D4568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giorgio  Bonanomi</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Capelli</span>, <span class="hlFld-ContribAuthor ">Anna  Checchia</span>, <span class="hlFld-ContribAuthor ">Romano  Di Fabio</span>, <span class="hlFld-ContribAuthor ">Carla  Marchioro</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Giovanna  Tedesco</span>, <span class="hlFld-ContribAuthor ">Silvia  Terreni</span>, <span class="hlFld-ContribAuthor ">Angela  Worby</span>, <span class="hlFld-ContribAuthor ">Christian  Heibreder</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolyl Azabicyclo[3.1.0]hexanes: a Class of Potent and Selective Dopamine D3 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (5)
                                     , 705-715. <a href="https://doi.org/10.1002/cmdc.201000026" title="DOI URL">https://doi.org/10.1002/cmdc.201000026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201000026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201000026%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTriazolyl%252BAzabicyclo%25255B3.1.0%25255Dhexanes%25253A%252Ba%252BClass%252Bof%252BPotent%252Band%252BSelective%252BDopamine%252BD3%252BReceptor%252BAntagonists%26aulast%3DBonanomi%26aufirst%3DGiorgio%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D5%26spage%3D705%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the previously reported GSK selective DA D<sub>3</sub> receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedures for the Preparation of Compounds <b>5</b>−<b>105</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) T3P in AcOEt; (ii) 4-methyl-3-thiosemicarbazide; (iii) NaOH; (iv) K<sub>2</sub>CO<sub>3</sub>/acetone; (v) K<sub>2</sub>CO<sub>3</sub>/DMF or CH<sub>3</sub>CN.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Relevant interactions of derivative <b>35</b> in docking to the DA D<sub>3</sub> receptor model. Portions of the backbone ribbon has been removed for clarity. (B) Interactions of compound <b>35</b> in the hERG channel models. The backbone ribbon of the pore domain is included but that of the S5 and S6 helices has been removed for clarity. For details about the modeling techniques, please refer to ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">7</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/medium/jm-2009-01319p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Pie chart for RG-R2 fragmentation. See text for a comprehensive explanation of the technique. (B) General trend of DA D3 fp<i>K</i><sub>i</sub> vs whole molecule lipophilicity expressed as ACD logD 7.4. Ver 11. Dots are color coded according to RG-R1: yellow, quinoline series (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>); blue, oxazolo series (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>); red, other substituents (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). (C) RG-R2 D-scores for hERG vs RG-R2 D-scores for D<sub>3</sub>. Labels beneath the substituents are respectively D-score hERG, D-score D<sub>3</sub>. RG-R2 groups positioned above the unity line have on average a greater effect on D<sub>3</sub> than on hERG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm901319p/production/images/large/jm-2009-01319p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901319p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z-X</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanos, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">The role of central DA D<sub>3</sub> receptors in drug addiction: a review of pharmacological evidence</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.1016%2Fj.brainresrev.2004.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=15960988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Ghu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=77-105&author=C.+A.+Heidbrederauthor=E.+L.+Gardnerauthor=Z-X+Xiauthor=P.+K.+Thanosauthor=M.+Mugnainiauthor=J.+J.+Haganauthor=C.+R.+Ashby&title=The+role+of+central+DA+D3+receptors+in+drug+addiction%3A+a+review+of+pharmacological+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence</span></div><div class="casAuthors">Heidbreder, Christian A.; Gardner, Eliot L.; Xi, Zheng-Xiong; Thanos, Panayotis K.; Mugnaini, Manolo; Hagan, Jim J.; Ashby, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-105</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cDNA for the dopamine D3 receptor was isolated and characterized in 1990.  Subsequent studies have indicated that D3 receptors, as well as D3 receptor mRNA, are primarily localized in limbic regions in mammals.  This finding led to the postulate that D3 receptors may be involved in drug dependence and addiction.  However, this hypothesis has been difficult to test due to the lack of compds. with high selectivity for central D3 receptors.  The interpretation of results from studies using mixed D2/D3 agonists and/or antagonists is problematic because these agents have low selectivity for D3 over D2 receptors and it is likely that their actions are primarily related to D2 receptor antagonism and possibly interaction with other neurotransmitter receptors.  Currently, with the synthesis and characterization of new highly selective D3 receptor antagonists such as SB-277011-A this difficulty has been surmounted.  The purpose of the present article is to review, for the first time, the effects of various putative D3 receptor selective compds. in animal models of drug dependence and addiction.  The results obtained with highly selective D3 receptor antagonists such as SB-277011-A, SB-414796, and NGB-2904 indicate that central D3 receptors may play an important role in drug-induced reward, drug-taking, and cue-, drug-, and stress-induced reinstatement of drug-seeking behavior.  Provided these results can be extrapolated to human drug addicts, they suggest that selective DA D3 receptor antagonists may prove effective as potential pharmacotherapeutic agents to manage drug dependence and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwzEJPprm60rVg90H21EOLACvtfcHk0lhpWeeLeJsEnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Ghu7k%253D&md5=3e5948e0f94515fd240d1e3d18812028</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2004.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2004.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DXi%26aufirst%3DZ-X%26aulast%3DThanos%26aufirst%3DP.%2BK.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3DThe%2520role%2520of%2520central%2520DA%2520D3%2520receptors%2520in%2520drug%2520addiction%253A%2520a%2520review%2520of%2520pharmacological%2520evidence%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D49%26spage%3D77%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Joyce, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">DA D3 receptor antagonists as therapeutic agents</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=917-925&author=J.+N.+Joyceauthor=M.+J.+Millan&title=DA+D3+receptor+antagonists+as+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDA%2520D3%2520receptor%2520antagonists%2520as%2520therapeutic%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D917%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective DA D3 receptor antagonists: A review 2001−2005</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=271-288&author=F.+Micheliauthor=C.+Heidbreder&title=Selective+DA+D3+receptor+antagonists%3A+A+review+2001%E2%88%922005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520DA%2520D3%2520receptor%2520antagonists%253A%2520A%2520review%25202001%25E2%2588%25922005%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D271%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">DA D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3663</span><span class="NLM_x">–</span> <span class="NLM_lpage">3679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040190e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3663-3679&author=A.+H.+Newmanauthor=P.+Grundtauthor=M.+A.+Nader&title=DA+D3+receptor+partial+agonists+and+antagonists+as+potential+drug+abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm040190e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040190e%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDA%2520D3%2520receptor%2520partial%2520agonists%2520and%2520antagonists%2520as%2520potential%2520drug%2520abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3663%26epage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span> </span><span class="NLM_article-title">Selective Dopamine D3 Receptor Antagonists; 1997−2007: A Decade of Progress</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.1517%2F13543776.18.8.821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlagsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=821-840&author=F.+Micheliauthor=C.+A.+Heidbreder&title=Selective+Dopamine+D3+Receptor+Antagonists%3B+1997%E2%88%922007%3A+A+Decade+of+Progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective dopamine D3 receptor antagonists. A decade of progress: 1997 - 2007</span></div><div class="casAuthors">Micheli, Fabrizio; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">821-840</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: A growing no. of patent applications on dopamine (DA) D3 receptors have been filed over the last 10 years.  The increased interest in this target correlates with evidence that implicates the DA D3 receptor in the control of drug-seeking behavior and in the pathophysiol. of some impulse control disorders and schizophrenia.  Objectives: This manuscript provides an overview of the most recent literature in support of the biol. rationale for the use of selective DA D3 receptor antagonists for neuropsychiatric indications, and reviews > 80 patents that reflect 10-yr advances in the discovery of these compds. by pharmaceutical companies, national research institutes and academic groups.  Methods: Anal. of > 100 primary literature and 80 patent refs. of the last 10 years.  Conclusions: The recent synthesis and profiling of new highly potent and selective DA D3 receptor antagonists over the last 10 years has permitted the testing of these compds. in a wide range of preclin. animal models of neuropsychiatric diseases.  Clin. trials have now been initiated and clin. proof-of-concept is expected in the forthcoming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosoJQzC1c8ALVg90H21EOLACvtfcHk0lhGn44I3X7wxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlagsb0%253D&md5=aba421201368477a4e3c9961a31305f9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.8.821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.8.821%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26atitle%3DSelective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%253B%25201997%25E2%2588%25922007%253A%2520A%2520Decade%2520of%2520Progress%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D821%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span> <span class="citation_source-journal">CNS Neurol. Disord. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.2174%2F187152708786927822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=19128200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=410-421&author=C.+Heidbreder&title=Selective+antagonism+at+dopamine+D3+receptors+as+a+target+for+drug+addiction+pharmacotherapy%3A+a+review+of+preclinical+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span></div><div class="casAuthors">Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-421</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The focal distribution of the dopamine (DA) D3 receptor in brain regions implicated in emotional and cognitive functions has made this target a main focus of drug discovery efforts.  This paper will review the most recent lines of research in support of the use of selective DA D3 receptor antagonists for the pharmacotherapeutic management of drug addiction: (1) expression of the DA D3 receptor in the rodent and human brain; (2) changes in expression of the DA D3 receptor following exposure to drugs of abuse, and (3) efficacy of selective DA D3 receptor antagonists in preclin. paradigms assessing the behavioral effects of drugs such as cocaine, nicotine, alc., methamphetamine, and heroin.  This manuscript, however, will not review the effects of nonselective DA D2/D3 receptor antagonists or partial D3 receptor agonists.  Growing evidence suggests that selective DA D3 receptor antagonists do not affect the primary reinforcing effects of drugs of abuse, but rather seem to regulate the motivation to self-administer drugs under schedules of reinforcement that require an increase in work demand.  In addn., selective antagonism at DA D3 receptors appears to disrupt significantly the responsiveness to drug-assocd. stimuli that play a key role in reinstatement of drug-seeking behavior.  These preclin. findings will be discussed in the context of translational research relevant to the design of early clin. trials and hypothesis testing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcM0jWAd6GHrVg90H21EOLACvtfcHk0lhGn44I3X7wxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D&md5=8f187ba70d486dc49f745562fe3f9408</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F187152708786927822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927822%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520antagonism%2520at%2520dopamine%2520D3%2520receptors%2520as%2520a%2520target%2520for%2520drug%2520addiction%2520pharmacotherapy%253A%2520a%2520review%2520of%2520preclinical%2520evidence%26jtitle%3DCNS%2520Neurol.%2520Disord.%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D410%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curcuruto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di-Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarsi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecoraro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perini, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valerio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacroix, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D3 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5076</span><span class="NLM_x">–</span> <span class="NLM_lpage">5089</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0705612" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5076-5089&author=F.+Micheliauthor=G.+Bonanomiauthor=F.+E.+Blaneyauthor=S.+Braggioauthor=A.+M.+Capelliauthor=A.+Checchiaauthor=O.+Curcurutoauthor=F.+Damianiauthor=R.+Di-Fabioauthor=D.+Donatiauthor=G.+Gentileauthor=A.+Gribbleauthor=D.+Hamprechtauthor=G.+Tedescoauthor=S.+Terreniauthor=L.+Tarsiauthor=A.+Lightfootauthor=M.+Pecoraroauthor=M.+Petroneauthor=O.+Periniauthor=J.+Pinerauthor=T.+Rossiauthor=A.+Worbyauthor=M.+Pillaauthor=E.+Valerioauthor=C.+Griffanteauthor=M.+Mugnainiauthor=M.+Woodauthor=C.+Scottauthor=M.+Andreoliauthor=L.+Lacroixauthor=A.+Schwarzauthor=A.+Gozziauthor=A.+Bifoneauthor=C.+R.+Ashbyauthor=J.+J.+Haganauthor=C.+Heidbreder&title=1%2C2%2C4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines%3A+a+series+of+potent+and+selective+dopamine+D3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0705612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705612%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DChecchia%26aufirst%3DA.%26aulast%3DCurcuruto%26aufirst%3DO.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi-Fabio%26aufirst%3DR.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DGribble%26aufirst%3DA.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DLightfoot%26aufirst%3DA.%26aulast%3DPecoraro%26aufirst%3DM.%26aulast%3DPetrone%26aufirst%3DM.%26aulast%3DPerini%26aufirst%3DO.%26aulast%3DPiner%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DT.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DPilla%26aufirst%3DM.%26aulast%3DValerio%26aufirst%3DE.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DScott%26aufirst%3DC.%26aulast%3DAndreoli%26aufirst%3DM.%26aulast%3DLacroix%26aufirst%3DL.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DGozzi%26aufirst%3DA.%26aulast%3DBifone%26aufirst%3DA.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines%253A%2520a%2520series%2520of%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5076%26epage%3D5089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celestini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagliardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">New fused benzazepine as selective D<sub>3</sub> receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=901-907&author=F.+Micheliauthor=G.+Bonanomiauthor=S.+Braggioauthor=A.+M.+Capelliauthor=P.+Celestiniauthor=F.+Damianiauthor=R.+Di+Fabioauthor=D.+Donatiauthor=S.+Gagliardiauthor=G.+Gentileauthor=D.+Hamprechtauthor=M.+Petroneauthor=S.+Radaelliauthor=G.+Tedescoauthor=S.+Terreniauthor=A.+Worbyauthor=C.+Heidbreder&title=New+fused+benzazepine+as+selective+D3+receptor+antagonists.+Synthesis+and+biological+evaluation.+Part+one%3A+%5Bh%5D-fused+tricyclic+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DCelestini%26aufirst%3DP.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGagliardi%26aufirst%3DS.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DPetrone%26aufirst%3DM.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DNew%2520fused%2520benzazepine%2520as%2520selective%2520D3%2520receptor%2520antagonists.%2520Synthesis%2520and%2520biological%2520evaluation.%2520Part%2520one%253A%2520%255Bh%255D-fused%2520tricyclic%2520systems%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D901%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celestini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagliardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perini, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">New fused benzazepine as selective D<sub>3</sub> receptor antagonists. Synthesis and biological evaluation. Part two: [g]-fused and hetero fused systems</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=908-912&author=F.+Micheliauthor=G.+Bonanomiauthor=S.+Braggioauthor=A.+M.+Capelliauthor=P.+Celestiniauthor=F.+Damianiauthor=R.+Di+Fabioauthor=D.+Donatiauthor=S.+Gagliardiauthor=G.+Gentileauthor=D.+Hamprechtauthor=O.+Periniauthor=M.+Petroneauthor=S.+Radaelliauthor=G.+Tedescoauthor=S.+Terreniauthor=A.+Worbyauthor=C.+Heidbreder&title=New+fused+benzazepine+as+selective+D3+receptor+antagonists.+Synthesis+and+biological+evaluation.+Part+two%3A+%5Bg%5D-fused+and+hetero+fused+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DCelestini%26aufirst%3DP.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGagliardi%26aufirst%3DS.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DPerini%26aufirst%3DO.%26aulast%3DPetrone%26aufirst%3DM.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DNew%2520fused%2520benzazepine%2520as%2520selective%2520D3%2520receptor%2520antagonists.%2520Synthesis%2520and%2520biological%2520evaluation.%2520Part%2520two%253A%2520%255Bg%255D-fused%2520and%2520hetero%2520fused%2520systems%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D908%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bonanomi, G.; Checchia, A.; Fazzolari, E.; Hamprecht, D.; Micheli, F.; Tarsi, L.; Terreni, S.</span><span> </span><span class="NLM_article-title">3-(1,2,4-Triazol-3-ylalkyl) azabiciclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors</span>. Patent WO 2006108701,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=G.+Bonanomi&author=A.+Checchia&author=E.+Fazzolari&author=D.+Hamprecht&author=F.+Micheli&author=L.+Tarsi&author=S.+Terreni&title=3-%281%2C2%2C4-Triazol-3-ylalkyl%29+azabiciclo+%5B3.1.0%5D+hexane+derivatives+as+modulators+of+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonanomi%26aufirst%3DG.%26atitle%3D3-%25281%252C2%252C4-Triazol-3-ylalkyl%2529%2520azabiciclo%2520%255B3.1.0%255D%2520hexane%2520derivatives%2520as%2520modulators%2520of%2520dopamine%2520D3%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Arista, L.; Cardullo, F.; Checchia, A.; Hamprecht, D.; Micheli, F.; Tedesco, G.; Terreni, S..</span><span> </span><span class="NLM_article-title">Preparation of 3-azabicyclo[3.1.0]hexanes as selective modulators of dopamine D3 receptors</span>. Patent WO 2006133946,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=L.+Arista&author=F.+Cardullo&author=A.+Checchia&author=D.+Hamprecht&author=F.+Micheli&author=G.+Tedesco&author=S..+Terreni&title=Preparation+of+3-azabicyclo%5B3.1.0%5Dhexanes+as+selective+modulators+of+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArista%26aufirst%3DL.%26atitle%3DPreparation%2520of%25203-azabicyclo%255B3.1.0%255Dhexanes%2520as%2520selective%2520modulators%2520of%2520dopamine%2520D3%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">The research complied with national legislation and with company policy on the Care and Use of Animals and with related codes of practice.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Atkinson, F.; Bravi, G.</span>The SAR Toolkit, <span class="NLM_conf-name">UK-QSAR and ChemoInformatics Group Meeting</span>, <span class="NLM_conf-date">October 2007</span>; Abstract (<a href="http://www.iainm.demon.co.uk/ukqsar/meetings/2007-10-11.html#abstract_e013ca26c3a3c590184b907a3d2668c2" class="extLink">http://www.iainm.demon.co.uk/ukqsar/meetings/2007-10-11.html#abstract_e013ca26c3a3c590184b907a3d2668c2</a>) and presentation (<a href="http://www.documentarea.com/qsar/Francis_Atkinson07.pdf" class="extLink">http://www.documentarea.com/qsar/Francis_Atkinson07.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Atkinson%2C+F.%3B+Bravi%2C+G.The+SAR+Toolkit%2C+UK-QSAR+and+ChemoInformatics+Group+Meeting%2C+October+2007%3B+Abstract+%28http%3A%2F%2Fwww.iainm.demon.co.uk%2Fukqsar%2Fmeetings%2F2007-10-11.html%23abstract_e013ca26c3a3c590184b907a3d2668c2%29+and+presentation+%28http%3A%2F%2Fwww.documentarea.com%2Fqsar%2FFrancis_Atkinson07.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DF.%26jtitle%3DThe%2520SAR%2520Toolkit" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Daylight v4.92; <span class="NLM_publisher-name">Chemical Information Systems Inc.</span>: <span class="NLM_publisher-loc">Aliso Viejo, CA</span>, <a href="http://www.daylight.com" class="extLink">http://www.daylight.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Daylight+v4.92%3B+Chemical+Information+Systems+Inc.%3A+Aliso+Viejo%2C+CA%2C+http%3A%2F%2Fwww.daylight.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDaylight%2520v4.92%26pub%3DChemical%2520Information%2520Systems%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>Spotfire Decision Site 8.2.1; available from <a href="http://www.spotfire.com/" class="extLink">http://www.spotfire.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Spotfire+Decision+Site+8.2.1%3B+available+from+http%3A%2F%2Fwww.spotfire.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DSpotfire%2520Decision%2520Site%25208.2.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_publisher-name">Aptuit Limited</span>, <span class="NLM_publisher-loc">3 Simpson Parkway, Livingston,West Lothian, EH54 7BH, Scotland</span>, <a href="http://www.aptuit.uk" class="extLink">www.aptuit.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aptuit+Limited%2C+3+Simpson+Parkway%2C+Livingston%2CWest+Lothian%2C+EH54+7BH%2C+Scotland%2C+www.aptuit.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DAptuit%2520Limited" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">A structural basis for drug-induced long QT syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci.U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">12329</span><span class="NLM_x">–</span> <span class="NLM_lpage">12333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901319p&amp;key=10.1073%2Fpnas.210244497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=11005845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=12329-12333&author=J.+S.+Mitchesonauthor=J.+Chenauthor=M.+Linauthor=C.+Culbersonauthor=M.+C.+Sanguinetti&title=A+structural+basis+for+drug-induced+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A structural basis for drug-induced long QT syndrome</span></div><div class="casAuthors">Mitcheson, John S.; Chen, Jun; Lin, Monica; Culberson, Chris; Sanguinetti, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12329-12333</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the HERG K+ channel gene cause inherited long QT syndrome (LQT), a disorder of cardiac repolarization that predisposes affected individuals to lethal arrhythmias.  Acquired LQT is far more common and is most often caused by block of cardiac HERG K+ channels by commonly used medications.  It is unclear why so many structurally diverse compds. block HERG channels, but this undesirable side effect now is recognized as a major hurdle in the development of new and safe drugs.  Here we use alanine-scanning mutagenesis to det. the structural basis for high-affinity drug block of HERG channels by MK-499, a methanesulfonanilide antiarrhythmic drug.  The binding site, corroborated with homol. modeling, is comprised of amino acids located on the S6 transmembrane domain (G648, Y652, and F656) and pore helix (T623 and V625) of the HERG channel subunit that face the cavity of the channel.  Other compds. that are structurally unrelated to MK-499, but cause LQT, also were studied.  The antihistamine terfenadine and a gastrointestinal prokinetic drug, cisapride, interact with Y652 and F656, but not with V625.  The arom. residues of the S6 domain that interact with these drugs (Y652 and F656) are unique to eag/erg K+ channels.  Other voltage-gated K+ (Kv) channels have lle and Val (lle) in the equiv. positions.  These findings suggest a possible structural explanation for how so many commonly used medications block HERG but not other Kv channels and should facilitate the rational design of drugs devoid of HERG channel binding activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczBuinwjCZrVg90H21EOLACvtfcHk0ljreJrGyWay2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D&md5=595505ebd987ee7a4af280016c03ea35</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.210244497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.210244497%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DA%2520structural%2520basis%2520for%2520drug-induced%2520long%2520QT%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.U.S.A.%26date%3D2000%26volume%3D97%26spage%3D12329%26epage%3D12333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug-hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-124&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug-hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug-hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_publisher-name">CERB</span>, <span class="NLM_publisher-loc">Chemin de Montifault, 18800 Baugy, France</span><a href="http://www.cerb.fr" class="extLink">www.cerb.fr</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CERB%2C+Chemin+de+Montifault%2C+18800+Baugy%2C+Francewww.cerb.fr."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DCERB" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Burris, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filtz, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumpradit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulon, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinoff, P. B.</span><span> </span><span class="NLM_article-title">Characterization of [<sup>125</sup>I](<i>R</i>)-<i>trans</i>-7-hydroxy-2-[<i>N</i>-propyl-<i>N</i>-(3′-iodo-2′-propenyl)amino] tetralin binding to dopamine D<sub>3</sub> receptors in rat olfactory tubercle</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901319p&amp;key=8114008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901319p&amp;key=1%3ACAS%3A528%3ADyaK2cXitVynu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1994&pages=935-942&author=K.+D.+Burrisauthor=T.+M.+Filtzauthor=S.+Chumpraditauthor=M.+P.+Kungauthor=C+Foulonauthor=J.+G.+Henslerauthor=H.+F.+Kungauthor=P.+B.+Molinoff&title=Characterization+of+%5B125I%5D%28R%29-trans-7-hydroxy-2-%5BN-propyl-N-%283%E2%80%B2-iodo-2%E2%80%B2-propenyl%29amino%5D+tetralin+binding+to+dopamine+D3+receptors+in+rat+olfactory+tubercle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin binding to dopamine D3 receptors in rat olfactory tubercle</span></div><div class="casAuthors">Burris, Kevin D.; Filtz, Theresa M.; Chumpradit, Sumalee; Kung, Mei Ping; Foulon, Catherine; Hensler, Julie G.; Kung, Hank F.; Molinoff, Perry B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">935-42</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">[125I](R,S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin {[125I](R,S)-trans-7-OH-PIPAT} has been shown to bind with high affinity to dopamine D3 receptors expressed in Spodoptera frugiperda cells.  No specific binding was seen in S. frugiperda cells expressing a high d. of D2 receptors.  It was therefore, suggested that [125I](R,S)-trans-7-OH-PIPAT selectively labels D3 receptors.  In the present study, satn. binding of [125I](R)-trans-7-OH-PIPAT to membranes from rat olfactory tubercle resulted in markedly curvilinear Scatchard plots, suggesting that the radioligand was binding to more than one receptor class or affinity state.  [125I](R)-trans-7-OH-PIPAT bound with high affinity to membranes from human embryonic kidney-293 cells expressing transfected D2 or D3 receptors and to membranes from Chinese hamster ovary cells expressing serotonin1A receptors.  Binding of [125I](R)-trans-7-OH-PIPAT to serotonin1A and D2 receptors was decreased or eliminated in the presence of NaCl and/or guanylylimidodiphosphate [Gpp(NH)p].  In the presence of Gpp(NH)p and NaCl, a linear Scatchard plot with a Kd value of 0.4 nM and a d. of 100 fmol/mg of protein was obtained in membranes from rat olfactory tubercle.  Agonists and antagonists inhibited binding of [125I](R)-trans-7-OH-PIPAt with a rank order of potency consistent with an interaction at D3 receptors.  These results suggest that, in the presence of Gpp(NH)p and NaCl, [125I](R)-trans-7-OH-PIPAT specifically labels D3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-V0z3zdC1jbVg90H21EOLACvtfcHk0ljRMl1rYV3gqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitVynu7w%253D&md5=5b4a38e09888fe1b2c5b742ee445901e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DK.%2BD.%26aulast%3DFiltz%26aufirst%3DT.%2BM.%26aulast%3DChumpradit%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DFoulon%26aufirst%3DC%26aulast%3DHensler%26aufirst%3DJ.%2BG.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DMolinoff%26aufirst%3DP.%2BB.%26atitle%3DCharacterization%2520of%2520%255B125I%255D%2528R%2529-trans-7-hydroxy-2-%255BN-propyl-N-%25283%25E2%2580%25B2-iodo-2%25E2%2580%25B2-propenyl%2529amino%255D%2520tetralin%2520binding%2520to%2520dopamine%2520D3%2520receptors%2520in%2520rat%2520olfactory%2520tubercle%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D268%26spage%3D935%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dewey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerasimov, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">A pharmacologic strategy for the treatment of nicotine addiction</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1999&pages=76-86&author=S.+L.+Deweyauthor=J.+D.+Brodieauthor=M+Gerasimovauthor=B+Horanauthor=E.+L.+Gardnerauthor=C.+R.+Ashby&title=A+pharmacologic+strategy+for+the+treatment+of+nicotine+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDewey%26aufirst%3DS.%2BL.%26aulast%3DBrodie%26aufirst%3DJ.%2BD.%26aulast%3DGerasimov%26aufirst%3DM%26aulast%3DHoran%26aufirst%3DB%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3DA%2520pharmacologic%2520strategy%2520for%2520the%2520treatment%2520of%2520nicotine%2520addiction%26jtitle%3DSynapse%26date%3D1999%26volume%3D31%26spage%3D76%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Horan, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepore, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">(−)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1997&pages=93-94&author=B+Horanauthor=M+Smithauthor=E.+L.+Gardnerauthor=M+Leporeauthor=C.+R.+Ashby&title=%28%E2%88%92%29-Nicotine+produces+conditioned+place+preference+in+Lewis%2C+but+not+Fischer+344+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DB%26aulast%3DSmith%26aufirst%3DM%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DLepore%26aufirst%3DM%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3D%2528%25E2%2588%2592%2529-Nicotine%2520produces%2520conditioned%2520place%2520preference%2520in%2520Lewis%252C%2520but%2520not%2520Fischer%2520344%2520rats%26jtitle%3DSynapse%26date%3D1997%26volume%3D26%26spage%3D93%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Horan, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodie, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (−)-nicotine in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">R1</span><span class="NLM_x">–</span> <span class="NLM_lpage">R2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2001&pages=R1-R2&author=B+Horanauthor=E.+L.+Gardnerauthor=S.+L.+Deweyauthor=J.+D.+Brodieauthor=C.+R.+Ashby&title=The+selective+sigma%281%29+receptor+agonist%2C+1-%283%2C4-dimethoxyphenethyl%29-4-%28phenylpropyl%29piperazine+%28SA4503%29%2C+blocks+the+acquisition+of+the+conditioned+place+preference+response+to+%28%E2%88%92%29-nicotine+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DB%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DDewey%26aufirst%3DS.%2BL.%26aulast%3DBrodie%26aufirst%3DJ.%2BD.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26atitle%3DThe%2520selective%2520sigma%25281%2529%2520receptor%2520agonist%252C%25201-%25283%252C4-dimethoxyphenethyl%2529-4-%2528phenylpropyl%2529piperazine%2520%2528SA4503%2529%252C%2520blocks%2520the%2520acquisition%2520of%2520the%2520conditioned%2520place%2520preference%2520response%2520to%2520%2528%25E2%2588%2592%2529-nicotine%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D426%26spage%3DR1%26epage%3DR2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kaab, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuckelmann, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, G. F.</span><span> </span><span class="NLM_article-title">Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=1383-1393&author=S.+Kaabauthor=J.+Dixonauthor=J.+Ducauthor=D.+Ashenauthor=M.+Nabauerauthor=D.+J.+Beuckelmannauthor=G.+Steinbeckauthor=D.+McKinnonauthor=G.+F.+Tomaselli&title=Molecular+basis+of+transient+outward+potassium+current+downregulation+in+human+heart+failure%3A+a+decrease+in+Kv4.3+mRNA+correlates+with+a+reduction+in+current+density"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaab%26aufirst%3DS.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DDuc%26aufirst%3DJ.%26aulast%3DAshen%26aufirst%3DD.%26aulast%3DNabauer%26aufirst%3DM.%26aulast%3DBeuckelmann%26aufirst%3DD.%2BJ.%26aulast%3DSteinbeck%26aufirst%3DG.%26aulast%3DMcKinnon%26aufirst%3DD.%26aulast%3DTomaselli%26aufirst%3DG.%2BF.%26atitle%3DMolecular%2520basis%2520of%2520transient%2520outward%2520potassium%2520current%2520downregulation%2520in%2520human%2520heart%2520failure%253A%2520a%2520decrease%2520in%2520Kv4.3%2520mRNA%2520correlates%2520with%2520a%2520reduction%2520in%2520current%2520density%26jtitle%3DCirculation%26date%3D1998%26volume%3D98%26spage%3D1383%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Torres, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursill, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauskin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewood, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuchel, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, J. I.</span><span> </span><span class="NLM_article-title">Structure of the HERG K<sup>+</sup> Channel S5P Extracellular Linker: Role of an Amphipathic alpha-Helix in C-Type Inactivation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">42136</span><span class="NLM_x">–</span> <span class="NLM_lpage">42148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=42136-42148&author=A.+M.+Torresauthor=P.+S.+Bansalauthor=M.+Sundeauthor=C.+E.+Clarkeauthor=J.+A.+Bursillauthor=D.+J.+Smithauthor=A.+Bauskinauthor=S.+N.+Breitauthor=T.+J.+Campbellauthor=P.+F.+Alewoodauthor=P.+W.+Kuchelauthor=J.+I.+Vandenberg&title=Structure+of+the+HERG+K%2B+Channel+S5P+Extracellular+Linker%3A+Role+of+an+Amphipathic+alpha-Helix+in+C-Type+Inactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DA.%2BM.%26aulast%3DBansal%26aufirst%3DP.%2BS.%26aulast%3DSunde%26aufirst%3DM.%26aulast%3DClarke%26aufirst%3DC.%2BE.%26aulast%3DBursill%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BJ.%26aulast%3DBauskin%26aufirst%3DA.%26aulast%3DBreit%26aufirst%3DS.%2BN.%26aulast%3DCampbell%26aufirst%3DT.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26aulast%3DKuchel%26aufirst%3DP.%2BW.%26aulast%3DVandenberg%26aufirst%3DJ.%2BI.%26atitle%3DStructure%2520of%2520the%2520HERG%2520K%252B%2520Channel%2520S5P%2520Extracellular%2520Linker%253A%2520Role%2520of%2520an%2520Amphipathic%2520alpha-Helix%2520in%2520C-Type%2520Inactivation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D42136%26epage%3D42148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><a href="http://www.accelrys.com" class="extLink">www.accelrys.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.accelrys.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Magis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Du, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charbonnier, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulain, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuniasse, P.</span><span> </span><span class="NLM_article-title">Structure-Based Secondary Structure-Independent Approach To Design Protein Ligands: Application to the Design of Kv1..2 Potassium Channel Blockers</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">16190</span><span class="NLM_x">–</span> <span class="NLM_lpage">16205</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0646491" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=16190-16205&author=C.+Magisauthor=D.+Gaspariniauthor=A.+Lecoqauthor=M.+H.+Le+Duauthor=E.+Sturaauthor=J.+B.+Charbonnierauthor=G.+Mourierauthor=J.-C.+Boulainauthor=L.+Pardoauthor=A.+Caruanaauthor=A.+Jolyauthor=M.+Lefrancauthor=M.+Masellaauthor=A.+Menezauthor=P.+Cuniasse&title=Structure-Based+Secondary+Structure-Independent+Approach+To+Design+Protein+Ligands%3A+Application+to+the+Design+of+Kv1..2+Potassium+Channel+Blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja0646491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0646491%26sid%3Dliteratum%253Aachs%26aulast%3DMagis%26aufirst%3DC.%26aulast%3DGasparini%26aufirst%3DD.%26aulast%3DLecoq%26aufirst%3DA.%26aulast%3DLe%2BDu%26aufirst%3DM.%2BH.%26aulast%3DStura%26aufirst%3DE.%26aulast%3DCharbonnier%26aufirst%3DJ.%2BB.%26aulast%3DMourier%26aufirst%3DG.%26aulast%3DBoulain%26aufirst%3DJ.-C.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DCaruana%26aufirst%3DA.%26aulast%3DJoly%26aufirst%3DA.%26aulast%3DLefranc%26aufirst%3DM.%26aulast%3DMasella%26aufirst%3DM.%26aulast%3DMenez%26aufirst%3DA.%26aulast%3DCuniasse%26aufirst%3DP.%26atitle%3DStructure-Based%2520Secondary%2520Structure-Independent%2520Approach%2520To%2520Design%2520Protein%2520Ligands%253A%2520Application%2520to%2520the%2520Design%2520of%2520Kv1..2%2520Potassium%2520Channel%2520Blockers%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D16190%26epage%3D16205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Blaney, F. E.; Tennant, M.</span><span class="NLM_x"> (</span><span class="NLM_year">1996</span><span class="NLM_x">) </span><span> </span><span class="NLM_article-title">Computational tools and results in the construction of G protein-coupled receptor models</span>. In  <span class="citation_source-book">Membrane Protein Models</span>; <span class="NLM_contrib-group">Findlay, J. B. C.</span>, Ed.; <span class="NLM_publisher-name">Bios Scientific Publishers Ltd.</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">161</span>− <span class="NLM_lpage">176</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=161-176&author=F.+E.+Blaney&author=M.+Tennantauthor=J.+B.+C.+Findlay&title=Membrane+Protein+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26date%3D1996%26atitle%3DComputational%2520tools%2520and%2520results%2520in%2520the%2520construction%2520of%2520G%2520protein-coupled%2520receptor%2520models%26btitle%3DMembrane%2520Protein%2520Models%26aulast%3DFindlay%26aufirst%3DJ.%2BB.%2BC.%26pub%3DBios%2520Scientific%2520Publishers%2520Ltd%26date%3D1996%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Polczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of rhodopsin: a G protein-coupled receptor</span>.  <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span>− <span class="NLM_lpage">745</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=739-745&author=K.+Polczewski&author=T.+Kumasaka&author=T.+Hori&author=C.+A.+Behnke&author=H.+Motoshima&author=B.+A.+Fox&author=I.+Le+Trong&author=D.+C.+Teller&author=T.+Okada&author=R.+E.+Stenkamp&author=M.+Yamamoto&author=M.+Miyano&title=Crystal+structure+of+rhodopsin%3A+a+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolczewski%26aufirst%3DK.%26atitle%3DCrystal%2520structure%2520of%2520rhodopsin%253A%2520a%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A..</span><span> </span><span class="NLM_article-title">The First Transmembrane Segment of the Dopamine D2 Receptor: Accessibility in the Binding-Site Crevice and Position in the Transmembrane Bundle</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">12339</span><span class="NLM_x">–</span> <span class="NLM_lpage">12348</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi011204a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=12339-12348&author=L.+Shiauthor=M.+M.+Simpsonauthor=J.+A.+Ballesterosauthor=J.+A..+Javitch&title=The+First+Transmembrane+Segment+of+the+Dopamine+D2+Receptor%3A+Accessibility+in+the+Binding-Site+Crevice+and+Position+in+the+Transmembrane+Bundle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi011204a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011204a%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSimpson%26aufirst%3DM.%2BM.%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DJavitch%26aufirst%3DJ.%2BA..%26atitle%3DThe%2520First%2520Transmembrane%2520Segment%2520of%2520the%2520Dopamine%2520D2%2520Receptor%253A%2520Accessibility%2520in%2520the%2520Binding-Site%2520Crevice%2520and%2520Position%2520in%2520the%2520Transmembrane%2520Bundle%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D12339%26epage%3D12348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><a href="http://www.openmopac.com" class="extLink">www.openmopac.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.openmopac.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901319p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm901319p%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-1" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901319p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c0209afb3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
